0001062993-22-015697.txt : 20220701 0001062993-22-015697.hdr.sgml : 20220701 20220630201007 ACCESSION NUMBER: 0001062993-22-015697 CONFORMED SUBMISSION TYPE: 1-A/A PUBLIC DOCUMENT COUNT: 14 FILED AS OF DATE: 20220701 DATE AS OF CHANGE: 20220630 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Naqi Logix Inc. CENTRAL INDEX KEY: 0001902337 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 1-A/A SEC ACT: 1933 Act SEC FILE NUMBER: 024-11841 FILM NUMBER: 221059226 BUSINESS ADDRESS: STREET 1: 1400-1040 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 4H1 BUSINESS PHONE: 604-803-4940 MAIL ADDRESS: STREET 1: 1400-1040 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 4H1 1-A/A 1 primary_doc.xml 1-A/A LIVE 0001902337 XXXXXXXX 024-11841 false false false Naqi Logix Inc. A1 2020 0001902337 3600 00-0000000 1 0 1400-1040 WEST GEORGIA STREET VANCOUVER A1 V6E 4H1 1-888-627-4564 Daniel Nauth Other 1112045.00 0.00 8800.00 673300.00 1794145.00 542755.00 0.00 542755.00 1251390.00 1794145.00 0.00 719027.00 0.00 719027.00 -0.05 -0.05 BDO Canada LLP Voting Common Shares 48473874 000000000 N/A 0 0 true true false Tier2 Audited Equity (common or preferred stock) N N N Y N N 5000000 48473874 2.0000 10000000.00 0.00 0.00 0.00 10000000.00 BDO Canada LLP 35000.00 Nauth LPC, Osler, Hoskin & Harcourt LLP 60000.00 9770000.00 Fees and net proceeds assume the offering is fully subscribed. false true AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY A0 A1 A2 A3 A4 A5 A6 A7 A8 A9 B0 Z4 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY A0 A1 A2 A3 A4 A5 A6 A7 A8 A9 B0 Z4 false Naqi Logix Inc. Voting Common Shares 48473874 0 USD$1,576.333.60 (assuming a conversion rate of CAD 0.80 to USD 1.00) section 4(a)(2) of the 1933 Act. PART II AND III 2 form1aa.htm PART II AND III Naqi Logix Inc.: Form 1-A/A - Filed by newsfilecorp.com

AN OFFERING STATEMENT PURSUANT TO REGULATION A RELATING TO THESE SECURITIES HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION (THE "SEC"). INFORMATION CONTAINED IN THIS PRELIMINARY OFFERING CIRCULAR IS SUBJECT TO COMPLETION OR AMENDMENT. THESE SECURITIES MAY NOT BE SOLD NOR MAY OFFERS TO BUY BE ACCEPTED BEFORE THE OFFERING STATEMENT FILED WITH THE SEC IS QUALIFIED. THIS PRELIMINARY OFFERING CIRCULAR SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY NOR MAY THERE BE ANY SALES OF THESE SECURITIES IN ANY STATE IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL BEFORE REGISTRATION OR QUALIFICATION UNDER THE LAWS OF ANY SUCH STATE. WE MAY ELECT TO SATISFY OUR OBLIGATION TO DELIVER A FINAL OFFERING CIRCULAR BY SENDING YOU A NOTICE WITHIN TWO BUSINESS DAYS AFTER THE COMPLETION OF OUR SALE TO YOU THAT CONTAINS THE URL WHERE THE FINAL OFFERING CIRCULAR OR THE OFFERING STATEMENT IN WHICH SUCH FINAL OFFERING CIRCULAR WAS FILED MAY BE OBTAINED.

REGULATION A OFFERING CIRCULAR UNDER THE SECURITIES ACT OF 1933

PRELIMINARY OFFERING CIRCULAR, SUBJECT TO COMPLETION

DATED JUNE 30, 2022

AMENDMENT NO. 1

NAQI LOGIX INC.

UP TO 5,000,000 VOTING COMMON SHARES

MINIMUM INVESTMENT OF 750 VOTING COMMON SHARES ($1,500.00)

1400-1040 West Georgia Street
Vancouver, BC V6E 4H1
Canada
1-888- 627-4564
www.naqilogix.com

Copy to:

Daniel D. Nauth
Nauth LPC
217 Queen Street West, Suite 401
Toronto, Ontario M5V 0R2
Canada
(416) 477-6031

Naqi Logix Inc., a corporation formed pursuant to the laws of the Province of British Columbia and domiciled in the Province of British Columbia (the "Company," "we," or "our"), is offering up to 5,000,000 (the "Maximum Offering") Voting Common Shares, no par value per share (the "Common Shares") of the Company to be sold in this Tier 2 Offering (this "Offering") pursuant to Regulation A under the Securities Act of 1933, as amended (the "Securities Act").  Each investor must invest a minimum of $1,500.00; however, we reserve the right to waive this minimum in our sole discretion. This Offering will terminate on the earlier of the date on which (i) the Maximum Offering is sold, or (ii) the board of directors of the Company (the "Board") elects to terminate this Offering (either such case, the "Termination Date"). We expect to commence the sale of the Common Shares on the date on which the SEC qualifies the offering statement of which this offering circular is a part.


There is currently no escrow established for this Offering, although management reserves the right to establish an escrow and engage an escrow agent in its discretion without a subsequent offering circular supplement or prior notice to investors. We will hold closings upon the receipt of investors' subscriptions and acceptance of such subscriptions by us. If, on the initial closing date, we have sold less than the Maximum Offering, then we may hold one or more additional closings for additional sales, until the Termination Date.

The Company has engaged Dalmore Group, LLC, member FINRA/SIPC (the "Broker"), to act as the broker-dealer of record in connection with this Offering, but not for underwriting or placement agent services. This includes the 1% commission, but it does not include the one-time set-up fee and consulting fee payable by the Company to the Broker. See "Plan of Distribution" for more details. To the extent that the Company's officers and directors make any communications in connection with the Offering they intend to conduct such efforts in accordance with an exemption from registration contained in Rule 3a4-1 under the Securities Exchange Act of 1934, as amended, and, therefore, none of them is required to register as a broker-dealer.

No application is currently being prepared for the Common Shares to trade on any public market. As a result, the Common Shares sold in this Offering may not be listed on a securities exchange or quoted on an alternative trading system for an extended period of time, if at all. If the Common Shares are not listed on a securities exchange or quoted on an alternative trading system, it may be difficult to sell or trade in the Common Shares. There can be no assurance that a liquid market for the Common Shares will develop or, if it does develop, that it will continue. If a market does develop, it may not be liquid. Therefore, investors may not be able to sell the Common Shares easily or at prices that will provide them with yield comparable to similar investments that have a developed secondary market. Illiquidity may have a severely adverse effect on the market value of the Common Shares and investors wishing to sell the Common Shares might therefore suffer losses.

We have engaged Novation Solutions Inc. dba Dealmaker (the "Technology Agent") to provide certain technology services to us in connection with this Offering, including the online subscription processing platform of the Technology Agent. After the qualification by the SEC of the Offering Statement of which this Offering Circular is a part, this Offering will be conducted on the online platform of the Technology Agent through the Investor Relations page of our website at www.naqilogix.com, whereby investors will receive, review, execute, and deliver subscription agreements electronically as well as make payment of the purchase price through a third party processor by ACH debit transfer or wire transfer to an account designated by us. There is no escrow established for this Offering. We will hold closings upon the receipt of investors' subscriptions and acceptance of such subscriptions by us. If, on the initial closing date, we have sold less than the Maximum Offering, then we may hold one or more additional closings for additional sales, until the Termination Date. Funds will be promptly refunded without interest, for sales that are not consummated.

The Company has three shareholder agreements in place: (i) a shareholder rights agreement (the "Shareholder Rights Agreement"); (ii) a right of first refusal and co-sale agreement (the "Right of First Refusal and Co-Sale Agreement"); and (iii) a voting agreement (the "Voting Agreement") (each, a "Shareholder Agreement" and collectively, the "Shareholder Agreements"), each of which is summarized in greater detail in this Offering Circular under "Securities Being Offered" and attached as an exhibit hereto. Each of the Company's current shareholders has been required to execute the Shareholder Agreements. ALL INCOMING INVESTORS PURSUANT TO THIS OFFERING ARE REQUIRED TO SIGN AN ADOPTION AGREEMENT TO THE SHAREHOLDER AGREEMENTS AS A CONDITION OF ACQUIRING COMMON SHARES. Your subscription agreement ("Subscription Agreement") will include an adoption agreement for the Shareholder Agreements as a schedule, which must be completed and returned to the Company along with the signed Subscription Agreement. The Shareholder Agreements will terminate in connection with the closing of a future initial public offering or other going public transaction involving the Common Shares.

The Shareholder Rights Agreement provides the Company's shareholders with a number of rights and ensures the Company operates according to best practices. The Shareholder Rights Agreement establishes the right of owners of over 5% of the Company's issued and outstanding shares (the "Major Shareholders") to receive financial statements from the Company unless waived. All other shareholders of the Company may receive such financial statements following their delivery of a written request to the Company. The Shareholder Rights Agreement provides that, subject to the terms of the Shareholder Rights Agreement and applicable law, the Company shall first offer any new securities of the Company to each Major Shareholder, and each Major Shareholder shall have right to participate in such offering of new securities up to the percentage of the Common Shares then held by such Major Shareholder. The Major Shareholders are not required to purchase the additional securities but can do so at their option. The Shareholder Rights Agreement provides for additional standard covenants of the Company including: (i) director and officer insurance; (ii) protection of the Company's IP and confidential information; and (iii) meetings of the Board.

The Right of First Refusal and Co-Sale Agreement regulates the mechanics of sales and transfers of the Common shares. The right of first refusal provides that where a shareholder proposes to transfer shares of the Company, the Company shall have a right of first refusal to purchase all or any portion of such shares that such shareholder may propose to transfer at the same price and on the same terms and conditions as those offered to the prospective transferee. The Major Shareholders shall have a secondary refusal right to purchase all or any portion of the shares proposed to be transferred but not purchased by the Company pursuant to its right of first refusal. The right of co-sale provides that if any shares to be transferred to a proposed transferee and they are not purchased pursuant to the right of first refusal by the Company (or the secondary refusal right by the Major Shareholders, as applicable), each Major Shareholder may elect to exercise its right of co-sale and participate in the proposed share transfer on a pro-rata basis on the same terms and conditions in the proposed transfer. The right of first refusal (and secondary refusal right) and the right of co-sale shall not apply to certain "exempt" transfers, which include: (i) in the case of a shareholder that is an entity, to transfers to its shareholders, members, partners or other equity holders; (ii) repurchases of shares by the Company where such repurchase is pursuant to an agreement containing vesting and/or repurchase provisions approved by a majority of the Board; and (iii) in the case of a shareholder that is a natural person, upon a transfer of shares made for bona fide estate planning purposes. Shareholders are prohibited from transferring shares to any competitor or any customer, distributor or supplier of the company if such transfer would place the Company at a competitive disadvantage with respect to such customer, distributor or supplier. The Right of First Refusal and Co-Sale Agreement further provides for a prohibition on the sale of the Company's shares for 180 days (or such other period as may be requested by the Company or an underwriter to accommodate regulatory restrictions) following the closing of a going public transaction. A transfer of shares that is not made in compliance with the agreement shall be null and void, shall not be recorded on the books of the Company or with its transfer agent and shall not be recognized by the Company.


The Voting Agreement provides certain shareholders with the right to, among other things, designate the election of certain members of the Board and sets forth how shareholders are to vote their respective shares in connection with the sale of the Company.  Mark Godsy is entitled to designate up to seven director nominees, and each shareholder is required to vote their shares in favor of the election of such director nominees. Further, the Voting Agreement provides that any corporate action that is approved by the Board but which also requires shareholder approval, whether by special resolution or ordinary resolution, as applicable, shareholders are obligated to vote their shares in favor of such corporate action. The Voting Agreement establishes a drag-along right, which requires a minority shareholder to sell their shares in the context of a Board approved sale of the Company if more than 66 2/3% of shareholders approve such sale of the Company.

Investing in the Common Shares involves a high degree of risk. These are speculative securities. An investor should purchase the Common Shares only if the investor can afford a complete loss of the investment. See "Risk Factors" for a discussion of certain risks that the investor should consider in connection with an investment in the Common Shares.

THE SEC DOES NOT PASS UPON THE MERITS OF OR GIVE ITS APPROVAL TO ANY SECURITIES OFFERED, INCLUDING THE COMMON SHARES, OR THE TERMS OF THIS OFFERING, NOR DOES IT PASS UPON THE ACCURACY OR COMPLETENESS OF ANY OFFERING CIRCULAR OR OTHER SOLICITATION MATERIALS. THE COMMON SHARES ARE OFFERED PURSUANT TO AN EXEMPTION FROM REGISTRATION WITH THE SEC; HOWEVER, THE SEC HAS NOT MADE AN INDEPENDENT DETERMINATION THAT THE COMMON SHARES OFFERED ARE EXEMPT FROM REGISTRATION.

NOTICE TO FOREIGN INVESTORS

IF THE INVESTOR LIVES OUTSIDE OF THE UNITED STATES, IT IS THE INVESTOR'S RESPONSIBILITY TO FULLY OBSERVE THE LAWS OF ANY RELEVANT TERRITORY OR JURISDICTION OUTSIDE THE UNITED STATES IN CONNECTION WITH ANY PURCHASE OF THE SECURITIES, INCLUDING OBTAINING REQUIRED GOVERNMENTAL OR OTHER CONSENTS OR OBSERVING ANY OTHER REQUIRED LEGAL OR OTHER FORMALITIES. THE COMPANY RESERVES THE RIGHT TO DENY THE PURCHASE OF THE SECURITIES BY ANY FOREIGN INVESTOR.

Title and Class of
Securities to be
Offered
  Maximum Number of
Share to be Offered
    Proposed Offering
Price per Share
    Proposed Maximum
Aggregate Offering
Proceeds
    Commissions and
Discounts(1)
    Proceeds to
Company(2)
 
                               
Common Shares   5,000,000   $ 2.00   $ 10,000,000   $ 100,000   $ 9,770,000  

Notes:

(1) Assumes this Offering is fully subscribed. The Common Shares are being offered on a best efforts basis, (i) directly by the Company and (ii) pursuant to an agreement entered into with the Broker. As compensation for these services the Broker will receive a $5,000 advance fee for accountable expenses and a $20,000 consulting fee after the issuance of a "No Objection Letter" by the Financial Industry Regulatory Authority. In addition, the Broker will receive a fee of 1% on the aggregate amount of capital raised under this Offering. Please see "Plan of Distribution" on page 23 for additional information. The proceeds of this Offering may be deposited directly into the Company's operating account for immediate use by it, with no obligation to refund subscriptions.


(2) The amount shown assumes deducting offering costs which may include legal, accounting, marketing, consulting and other costs incurred in undertaking this Offering. Such costs are estimated to amount to $230,000, including commissions and discounts paid to the Broker, assuming this Offering is fully subscribed.

GENERALLY, NO SALE MAY BE MADE TO YOU IN THIS OFFERING IF THE AGGREGATE PURCHASE PRICE YOU PAY IS MORE THAN TEN PERCENT (10%) OF THE GREATER OF YOUR ANNUAL INCOME OR YOUR NET WORTH. DIFFERENT RULES APPLY TO ACCREDITED INVESTORS AND NON-NATURAL PERSONS. BEFORE MAKING ANY REPRESENTATION THAT YOUR INVESTMENT DOES NOT EXCEED APPLICABLE THRESHOLDS, WE ENCOURAGE YOU TO REVIEW RULE 251(d)(2)(i)(C) OF REGULATION A PROMULGATED UNDER THE SECURITIES ACT. FOR GENERAL INFORMATION ON INVESTING, WE ENCOURAGE YOU TO REFER TO WWW.INVESTOR.GOV.

THIS OFFERING CIRCULAR CONTAINS ALL OF THE REPRESENTATIONS BY US CONCERNING THIS OFFERING, AND NO PERSON SHALL MAKE DIFFERENT OR BROADER STATEMENTS THAN THOSE CONTAINED HEREIN. INVESTORS ARE CAUTIONED NOT TO RELY UPON ANY INFORMATION NOT EXPRESSLY SET FORTH IN THIS OFFERING CIRCULAR.

The Company is following the "Offering Circular" format of disclosure under Regulation A promulgated under the Securities Act.

In the event that we become a reporting company under the Securities Exchange Act of 1934, as amended, we intend to rely on the provisions that relate to "Emerging Growth Companies" under the Jumpstart Our Business Startups Act of 2012. See "Implications of Being an Emerging Growth Company."

TABLE OF CONTENTS

IMPORTANT INFORMATION ABOUT THIS OFFERING CIRCULAR 1
   
CERTAIN TAX CONSIDERATIONS 2
   
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS 3
   
IMPLICATIONS OF BEING AN EMERGING GROWTH COMPANY 6
   
SUMMARY 8
   
THIS OFFERING 11
   
RISK FACTORS 12
   
DILUTION 22
   
PLAN OF DISTRIBUTION 23
   
USE OF PROCEEDS TO COMPANY 25
   
DESCRIPTION OF BUSINESS 27
   
DESCRIPTION OF PROPERTY 36
   
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 37
   
DIRECTORS, EXECUTIVE OFFICERS AND SIGNIFICANT EMPLOYEES 40
   
COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS 43
   
SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN SECURITYHOLDERS 44
   
INTEREST OF MANAGEMENT AND OTHERS IN CERTAIN TRANSACTIONS 45
   
SECURITIES BEING OFFERED 46
   
WHERE YOU CAN FIND MORE INFORMATION 52
   
INDEX TO FINANCIAL STATEMENTS F-1
   
PART III - EXHIBITS E-1
   
SIGNATURES S-1


IMPORTANT INFORMATION ABOUT THIS OFFERING CIRCULAR

In this offering (this "Offering"), we are offering to sell, and seeking offers to buy, Voting Common Shares, no par value per share (the "Common Shares"), of Naqi Logix Inc., a corporation formed pursuant to the laws of the Province of British Columbia and domiciled in the Province of British Columbia (the "Company," "we," "our," and "us"), only in jurisdictions where such offers and sales are permitted. Please carefully read the information in this offering circular and any accompanying offering circular supplements, which we refer to collectively as the "Offering Circular." You should rely only on the information contained in this Offering Circular. We have not authorized anyone to provide you with any information other than the information contained in this Offering Circular. The information contained in this Offering Circular is accurate only as of its date or as of the respective dates of any documents or other information incorporated herein by reference, regardless of the time of its delivery or of any sale or delivery of our securities. Neither the delivery of this Offering Circular nor any sale or delivery of the Common Shares shall, under any circumstances, imply that there has been no change in our affairs since the date of this Offering Circular. This Offering Circular will be updated and made available for delivery to the extent required by the federal securities laws.

This Offering Circular is part of an offering statement (the "Offering Statement") that we filed with the Securities and Exchange Commission (the "SEC") using a continuous offering process. Periodically, we may provide an Offering Circular supplement that would add, update or change information contained in this Offering Circular. Any statement that we make in this Offering Circular will be modified or superseded by any inconsistent statement made by us in a subsequent Offering Circular supplement. The Offering Statement we filed with the SEC includes exhibits that provide more detailed descriptions of the matters discussed in this Offering Circular. You should read this Offering Circular and the related exhibits filed with the SEC and any Offering Circular supplement, together with additional information contained in our annual reports, semi-annual reports and other reports and information statements that we will file periodically with the SEC. The Offering Statement and all supplements and reports that we have filed or will file in the future can be read at the SEC website, www.sec.gov.

Unless otherwise indicated, data contained in this Offering Circular concerning the business of the Company are based on information from various public sources. This Offering Circular also includes statistical and other market data that we obtained from industry publications and research, surveys and studies conducted by third parties. Although we believe that these data are generally reliable, such information is inherently imprecise, and our estimates and expectations based on these data involve a number of assumptions and limitations. As a result, you are cautioned not to give undue weight to such data, estimates or expectations. All references in this Offering Circular to "$" or "dollars" are to United States dollars, unless specifically stated otherwise. All references in this Offering Circular to "C$" are to Canadian dollars. 


CERTAIN TAX CONSIDERATIONS

No information contained herein, nor in any prior, contemporaneous or subsequent communication should be construed by a prospective investor as legal or tax advice. We are not providing any tax advice as to the acquisition, holding or disposition of the Common Shares. In making an investment decision, investors are strongly encouraged to consult their own tax advisor to determine the U.S. Federal, state and any applicable foreign tax consequences relating to their investment in the Common Shares. This written communication is not intended to be "written advice," as defined in Circular 230 published by the U.S. Treasury Department.


CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

Some of the statements under "Summary," "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Description of Business" and elsewhere in this Offering Circular constitute forward-looking statements. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar matters that are not historical facts. In some cases, you can identify forward-looking statements by terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "potential," "should," "will" and "would" or the negatives of these terms, or other comparable terminology.

You should not place undue reliance on forward-looking statements. The cautionary statements set forth in this Offering Circular, including in "Risk Factors" and elsewhere, identify important factors which you should consider in evaluating our forward-looking statements. These factors include business and industry risks, including that:

  • we have a history of losses and can provide no assurance of our future operating results;

  • the Company was recently formed and has no operating history and no revenues;

  • we may not have adequate capital to fund our business and may need substantial additional funding to continue operations; We may not be able to raise capital when needed, if at all, which would force us to delay, reduce or eliminate our product development programs or commercialization efforts and could cause our business to fail;

  • we have limited existing brand identity and customer loyalty; if we fail to attract customers to use our service offerings, our business could suffer;

  • delays and dealing with unknown factors during the manufacturing process of the Naqi Earbud;

  • our success is dependent on the completed development and potential performance of the Naqi Earbuds and Naqi Framework;

  • we will need to increase the size of our organization, and we may be unable to manage rapid growth effectively;

  • we are not subject to Sarbanes-Oxley and lack the internal controls over financial reporting required of public companies;

  • the smart earbud, gestural input, brain-computer interface and non-tactile input industries are competitive, and we may be unable to compete with companies with greater financial or technical resources than us, which could negatively affect our operations;

  • the successful development of the Naqi Earbuds and Naqi Framework is highly speculative and is dependent on numerous factors, many of which are beyond our control;

  • new products and services may subject us to additional risks; A failure to successfully manage these risks may have a material adverse effect on our business;

  • if we are unable to develop a partner ecosystem, sales, marketing and distribution channels or enter into agreements with third parties to perform these functions on acceptable terms, we may be unable to generate revenue;

  • we may face significant competition in Canada and in other markets, including the United States, Europe and Asia where we may decide to operate in the future;

  • our revenue could fluctuate from period to period, which could have an adverse material impact on our business;

  • if we are unable to effectively protect our intellectual property and trade secrets, it may impair our ability to compete;

  • customer complaints regarding our products and services could hurt our business;

  • computer, website and/or information system breakdowns, as well as cyber security attacks, could affect our business;

  • we will depend on third-party providers for a reliable Internet infrastructure as well as other aspects of our technology and applications and the failure of these third parties, or the Internet in general, for any reason would significantly impair our ability to conduct our business;

  • compliance with laws and regulations designed to protect personal data, and our actual or perceived failure to adequately protect personal data, could harm our business;

  • we may be involved in legal and regulatory proceedings;

  • the liability of our directors and officers and others is limited under certain circumstances;

  • our executive officers, directors and insider shareholders beneficially own or control a substantial portion of the outstanding Common Shares;

  • because we do not have an audit or compensation committee, shareholders will have to rely on management to perform these functions;

  • we may have difficulty retaining and acquiring personnel;

  • our directors and officers may have conflicts of interest;

  • our financial statements have been prepared in accordance with IFRS accounting principles; and

  • public health epidemics or outbreaks could adversely impact our business,

as well as risks related to this Offering and the Common Shares, including that:

  • we may terminate this Offering at any time during the Offering Period and do not have a minimum capitalization;

  • the Common Shares are being offered on a “best efforts” basis and we may not raise sufficient capital to satisfy our working capital needs;

  • this Offering is being conducted without the benefit of an underwriter, who could have confirmed the accuracy of the disclosures in this Offering Circular;

  • it is uncertain when the Common Shares will be listed on an exchange for trading, if ever;

  • if the Common Shares become subject to the penny stock rules, it would become more difficult to trade the Common Shares;

  • we have broad discretion in how we use the proceeds of this Offering and may not use these proceeds effectively, which could affect our results of operations and cause the price of our Common Shares to decline;

  • we may incur increased costs as a result of our public reporting obligations, and our management team will be required to devote substantial time to new compliance initiatives;

  • we may lose our status as a “foreign private issuer” in the United States, which would result in increased costs related to regulatory compliance under United States securities laws;

  • we do not intend to pay dividends on the Common Shares and, consequently, your ability to achieve a return on your investment will depend on appreciation in the price of the Common Shares;

  • terms of subsequent financings, if any, may adversely impact investors’ investments;

  • we determined the offering price for the Common Shares being sold in this Offering; and

  • if an investor purchases Common Shares in this Offering, the investor will incur immediate and substantial dilution in the book value of the Common Shares.

Although the forward-looking statements in this Offering Circular are based on our beliefs, assumptions and expectations, taking into account all information currently available to us, we cannot guarantee future transactions, results, performance, achievements or outcomes. No assurance can be made to any investor by anyone that the expectations reflected in our forward-looking statements will be attained, or that deviations from them will not be material and adverse. We undertake no obligation, other than as may be required by law, to re-issue this Offering Circular or otherwise make public statements updating our forward-looking statements.


IMPLICATIONS OF BEING AN EMERGING GROWTH COMPANY

We are not subject to the ongoing reporting requirements of the Exchange Act of 1934, as amended (the "Exchange Act"), because we are not registering the Common Shares under the Exchange Act. Rather, we will be subject to the more limited reporting requirements under Regulation A, including the obligation to electronically file:

  • annual reports (including disclosure relating to our business operations for the preceding three fiscal years, or, if in existence for less than three years, since inception, related party transactions, beneficial ownership of the Company’s securities, executive officers and directors and certain executive compensation information, management’s discussion and analysis (“MD&A”) of the Company’s liquidity, capital resources, and results of operations, and two years of audited financial statements);

  • semiannual reports (including disclosure primarily relating to the Company’s interim financial statements and MD&A); and

  • current reports for certain material events.

In addition, at any time after completing reporting for the fiscal year in which the Offering Statement was qualified, if the securities of each class to which the Offering Statement relates are held of record by fewer than 300 persons and offers or sales are not ongoing, we may immediately suspend our ongoing reporting obligations under Regulation A.

If and when we become subject to the ongoing reporting requirements of the Exchange Act, so long as we remain a company with less than $1.07 billion in total annual gross revenues during our last fiscal year, which is currently the case, we will be an "emerging growth company" under the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"), which will be significant. An emerging growth company may take advantage of certain reduced reporting requirements and is relieved of certain other significant requirements that are otherwise generally applicable to public companies. In particular, as an emerging growth company we:

  • will not be required to obtain an auditor attestation on our internal controls over financial reporting pursuant to the Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley”);

  • will not be required to provide a detailed narrative disclosure discussing our compensation principles, objectives and elements and analyzing how those elements fit with our principles and objectives (commonly referred to as “compensation discussion and analysis”);

  • will not be required to obtain a non-binding advisory vote from our stockholders on executive compensation or golden parachute arrangements (commonly referred to as the “say-on-pay,” “say-on-frequency” and “say-on-golden-parachute” votes);

  • will be exempt from certain executive compensation disclosure provisions requiring a pay-for-performance graph and Chief Executive Officer pay ratio disclosure;

  • may present only two years of audited financial statements and only two years of related Management’s Discussion and Analysis of Financial Condition and Results of Operations, or MD&A; and

  • will be eligible to claim longer phase-in periods for the adoption of new or revised financial accounting standards.

We intend to take advantage of all of these reduced reporting requirements and exemptions, including the longer phase-in periods for the adoption of new or revised financial accounting standards under Section 107 of the JOBS Act. Our election to use the phase-in periods may make it difficult to compare our financial statements to those of non-emerging growth companies and other emerging growth companies that have opted out of the phase-in periods under Section 107 of the JOBS Act.

Under the JOBS Act, we may take advantage of the above-described reduced reporting requirements and exemptions for up to five years after our initial sale of common equity pursuant to a registration statement declared effective under the Securities Act of 1933, as amended (the "Securities Act"), or such earlier time that we no longer meet the definition of an emerging growth company. Note that this Offering, while a public offering, is not a sale of common equity pursuant to a registration statement, since this Offering is conducted pursuant to an exemption from the registration requirements. In this regard, the JOBS Act provides that we would cease to be an "emerging growth company" if we have more than $1.07 billion in annual revenues, have more than $700 million in market value of our common stock held by non-affiliates, or issue more than $1 billion in principal amount of non-convertible debt over a three-year period. 


Certain of these reduced reporting requirements and exemptions are also available to us due to the fact that we may also qualify, once listed, as a "smaller reporting company" under the SEC's rules. For instance, smaller reporting companies are not required to obtain an auditor attestation on their assessment of internal control over financial reporting; are not required to provide a compensation discussion and analysis; are not required to provide a pay-for-performance graph or Chief Executive Officer pay ratio disclosure; and may present only two years of audited financial statements and related MD&A disclosure. 


SUMMARY

This Offering summary highlights material information regarding our business, and this Offering. Because it is a summary, it may not contain all of the information that is important to you. To understand this Offering fully, you should read the entire Offering circular carefully, including the "Risk Factors" section, before making a decision to invest in the Company. Some of the statements in this Offering Circular are forward-looking statements. See the section entitled "Cautionary Statement Regarding Forward-Looking Statements" above.

Our Business

The Company was incorporated on August 4, 2020, pursuant to the laws of the Province of British Columbia and is domiciled in the Province of British Columbia. The Company engages in the business of (i) developing the Naqi Earbuds, smart earbuds that will enable users to control their Internet of Things ("IoT") environment without looking at, speaking to or touching the devices being controlled, and the Naqi Framework, which enables original equipment manufacturers ("OEMs") of wearable devices to create user interfaces that are capable of discreet and inconspicuous user input and navigation; (ii) commercializing the Naqi Earbuds and Naqi Framework; (iii) developing and licensing Naqi Earbud and Naqi Framework integrations into common information systems, such as residential and commercial IoT systems and potentially leading gaming systems; and (iv) developing and licensing Naqi Operator Vigilance and Naqi Wheelchair Control applications.

As of the date of this Offering Circular, we continue to develop the Naqi Earbuds and Naqi Framework and have not commenced revenue-generating operations. We anticipate sharing prototypes of the Naqi Earbuds and Naqi Framework during the fourth quarter of 2022, aiming for the first commercial (minimum viable product) release of these products by mid 2023.

Our technologies and services offerings are described in greater detail in "Description of Business" below together with a detailed description of our entire business.

Our direct personnel consists of one full-time employee, one full-time consultant and nine part-time consultants. The Company also indirectly employs an additional 33 consultants as part of our research and development team.

Our principal place of business and mailing address is Naqi Logix Inc., 1400-1040 West Georgia Street, Vancouver, BC V6E 4H1, Canada and our telephone number is 1-888- 627-4564. Our website address is www.naqilogix.com. The information contained therein or accessible thereby shall not be deemed to be incorporated into this Offering Circular.

Description of Property

We do not own any facilities and do not expect to do so in the immediate future. Our mailing address is 1400-1040 West Georgia Street, Vancouver, BC V6E 4H1, Canada, and all of the Company's personnel operate virtually from remote locations.

Risks Related to Our Business

Our business and our ability to execute our business strategy are subject to a number of risks, which are more fully described in the section titled "Risk Factors" beginning on page 12. These risks include business and industry risks, including that:

  • we have a history of losses and can provide no assurance of our future operating results;

  • the Company was recently formed and has no operating history and no revenues;

  • we may not have adequate capital to fund our business and may need substantial additional funding to continue operations; We may not be able to raise capital when needed, if at all, which would force us to delay, reduce or eliminate our product development programs or commercialization efforts and could cause our business to fail;

  • we have limited existing brand identity and customer loyalty; if we fail to attract customers to use our service offerings, our business could suffer;

  • delays and dealing with unknown factors during the manufacturing process of the Naqi Earbud;

  • our success is dependent on the completed development and potential performance of the Naqi Earbuds and Naqi Framework;

  • we will need to increase the size of our organization, and we may be unable to manage rapid growth effectively;

  • we are not subject to Sarbanes-Oxley and lack the internal controls over financial reporting required of public companies;

  • the smart earbud, gestural input, brain-computer interface and non-tactile input industries are competitive, and we may be unable to compete with companies with greater financial or technical resources than us, which could negatively affect our operations;

  • the successful development of the Naqi Earbuds and Naqi Framework is highly speculative and is dependent on numerous factors, many of which are beyond our control;

  • new products and services may subject us to additional risks; A failure to successfully manage these risks may have a material adverse effect on our business;

  • if we are unable to develop a partner ecosystem, sales, marketing and distribution channels or enter into agreements with third parties to perform these functions on acceptable terms, we may be unable to generate revenue;

  • we may face significant competition in Canada and in other markets, including the United States, Europe and Asia where we may decide to operate in the future;

  • our revenue could fluctuate from period to period, which could have an adverse material impact on our business;

  • if we are unable to effectively protect our intellectual property and trade secrets, it may impair our ability to compete;

  • customer complaints regarding our products and services could hurt our business;

  • computer, website and/or information system breakdowns, as well as cyber security attacks, could affect our business;

  • we will depend on third-party providers for a reliable Internet infrastructure as well as other aspects of our technology and applications and the failure of these third parties, or the Internet in general, for any reason would significantly impair our ability to conduct our business;

  • compliance with laws and regulations designed to protect personal data, and our actual or perceived failure to adequately protect personal data, could harm our business;

  • we may be involved in legal and regulatory proceedings;

  • the liability of our directors and officers and others is limited under certain circumstances;

  • our executive officers, directors and insider shareholders beneficially own or control a substantial portion of the outstanding Common Shares;

  • because we do not have an audit or compensation committee, shareholders will have to rely on management to perform these functions;

  • we may have difficulty retaining and acquiring personnel;

  • our directors and officers may have conflicts of interest;

  • our financial statements have been prepared in accordance with IFRS accounting principles; and

  • public health epidemics or outbreaks could adversely impact our business,

and risks related to this Offering and the Common Shares, including that:


  • we may terminate this Offering at any time during the Offering Period and do not have a minimum capitalization;

  • the Common Shares are being offered on a “best efforts” basis and we may not raise sufficient capital to satisfy our working capital needs;

  • this Offering is being conducted without the benefit of an underwriter, who could have confirmed the accuracy of the disclosures in this Offering Circular;

  • it is uncertain when the Common Shares will be listed on an exchange for trading, if ever;

  • if the Common Shares become subject to the penny stock rules, it would become more difficult to trade the Common Shares;

  • we have broad discretion in how we use the proceeds of this Offering and may not use these proceeds effectively, which could affect our results of operations and cause the price of our Common Shares to decline;

  • we may incur increased costs as a result of our public reporting obligations, and our management team will be required to devote substantial time to new compliance initiatives;

  • we may lose our status as a “foreign private issuer” in the United States, which would result in increased costs related to regulatory compliance under United States securities laws;

  • we do not intend to pay dividends on the Common Shares and, consequently, your ability to achieve a return on your investment will depend on appreciation in the price of the Common Shares;

  • terms of subsequent financings, if any, may adversely impact investors’ investments;

  • we determined the offering price for the Common Shares being sold in this Offering; and

  • if an investor purchases Common Shares in this Offering, the investor will incur immediate and substantial dilution in the book value of the Common Shares.

If an investor purchases Common Shares in this Offering, the investor will incur immediate and substantial dilution in the book value of the Common Shares.

Regulation A+

We are offering the Common Shares pursuant to rules of the SEC mandated under the JOBS Act. These offering rules are often referred to as "Regulation A+." We are relying upon "Tier 2" of Regulation A+, which allows us to offer securities of up to $75 million in a 12-month period.

In accordance with the requirements of Tier 2 of Regulation A+, we are required to publicly file annual, semiannual, and current event reports with the SEC. 


THIS OFFERING

Company:

Naqi Logix Inc., a corporation formed pursuant to the laws of the Province of British Columbia and domiciled in the Province of British Columbia

 

 

Shares Offered:

Up to 5,000,000 Common Shares, no par value per share.

 

 

Price per Share:

$2.00

 

 

Minimum Investment:

$1,500.00 per investor.

 

 

Common Shares Outstanding before this Offering:

48,473,874 Common Shares.

 

 

Common Shares Outstanding after this Offering:

53,473,874 Common Shares, if the Maximum Offering is sold.

 

 

Use of Proceeds:

If we sell all of the 5,000,000 Common Shares being offered, our net proceeds (after deducting fees and commissions and estimated offering expenses) will be approximately $9,770,000. We will use these net proceeds for cash reserves, working capital, technology development, marketing and business development, as described in "Use of Proceeds to Company" beginning on page 25.

 

 

Subscribing Online:

After the qualification of the Offering Statement of which this Offering Circular is a part, this Offering will be conducted through the online subscription processing platform of Novation Solutions, Inc. dba DealMaker (the "Technology Agent") through the Investor Relations page of our website at www.naqilogix.com, whereby investors will receive, review, execute, and deliver subscription agreements electronically as well as make payment of the purchase price through a third party processor by ACH debit transfer or wire transfer to an account we designate.

 

 

Risk Factors:

Investing in our Common Shares involves a high degree of risk. See "Risk Factors" beginning on page 12.

 


RISK FACTORS

An investment in the Common Shares involves a high degree of risk. Each investor should carefully consider the risks described below, together with all of the other information included in this Offering Circular, before making an investment decision. If any of the following risks actually occurs, our business, financial condition or results of operations could suffer. In that case, the price of the Common Shares could decline and the investors may lose all or part of their investments. See "Cautionary Statement Regarding Forward Looking Statements" above for a discussion of forward-looking statements and the significance of such statements in the context of this Offering Circular.

Risks Related to our Business and Industry

We have a history of losses and can provide no assurance of our future operating results.

As of the date of this Offering Circular, we continue to develop the Naqi Earbuds and Naqi Framework and have not commenced revenue-generating operations. We anticipate sharing prototypes of the Naqi Earbuds and Naqi Framework during the fourth quarter of 2022, aiming for the first commercial (minimum viable product) release of these products by mid 2023.

As we continue to develop and have not begun generating revenue from the sale of our products and services, we have experienced net losses and negative cash flows from operating activities since inception, and we expect such losses and negative cash flows to continue in the foreseeable future. As at March 31, 2022, the Company had negative working capital of $516,763 and a cumulative loss since inception of $(3,068,062). As a result, our continuance as a going concern is dependent upon our ability to obtain adequate financing and to reach profitable levels of operation upon commercialization of our products and services. It is not possible to predict whether financing efforts will be successful or if we will attain profitable levels of operations. Management believes it will be successful in raising the necessary funding to continue operations in the normal course of operations, however, there is no assurance that funds will continue to be available on acceptable terms or at all. Our financial statements do not reflect adjustments to the carrying value of assets and liabilities that would be necessary should we be unable to continue operations and such adjustments could be material.

The Company was recently formed and has no operating history and no revenues.

The Company was only recently formed to engage in developing the Naqi Earbuds and Naqi Framework. We have no operating history upon which to base an evaluation of our business and prospects. Operating results for future periods are subject to numerous uncertainties and we cannot assure you that we will achieve or sustain profitability. Our prospects must be considered in light of the risks encountered by companies in the early stage of development, particularly companies in new and rapidly evolving markets. Future operating results will depend upon many factors, including, but not limited to, our success in attracting necessary financing, such as that contemplated in this offering, or obtaining financing from other sources, establishing credit or operating facilities, our ability to develop new products, our ability to successfully market our products and attract customers, our ability to control operational costs, and our ability to retain motivated and qualified personnel, legal and regulatory developments in the jurisdictions in which we operate, as well as the general economic conditions which affect our customers We cannot assure you that we will successfully address any of these risks.

We may not have adequate capital to fund our business and may need substantial additional funding to continue operations. We may not be able to raise capital when needed, if at all, which would force us to delay, reduce or eliminate our product development programs or commercialization efforts and could cause our business to fail.

We have not commenced revenue generating operations and are therefore dependent on securing sufficient capital to fund the further development of the Naqi Earbuds and Naqi Framework, as well as any other products and services that we may identify and develop from time to time. The Company anticipates that the first commercial (minimum viable product) offering of the product will be available by mid 2023. If our entire original capital is fully expended and additional costs cannot be funded from borrowings or capital from other sources, then our financial condition, results of operations, and business performance would be materially adversely affected. We may require additional capital for the development of our business operations and commercialization of the products and services we are currently developing or may develop in the future. We may also encounter unforeseen expenses, difficulties, complications due to unknown factors in the development of the technology which is unique and brand new, delays and other unknown factors that may increase our capital needs and/or cause us to spend our cash resources faster than we expect. Accordingly, we will need to obtain additional funding in order to continue our operations. We may not be able to raise needed additional capital or financing due to market conditions or for regulatory or other reasons. We cannot assure that we will have adequate capital to conduct our business. If additional funding is not obtained, we may need to reduce, defer or cancel development efforts or overhead expenditures to the extent necessary. The failure to fund our operating and capital requirements could have a material adverse effect on our business, financial condition and results of operations.


We have limited existing brand identity and customer loyalty; if we fail to attract customers to use our service offerings, our business could suffer.

Because we are engaged in developing, and have not yet commercialized, the Naqi Earbuds and Naqi Framework, we currently do not have a strong brand identity or brand loyalty. We believe that establishing and maintaining brand identity and brand loyalty is critical to attracting customers once we have commercially viable products and services. In order to attract customers to our products and services, we may be forced to spend substantial funds to create and maintain brand recognition among consumers. We believe that the cost of our sales campaigns could increase substantially in the future. If our efforts to market our products and establish our brand are not successful, our ability to earn revenues and sustain our operations could be harmed.

Delays and dealing with unknown factors during the manufacturing process of the Naqi Earbud.

Due to current coronavirus ("COVID-19") and possible upcoming COVID-19 variant-related complications in the global supply chain, there may be delays in acquiring raw material and electronic parts for the Naqi Earbud. For the same reasons there may be delays in the distribution of the finished products. Since this is a new Earbud design, some unknown engineering problems during manufacturing may be encountered and delays the completion of the final product, consequently, delays the commercialization of the Naqi products.

Our success is dependent on the completed development and potential performance of the Naqi Earbuds and Naqi Framework.

Because we are still developing the Naqi Earbuds and Naqi Framework, a number of factors, including technological and regulatory barriers in the markets in which we operate, could delay or prevent the potential launch of such products or limit our potential profitability. As these are our only products in development at this time, our overall financial performance is directly tied to their completed development and potential performance.

We will need to increase the size of our organization, and we may be unable to manage rapid growth effectively.

Our failure to manage growth effectively could have a material and adverse effect on our business, results of operations and financial condition. We anticipate that a period of significant expansion will be required to address the development and release of new products and services and potential internal growth to handle research and marketing activities. This expansion will place a significant strain on management, operational and financial resources. To manage the expected growth of our operations and personnel, we must both improve our existing operational and financial systems, procedures and controls and implement new systems, procedures and controls. We must also expand our finance, administrative, and operations staff. Our current personnel, systems, procedures and controls may not adequately support future operations. Management may be unable to hire, train, retain, motivate and manage necessary personnel or to identify, manage and exploit existing and potential strategic relationships and market opportunities.

We are not subject to Sarbanes-Oxley and lack the internal controls over financial reporting required of public companies.

We currently do not have the internal infrastructure necessary, and are not required, to complete an attestation about our internal controls over financial reporting that would be required under Section 404 of the Sarbanes-Oxley Act. As a result, we may fail to identify material deficiencies or weaknesses in the quality of such internal controls. We may in the future be required, by Sarbanes-Oxley or other applicable laws (including exchange and market regulations) to establish and maintain appropriate internal controls over financial reporting. Establishing such controls may require us to incur significant expenses and diversion of management's time. Failure to establish appropriate controls, or any failure of those controls once established, could adversely impact our public disclosures regarding our business, financial condition or results of operations.

In addition, management's assessment of internal controls over financial reporting may identify weaknesses and conditions that need to be addressed in our internal controls over financial reporting or other matters that may raise concerns for investors. Any actual or perceived weaknesses and conditions that need to be addressed in our internal control over financial reporting, disclosure of management's assessment of our internal controls over financial reporting or disclosure of our public accounting firm's attestation to or report on management's assessment of our internal controls over financial reporting may have an adverse impact on the price of our Common Stock. 


The smart earbud, gestural input, brain-computer interface and non-tactile input industries are competitive, and we may be unable to compete with companies with greater financial or technical resources than us, which could negatively affect our operations.

The smart earbud, gestural input, brain-computer interface and non-tactile input industries are characterized by rapid technological developments and a high degree of competition. Access to patents and other protection for technology and products, the ability to commercialize technological developments, access to necessary capital, access to market channels and the ability to obtain necessary approvals for testing, manufacturing and commercialization will impact our potential success.

We will be competing with the largest technology firms in the world that may be applying novel biotechnology, signal analysis, sensor development and computing logic to their products and services and eager to tap into the unique patented technology we are developing.  These companies, as well as academic institutions, government agencies and private research organizations, also compete with us in research and development, product development, and market and brand development. Additionally, these companies and entities all compete for highly-qualified scientific personnel and consultants, and capital from investors.

The successful development of the Naqi Earbuds and Naqi Framework is highly speculative and is dependent on numerous factors, many of which are beyond our control.

The Company was only recently formed to engage in developing the Naqi Earbuds and Naqi Framework and we have not commenced revenue-generating operations. Our business is dependent on the development and implementation of such products, prototypes of which will not be shared with original equipment manufacturers ("OEMs") or other partner types such as independent software vendors, resellers, solution partners and Value-Added Resellers until the fourth quarter of 2022, or the identification and development of new products and services, all of which are highly speculative and subject to numerous risks and uncertainties. For example, our business is dependent on our success in:

  • establishing brand recognition and customer loyalty;

  • successfully developing and deploying new products and services;

  • competing with other companies that are currently in, or may in the future enter, the markets in which we will compete;

  • managing growth in administrative overhead costs;

  • navigating economic conditions;

  • developing our partner ecosystem

  • successfully testing and validating our technology with co-innovation partners

  • managing the growth of our business; and

  • expanding our business into adjacent markets (including cloud, Big Data, gaming, augmented reality and virtual reality integration and defense applications).

There is no assurance that we will succeed in addressing these risks and uncertainties or that we will generate significant revenues or profits. An investment in the Common Shares is speculative and there is no assurance that investors will obtain any return on their investment. Investors will be subject to substantial risks involved in an investment in us, including the risk of losing their entire investment. 


New products and services may subject us to additional risks. A failure to successfully manage these risks may have a material adverse effect on our business.

From time to time, we may develop and implement new products and services. There are substantial risks and uncertainties associated with these efforts, particularly in instances where the markets are not fully developed. In developing and marketing new products and services, we may invest significant time and resources. Initial timetables for the introduction and development of new products or services may not be achieved and price and profitability targets may not prove feasible. External factors, such as compliance with regulations, competitive alternatives, and shifting market preferences, may also impact the successful implementation of a new product or service. Failure to successfully manage these risks in the development and implementation of new products or services could have a material adverse effect on our business, results of operations and financial condition.

If we are unable to develop a partner ecosystem, sales, marketing and distribution channels or enter into agreements with third parties to perform these functions on acceptable terms, we may be unable to generate revenue.

We do not currently have any sales, marketing or distribution capabilities. For any products or services we intend to introduce into the market, we will need to develop sales, marketing and distribution channels to commercialize such products, which may be expensive and time-consuming, or enter into collaborations with third parties to perform these services. If we decide to market our products directly, we will need to commit significant financial and managerial resources to develop a marketing and sales force with technical expertise and supporting distribution, administration and compliance capabilities. If we rely on third party collaborations with such capabilities to market our products or decide to co-promote products with collaborators, we will need to establish and maintain marketing and distribution arrangements with third parties, and there can be no assurance that we will be able to enter into such arrangements on acceptable terms or at all. In entering into third-party marketing or distribution arrangements, any direct and indirect revenue we receive will depend upon the efforts and profitability of the third parties from our products. There can be no assurance that such third parties will establish adequate sales and distribution capabilities or be successful in gaining market acceptance of any product. If we are not successful in commercializing any products in the future, either on our own or through third parties, our business, financial condition and results of operations could be materially adversely affected.

We may face significant competition in Canada and in other markets like United States, Europe and Asia where we may decide to operate in the future.

We may face significant competition in Canada and in other markets where we decide to offer the Naqi Earbuds or Naqi Framework, including in the United States, Europe and Asia, or other products and services which we have not yet identified or developed. Many of our competitors may have substantially greater financial, technical and other resources, such as larger research and development staff and experienced marketing organizations. Additional mergers and acquisitions in our industry may result in even more resources being concentrated in our competitors. As a result, these companies may obtain market acceptance more rapidly than we can and may be more effective as well. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large, established companies. Competition may increase further as a result of our successful penetration into such additional markets.

Our revenue could fluctuate from period to period, which could have an adverse material impact on our business.

Our revenue may fluctuate from period-to-period in the future due to a variety of factors, many of which are beyond our control. Factors relating to our business that may contribute to these fluctuations include the following events, as well as other factors described elsewhere in this Offering Circular:

  • Changes in state and federal government regulations, international government laws and regulations or the enforcement of those laws and regulations; and
  • General economic and political conditions, both domestically and internationally, as well as natural disasters, risk of slow recovery from the COVID-19 pandemic conditions, and other unforeseen factors.

As a result of these and other factors, the results of operations for any quarterly or annual period may differ materially from the results of operations for any prior or future quarterly or annual period and should not be relied upon as indications of our future performance.


If we are unable to effectively protect our intellectual property and trade secrets, it may impair our ability to compete.

Our success will depend in part on our ability to obtain and maintain meaningful intellectual property protection for our intellectual property. The names and/or logos of our brands may be challenged by holders of trademarks who file opposition notices, or otherwise contest, trademark applications by us. Similarly, domains owned and used by us may be challenged by others who contest our ability to use the domain name or URL. Patents, trademarks and copyrights that have been or may be obtained by us may be challenged by others, or enforcement of the patents, trademarks and copyrights may be required. We also rely upon, and will rely upon in the future, trade secrets. While we use reasonable efforts to protect these trade secrets, we cannot assure that our employees, consultants, contractors or advisors will not, unintentionally or willfully, disclose our trade secrets to competitors or other third parties. In addition, courts outside the United States are sometimes less willing to protect trade secrets. Moreover, our competitors may independently develop equivalent knowledge, methods and know-how. If we are unable to defend our trade secrets from others' use, or if our competitors develop equivalent knowledge, it could have a material adverse effect on our business. Any infringement of our patent, trademark, copyright or trade secret rights could result in significant litigation costs, and any failure to adequately protect our trade secret rights could result in our competitors offering similar products, potentially resulting in loss of a competitive advantage and decreased revenues. Existing patent, copyright, trademark and trade secret laws afford only limited protection. In addition, the laws of some foreign countries do not protect our rights to the same extent as do the laws of Canada or the United States. Therefore, we may not be able to protect our existing patent, copyright, trademark and trade secret rights against unauthorized third-party use. Enforcing a claim that a third party illegally obtained and is using our existing patent, copyright, trademark and trade secret rights could be expensive and time consuming, and the outcome of such a claim is unpredictable. Such litigation could result in diversion of resources and could materially adversely affect our operating results.

Customer complaints regarding our products and services could hurt our business.

From time to time, we may receive complaints from customers regarding the quality of products and services purchased from or licensed by us. We may in the future receive correspondence from customers requesting reimbursement. Certain dissatisfied customers may threaten legal action against us if no reimbursement is made. We may become subject to product liability lawsuits from customers alleging injury because of a purported defect in our products or services, claiming substantial damages and demanding payments from us. We are in the chain of title when we supply or distribute products, and therefore are subject to the risk of being held legally responsible for them. These claims may not be covered by our insurance policies. Any resulting litigation could be costly for us, divert management attention, and could result in increased costs of doing business, or otherwise have a material adverse effect on our business, results of operations, and financial condition. Any negative publicity generated as a result of customer frustration with our products or services, or with our websites, could damage our reputation and diminish the value of our brand name, which could have a material adverse effect on our business, results of operations, and financial condition.

Computer, website and/or information system breakdowns, as well as cyber security attacks, could affect our business.

Computer, website and/or information system breakdowns as well as cyber security attacks could impair our ability to implement our business plans, leading to reduced revenue and/or reputational damage, which could have a material adverse effect on our financial results as well as the investor's investment.

We will depend on third-party providers for a reliable Internet infrastructure as well as other aspects of our technology and applications and the failure of these third parties, or the Internet in general, for any reason would significantly impair our ability to conduct our business.

We will outsource some or all of our online presence, server needs, technology development and data management to third parties who host the actual servers and provide power and security in multiple data centers in each geographic location. These third-party facilities require uninterrupted access to the Internet. If the operation of the servers is interrupted for any reason, including natural disaster, financial insolvency of a third-party provider, or malicious electronic intrusion into the data center, our business would be significantly damaged. As has occurred with many Internet-based businesses, we may be subject to "denial-of-service" attacks in which unknown individuals bombard our computer servers with requests for data, thereby degrading the servers' performance. We cannot be certain we would be successful in quickly identifying and neutralizing these attacks. If either a third-party facility failed, or our ability to access the Internet was interfered with because of the failure of Internet equipment in general or if we become subject to malicious attacks of computer intruders, our business and operating results will be materially adversely affected specifically in our Naqi Cloud environment. 


Compliance with laws and regulations designed to protect personal data, and our actual or perceived failure to adequately protect personal data, could harm our business.

A variety of state/provincial/territorial, national, foreign, and international laws and regulations apply to the collection, use, retention, protection, disclosure, transfer and other processing of personal data. These privacy and data protection-related laws and regulations are evolving, with new or modified laws and regulations proposed and implemented frequently and existing laws and regulations subject to new or different interpretations. Compliance with these laws and regulations can be costly and can delay or impede the development of new products. Our actual, perceived or alleged failure to comply with applicable laws and regulations or to protect personal data, including sensitive cardholder data and account information, could result in enforcement actions and significant penalties against us, which could result in negative publicity, increase our operating costs, subject us to claims or other remedies and may harm our business and our investor's investment.

We may be involved in legal and regulatory proceedings.

From time to time, we may be a party to legal and regulatory proceedings, including matters involving governmental agencies, entities with whom we do business, customers, and other proceedings arising in the ordinary course of business. We will evaluate our exposure to these legal and regulatory proceedings and establish reserves for the estimated liabilities in accordance with generally accepted accounting principles. Assessing and predicting the outcome of these matters involves substantial uncertainties. Unexpected outcomes in these legal proceedings, or changes in management's evaluations or predictions and accompanying changes in established reserves, could have an adverse impact on our financial results.

The liability of our directors and officers and others is limited under certain circumstances.

We may provide for the indemnification of directors, officers and others to the fullest extent permitted by law and, to the extent permitted by such law, eliminate or limit the personal liability of directors, officers and others to us and our shareholders for monetary damages for certain breaches of fiduciary duty. Such indemnification may be available for liabilities arising in connection with this Offering. Insofar as indemnification for liabilities arising under the Securities Act may be provided to directors, officers or others controlling or working with us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and, therefore, is unenforceable. Despite this fact, if we provide such indemnification, it could have a material adverse effect on us.

Our executive officers, directors and insider shareholders beneficially own or control a substantial portion of the outstanding Common Shares.

Our executive officers, directors and insider shareholders beneficially own or control a substantial portion of the outstanding Common Shares, which may limit an investor's ability to propose or direct the management or overall direction of the Company. Additionally, this concentration of ownership could discourage or prevent a potential takeover of the Company that might otherwise result in an investor receiving a premium over the market price for the Common Shares. The majority of the currently outstanding Common Shares is beneficially owned and controlled by a group of insiders, including our directors, executive officers and inside shareholders. Accordingly, our directors, executive officers and insider shareholders may have the power to control the election of our directors and the approval of actions for which the approval of our shareholders is required. Such concentrated control of the Company may adversely affect the price of the Common Shares. Our executive officers, directors and insider shareholders may be able to control matters requiring approval by our shareholders, including mergers or other business combinations. Such concentrated control may also make it difficult for our shareholders to receive a premium for the Common Shares in the event that we merge with a third party or enter into different transactions which require shareholder approval. These provisions could also limit the price that investors might be willing to pay in the future for the Common Shares.

Because we do not have an audit or compensation committee, shareholders will have to rely on management to perform these functions.

We do not have an audit or compensation committee composed of independent directors or any audit or compensation committee. Our directors and management perform these functions as a whole. Thus, there is a potential conflict in that our directors and management will participate in discussions concerning director and management compensation and audit issues that may affect management decisions. 


We may have difficulty retaining and acquiring personnel.

The loss of any member of our management team could have a material adverse effect on our business and results of operations. In addition, the inability to hire or the increased costs of hiring new personnel, including members of executive management, could have a material adverse effect on our business and operating results. The expansion of marketing and sales of our impact products and services will require us to find, hire and retain additional capable employees or consultants who can understand, explain, market and sell our products. There is intense competition for capable personnel in all of these areas, and we may not be successful in attracting, training, integrating, motivating, or retaining new personnel, vendors, or subcontractors for these required functions. New employees and consultants often require significant training and, in many cases, take a significant amount of time before they achieve full productivity. As a result, we may incur significant costs to attract and retain employees and consultants, including significant expenditures related to salaries and benefits and other compensation expenses. We may lose new employees or consultants to our competitors or other companies before we realize the benefit of our investment in recruiting and training them. In addition, as we move into new jurisdictions, we will need to attract and recruit skilled employees and consultants in those new areas.

Our directors and officers may have conflicts of interest.

We may be subject to various potential conflicts of interest because of the fact that some of our officers and directors may be engaged in a range of business activities. In addition, our officers and directors may devote time to their outside business interests, so long as such activities do not materially or adversely interfere with their duties to the Company. In some cases, our officers and directors may have fiduciary obligations associated with these business interests that interfere with their ability to devote time to our business and affairs and that could adversely affect our operations. These business interests could require significant time and attention of our executive officers and directors.

Our financial statements have been prepared in accordance with IFRS accounting principles.

As a Canadian incorporated and resident company, our financial statements are prepared using IFRS accounting principles, which are different from the accounting principles under U.S. Generally Accepted Accounting Principles ("U.S. GAAP"). IFRS is an internationally recognized body of accounting principles that are used by many companies outside of the United States to prepare their financial statements. Regulation A permits Canadian issuers to prepare and file their financial statements in accordance with IFRS rather than U.S. GAAP.  U.S. Investors who are not familiar with IFRS may misunderstand certain information presented in our financial statements. Accordingly, we suggest that readers of our financial statements familiarize themselves with the provisions of IFRS accounting principles in order to better understand the differences between these two sets of principles.

Public health epidemics or outbreaks could adversely impact our business.

Our proposed business plan and activities may be adversely affected by potential medical pandemic issues, such as COVID-19 and mutations or variants thereof, and may result in potential related impact to employees, disruption to operations, supply chain delays, manufacturing delays, travel and trade restrictions and impact on economic activity in affected countries or regions. Such pandemics or diseases represent a serious threat to maintaining a skilled workforce and could be a major health-care challenge for the Company. There can be no assurance that the Company's personnel will not be impacted by these pandemic diseases and ultimately see its workforce productivity reduced or incur increased medical costs/insurance premiums as a result of these health risks. As well, there can be no assurance that the Company will not be impacted by adverse consequences that may be brought about by pandemics on global financial markets which may reduce resources, share prices and financial liquidity that may severely limit the financing capital available in this sector.

Risks Related to this Offering and the Common Shares

We may terminate this Offering at any time during the Offering Period and do not have a minimum capitalization.

We reserve the right to terminate this Offering at any time, regardless of the number of Common Shares sold. In the event that we terminate this Offering at any time prior to the sale of all of the Common Shares offered hereby, whatever amount of capital that we have raised at that time will have already been utilized by the Company and no funds will be returned to subscribers. We do not have a minimum capitalization, and we may use the proceeds from this Offering immediately following our acceptance of the corresponding subscription agreements. We do not have any track record for self-underwritten Regulation A offerings, and there can be no assurance the Maximum Offering or any other amount will be sold in this Offering. There is no assurance that we will raise sufficient capital solely from this Offering to implement our business plan, potentially resulting in greater operating losses unless we are able to raise the required capital from alternative sources. There is no assurance that alternative capital, if needed, would be available on terms acceptable to us, or at all.


The Common Shares are being offered on a "best efforts" basis and we may not raise sufficient capital to satisfy our working capital needs.

Since we are offering the Common Shares on a "best efforts" basis, there is no assurance that we will sell enough Common Shares to meet our working capital needs. If an investor purchases Common Shares, then the investor will do so without any assurance that we will raise enough money to satisfy the full use of proceeds that we have outlined in this Offering Circular or to meet our working capital needs.

This Offering is being conducted without the benefit of an underwriter, who could have confirmed the accuracy of the disclosures in this Offering Circular.

We have self-underwritten this Offering on a "best efforts" basis, which means that no underwriter has engaged in any due diligence activities to confirm the accuracy of the disclosure in this Offering Circular or to provide input as to this Offering price; we will attempt to sell the shares and there can be no assurance that all of the shares offered under this Offering Circular will be sold or that the proceeds raised from this Offering, if any, will be sufficient to cover the costs of this Offering; and there is no assurance that we can raise the intended Offering amount.

It is uncertain when the Common Shares will be listed on an exchange for trading, if ever.

No application is currently being prepared for the Common Shares to trade on a public market.  As a result, the Common Shares sold in this Offering may not be listed on a securities exchange or quoted on an alternative trading system for an extended period of time, if at all. If the Common Shares are not listed on a securities exchange or quoted on an alternative trading system, it may be difficult to sell or trade in the Common Shares. There can be no assurance that a liquid market for the Common Shares will develop or, if it does develop, that it will continue. If a market does develop, it may not be liquid. Therefore, investors may not be able to sell the Common Shares easily or at prices that will provide them with yield comparable to similar investments that have a developed secondary market. Illiquidity may have a severely adverse effect on the market value of the Common Shares and investors wishing to sell the Common Shares might therefore suffer losses.

Although to date we have not been subject to the continuous and timely disclosure requirements of Canadian securities laws or other rules, regulations and policies of a securities exchange or alternative trading system, we are working with our legal, accounting and financial advisors to identify those areas in which changes should be made to our financial management control systems to manage our obligations as a public company listed on a securities exchange or quoted on an alternative trading system. These areas include corporate governance, corporate controls, disclosure controls and procedures and financial reporting and accounting systems. We have made, and will continue to make, changes in these and other areas, including our internal controls over financial reporting. However, we cannot assure holders of the Common Shares that these and other measures that we might take will be sufficient to allow us to satisfy our obligations as a public company listed on a securities exchange or quoted on an alternative trading system on a timely basis. In addition, compliance with reporting and other requirements applicable to public companies listed on a securities exchange or quoted on an alternative trading system will create additional costs for us and will require the time and attention of management. We cannot predict the amount of the additional costs that we might incur, the timing of such costs or the impact that management's attention to these matters will have on our business.

If the Common Shares become subject to the penny stock rules, it would become more difficult to trade the Common Shares.

The SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5.00, other than securities registered on certain national securities exchanges or authorized for quotation on certain automated quotation systems, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system. If we do not obtain and retain a listing or quotation of the Common Stock and if the price of the Common Stock is less than $5.00, the Common Stock will be deemed a penny stock. The penny stock rules require a broker-dealer, before a transaction in a penny stock not otherwise exempt from those rules, to deliver a standardized risk disclosure document containing specified information. In addition, the penny stock rules require that before effecting any transaction in a penny stock not otherwise exempt from those rules, a broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive (i) the purchaser's written acknowledgment of the receipt of a risk disclosure statement; (ii) a written agreement to transactions involving penny stocks; and (iii) a signed and dated copy of a written suitability statement. These disclosure requirements may have the effect of reducing the trading activity in the secondary market for the Common Stock, and therefore stockholders may have difficulty selling the Common Shares.


We have broad discretion in how we use the proceeds of this Offering and may not use these proceeds effectively, which could affect our results of operations and cause the price of our Common Shares to decline.

We will have considerable discretion in the application of the net proceeds of this Offering. We intend to use the net proceeds from this Offering to fund our business strategy, including without limitation, new and ongoing technology development; marketing and business development; working capital; general corporate purposes, including hiring additional personnel; and expenses of this Offering. As a result, investors will be relying upon management's judgment with only limited information about our specific intentions for the use of the balance of the net proceeds of this Offering. We may use the net proceeds for purposes that do not end up yielding a significant return or any return at all for our shareholders. In addition, pending their use, we may invest the net proceeds from this Offering in a manner that does not produce income or that loses value.

We may incur increased costs as a result of our public reporting obligations, and our management team will be required to devote substantial time to new compliance initiatives.

We may become subject to the periodic reporting requirements for public reporting companies in the United States and Canada in the near future. Particularly, after we are no longer an "emerging growth company," we will continue to incur significant legal, accounting and other expenses that we have not incurred as a private company. Our management and other personnel would need to devote a substantial amount of time to comply with our reporting obligations. Moreover, these reporting obligations will increase our legal and financial compliance costs and will make some activities more time-consuming and costly.

We may lose our status as a "foreign private issuer" in the United States, which would result in increased costs related to regulatory compliance under United States securities laws.

The Company will cease to qualify as a "foreign private issuer," as defined in Rule 405 promulgated under the Securities Act and Rule 3b-4 promulgated under the Exchange Act, if, as of the last business day of our second fiscal quarter, more than 50 percent of the outstanding Common Shares are directly or indirectly owned by residents of the United States. If we determine that we fail to qualify as a foreign private issuer, the Company will cease to be eligible to avail itself of the forms and rules designated for foreign private issuers beginning on the first day of the fiscal year following such determination. Among other things, this will result in loss of the exemption from registration under the Exchange Act provided by Rule 12g3-2(b) promulgated thereunder, and, if the Company is required to register the Common Shares under section 12(g) of the Exchange Act, we will have to do so as a domestic Company. Further, any securities that we issue in unregistered or unqualified offerings both within and outside the United States will be "restricted securities" (as defined in Rule 144(a)(3) promulgated under the Securities Act), and will continue to be subject to United States resale restrictions notwithstanding their resale in "offshore transactions" pursuant to Regulation S promulgated under the Securities Act. As a practical matter, this will likely require us to register more offerings of our securities under the Securities Act on either a primary offering or resale basis, even if they take place entirely outside the United States. The resulting legal and administrative costs of complying with the resulting regulatory requirements are anticipated to be substantial, and to subject the Company to additional exposure to liability for which we may not be able to obtain insurance coverage on favorable terms or at all.

We do not intend to pay dividends on the Common Shares and, consequently, your ability to achieve a return on your investment will depend on appreciation in the price of the Common Shares.

We have never declared or paid any cash dividend on our Common Shares and do not currently intend to do so in the foreseeable future. We currently anticipate that we will retain future earnings for the development, operation and expansion of our business and do not anticipate declaring or paying any cash dividends in the foreseeable future. Therefore, the success of an investment in the Common Shares will depend upon any future appreciation in their value. There is no guarantee that the Common Shares will appreciate in value or even maintain the price at which you purchased them.


Terms of subsequent financings, if any, may adversely impact investors' investments.

We may have to engage in equity or debt financings in the future. The rights and the value of each investor's investment in the Common Shares could be reduced by the dilution caused by future equity issuances. Interest on debt securities could increase costs and negatively impact operating results. If we need to raise more equity capital from the sale of additional stock, institutional or other investors may negotiate terms at least as, and possibly more favorable than the terms of the investors' investments.

We determined the offering price for the Common Shares being sold in this Offering.

We determined arbitrarily the price at which the Common Shares are being offered in this Offering. There is no relationship between the offering price and our assets, book value, net worth, or any other economic or recognized criteria of value. Rather, the price of the Common Shares was derived as a result of internal decisions based upon various factors, including prevailing market conditions, the Company's future prospects and the Company's capital structure. The price does not necessarily accurately reflect the actual value of the Common Shares or the price that may be realized upon disposition of the Common Shares.

If an investor purchases Common Shares in this Offering, the investor will incur immediate and substantial dilution in the book value of the Common Shares.

Each investor will suffer immediate and substantial dilution in the net tangible book value of the Common Shares the investor purchases in this Offering. Assuming an offering price of $2.00 per Common Share and that all 5,000,000 Common Shares are sold for estimated net proceeds of $9,770,000 (after deducting estimated offering expenses), investors purchasing Common Shares in this Offering will experience dilution of approximately $0.01 per Common Share in net tangible book value of the Common Shares. In addition, assuming the Maximum Offering amount is sold in this Offering, investors purchasing Common Shares will contribute over 83.5% of the total amount shareholders have invested in the Company since inception and will own approximately 9.4% of the Common Shares outstanding.


DILUTION

As at the date of this Offering Circular, an aggregate of 48,473,874 Common Shares are issued and outstanding. The price of the Common Shares under this Offering is higher than the average per share value of the Common Shares previously issued. Accordingly, investors who purchase Common Shares in this Offering will incur immediate dilution in the pro forma value of their Common Shares. This means that investors that purchase Common Shares will pay a price per share that exceeds the average per share value of the Company's previously issued Common Shares.

The following table illustrates the approximate per share dilution to new investors, assuming the sale of, respectively, 100%, 75%, 50% and 25% of the Common Shares offering for sale in this Offering (after deducting our estimated offering expenses of $230,000, $205,000, $180,000 and $155,000, respectively):

 

25%

 

50%

 

75%

 

100%

 

 

 

 

 

 

 

 

Offering Proceeds

$2,500,000

 

$5,000,000

 

$7,500,000

 

$10,000,000

 

 

 

 

 

 

 

 

Offering Price per Common Share

$2.00

 

$2.00

 

$2.00

 

$2.00

 

 

 

 

 

 

 

 

Net tangible book value per Common Share before this Offering

$(0.03)

 

$(0.03)

 

$(0.03)

 

$(0.03)

 

 

 

 

 

 

 

 

Increase per Common Share attributable to investors in this Offering

$0.05

 

$0.10

 

$0.14

 

$0.19

 

 

 

 

 

 

 

 

Net tangible book value per Common Share after this Offering

$0.02

 

$0.07

 

$0.11

 

$0.16

 

 

 

 

 

 

 

 

Dilution to investors after this Offering

$1.98

 

$1.93

 

$1.89

 

$1.84

_______________

The Company may from time to time issue additional Common Shares or other equity securities, which may result in dilution of existing shareholders if the Common Shares or other equity securities are sold at a price that is less than the average per share value of the Common Shares previously issued.


PLAN OF DISTRIBUTION

The Common Shares are being offered pursuant to Regulation A of Section 3(b) of the Securities Act, for Tier 2 offerings, by the management of the Company on a "best-efforts" basis directly to purchasers who satisfy the requirements set forth in Regulation A. We have no minimum capitalization, and we may use the proceeds from this Offering immediately following our acceptance of the corresponding subscription agreements towards our offering (which include legal, accounting, printing, due diligence, marketing, selling and other costs incurred in this Offering), operating, technology development, marketing and business development expenses, as more specifically set forth in the "Use of Proceeds to the Company" beginning on page 25. There is no arrangement for the return of funds to investors if all of the Common Shares offered are not sold in this Offering.

This Offering will expire on the earlier of the date on which (1) the Maximum Offering is sold, or (2) the board of directors of the Company (the "Board") elects to terminate this Offering.

There is no arrangement to address the possible effect of this Offering on the price of the Common Shares.

The Company has engaged Dalmore Group, LLC (the "Broker"), a broker-dealer registered with the Commission and a member of the Financial Industry Regulatory Authority ("FINRA"), to act as the broker-dealer of record for this Offering, but not for underwriting or placement agent services. As compensation, the Company has agreed to pay the Broker a commission equal to 1% of the amount raised in the Offering to support the Offering on all invested funds after the issuance of a No Objection Letter by FINRA. In addition, the Company has paid the Broker a one-time advance set up fee of $5,000 to cover reasonable out-of-pocket accountable expenses actually anticipated to be incurred by the Broker, such as, among other things, preparing the FINRA filing. The Broker will refund any fee related to the advance to the extent it is not used, incurred or provided to the Company. In addition, the Company will pay a one time $20,000 consulting fee that will be due immediately after FINRA issues a No Objection Letter.

TAX CONSEQUENCES FOR EACH INVESTOR (INCLUDING FEDERAL, STATE, LOCAL AND FOREIGN INCOME TAX CONSEQUENCES) WITH RESPECT TO THE INVESTMENT ARE THE SOLE RESPONSIBILITY OF THE INVESTOR. INVESTORS MUST CONSULT WITH THEIR OWN PERSONAL ACCOUNTANT(S) AND/OR TAX ADVISOR(S) REGARDING THESE MATTERS.

Generally speaking, Rule 3a4-1 under the Exchange Act, provides an exemption from the broker-dealer registration requirements of the Exchange Act for persons associated with a company that participate in an offering of the Company's securities. None of our officers or directors are subject to any statutory disqualification, as that term is defined in Section 3(a)(39) of the Exchange Act. None of our officers or directors will be compensated in connection with their participation in this Offering by the payment of commissions or other remuneration based either directly or indirectly on transactions in our securities. None of our officers or directors are, or have been within the past 12 months, a broker or dealer, and none of them are, or have been within the past 12 months, an associated person of a broker or dealer. At the end of this Offering, our officers and directors will continue to primarily perform substantial duties for the Company or on its behalf otherwise than in connection with transactions in securities. Our officers and directors will not participate in selling an offering of securities for any company more than once every 12 months other than in reliance on Exchange Act Rule 3a4-1(a)(4)(i) or (iii) except that for securities issued pursuant to Rule 415 under the Securities Act, the 12 months shall begin with the last sale of any security included within one Rule 415 registration.

Technology Services

We have engaged Novation Solutions Inc. dba Dealmaker (the "Technology Agent") to provide certain technology services to us in connection with this Offering, including the online platform of the Technology Agent. After the qualification by the SEC of the Offering Statement of which this Offering Circular is a part, this Offering will be conducted on the online platform of the Technology Agent through the Investor Relations page of our website at www.naqilogix.com, whereby investors will receive, review, execute and deliver subscription agreements electronically as well as make payment of the purchase price through a third party processor by ACH debit transfer or wire transfer to an account we designate. There is no escrow established for this Offering. We will hold closings upon the receipt of investors' subscriptions and our acceptance of such subscriptions. If, on the initial closing date, we have sold less than the Maximum Offering, then we may hold one or more additional closings for additional sales, until the Termination Date Funds will be promptly refunded without interest, for sales that are not consummated.


We will pay certain itemized technology fees to Technology Agent for these services, including: (i) a $10,000 fee for platform hosting and maintenance fees; (ii) monthly subscription fee of $1,000; and (iii) transaction fees of $15 per investor for a signed and submitted purchase order and $15 per investor for a recorded payment. Additionally, we agreed to pay the Technology Agent certain processing and other administrative fees with regard to payments made on the DealMaker Platform.

The Technology Agent is not participating as an underwriter or placement agent of this Offering and will not solicit any investments, recommend our securities, provide investment advice to any prospective investor, or distribute this Offering Circular or other offering materials to potential investors. All inquiries regarding this Offering or escrow should be made directly to us.

Transfer Agent

The transfer agent for our Common Shares is DealMaker Transfer Agent LLC, 16540 Point Village Drive, Suite 201(J), Lutz, Florida 33558 (www.dealmaker.tech).

Selling Security Holders

No securities are being sold for the account of security holders; all net proceeds of this Offering will go to the Company.


USE OF PROCEEDS TO COMPANY

If the Maximum Offering is sold, the maximum gross proceeds from the sale of our Common Shares will be $10,000,000. As of the date of this Offering Circular, $0.00 has been raised under this Offering. The net proceeds from the total Maximum Offering is expected to be approximately $9,770,000, after the payment of offering costs (including legal, accounting, printing, due diligence, marketing, selling and other costs incurred in this Offering).  The estimate of the budget for offering costs is an estimate only and the actual offering costs may differ.

To account for a varying potential use of funds from the low to high ends of this range, we provide a summary of the net amount of proceeds net of offering expenses at the maximum raise amount, as well as at the 25%, 50%, 75%. 100%  intervals. The planned use of the net proceeds to us at each of these intervals will then be detailed by category, with each category described in detail afterward.

Net Proceeds to Company by Interval of Funds Raised

    25%     50%     75%     100%  
                         
Gross Proceeds $ 2,500,000   $ 5,000,000   $ 7,500,000   $ 10,000,000  
                         
Offering Expenses $ 155,000   $ 180,000   $ 205,000   $ 230,000  
                         
Net Proceeds to Company $ 2,345,000   $ 4,820,000   $ 7,295,000   $ 9,770,000  

Use of Proceeds by Interval of Funds Raised

All figures provided in this table are estimates and are subject to change based on adjustments to our business plan.

    25%     50%     75%     100%  
                         
Prototyping and Manufacturing Costs $ 400,000   $ 1,000,000   $ 1,350,000   $ 1,950,000  
                         
Research and Development $ 550,000   $ 1,250,000   $ 2,250,000   $ 2,900,000  
                         
Sales and Marketing, Branding $ 150,000   $ 500,000   $ 1,000,000   $ 1,750,000  
                         
Legal and Compliance $ 125,000   $ 250,000   $ 375,000   $ 500,000  
                         
General & Administrative $ 120,000   $ 320,000   $ 570,000   $ 670,000  
                         
General Working Capital $ 1,000,000   $ 1,500,000   $ 1,750,000   $ 2,000,000  
                         
Total $ 2,345,000   $ 4,820,000   $ 7,295,000   $ 9,770,000  


Prototyping and Manufacturing Costs

These funds will be used to produce quantities of Naqi Earbud prototypes for co-innovation relationships with partners and finished products for general distribution or sale.

Research and Development

Ongoing costs for applied research and development for Naqi Earbud in multiple iterations and development of the Naqi Framework.

Sales and Marketing, Branding

Funds for development of sales and marketing material including website, commercial partner ecosystem infrastructure for OEMs, and to build reseller relationships.

General and Administrative Costs

Included in general and administrative costs would be consulting, wages and salaries and other general office expenses.

Legal and Compliance

We anticipate our legal and compliance costs to increase, as the Company works with counsel on additional patent filings, and maintaining our existing trademarks and patents.

General Working Capital

We anticipate our operating or "burn" expenses for the next twelve months to include consulting, wages and salaries, research and development and legal and other professional fees, which we estimate will amount to approximately $175,000 per month in aggregate.

Disclaimers Regarding Use of Funds

This expected use of the net proceeds from this Offering represents our intentions based upon our current financial condition, results of operations, business plans and conditions. As of the date of this Offering Circular, we cannot specify with certainty all of the particular uses for the net proceeds to be received upon the closing of this Offering or the amounts that we will actually spend on the uses set forth above. In addition, the amount, allocation and timing of our actual expenditures will depend upon numerous factors. Our management will have broad discretion in the application of the net proceeds we receive from this Offering, and investors will be relying on the judgment of our management regarding the application and ultimate use of the net proceeds.

The Company reserves the right to alter the use of proceeds in this Offering without notice, except in circumstances in which such notice is required by law.

Although our business does not presently generate any cash, we believe that if we raise the maximum amount in this Offering, that we will have sufficient capital to finance our operations for at least the next twelve months. However, if we do not sell the maximum number of shares offered in this Offering, or if our operating, technology development, and/or marketing and business development costs are higher than expected, then we will need to obtain additional financing prior to that time. Further, we expect that during or after such twelve-month period, we will be required to raise additional funds to finance our operations until such time that we can conduct profitable revenue-generating activities.

Pending our use of the net proceeds from this Offering, we may invest the net proceeds in a variety of capital preservation investments, including without limitation short-term, investment grade, interest bearing instruments and United States government securities and including investments in related parties. We may also use a portion of the net proceeds for the investment in strategic partnerships and possibly the acquisition of complementary businesses, products or technologies, although we have no present commitments or agreements for any specific acquisitions or investments.


DESCRIPTION OF BUSINESS

Overview of the Company

The Company was incorporated on August 4, 2020, pursuant to the laws of the Province of British Columbia and is domiciled in the Province of British Columbia. The Company engages in the business of (i) developing the Naqi Earbuds, smart earbuds that will enable users to control their IoT environment without looking at, speaking to or touching the devices being controlled, and the Naqi Framework, which enables OEMs of wearable devices to create user interfaces that are capable of discreet and inconspicuous user input and navigation; (ii) commercializing the Naqi Earbuds and Naqi Framework; (iii) developing and licensing Naqi Earbud and Naqi Framework integrations into common information systems, such as residential and commercial IoT systems and potentially leading gaming systems; and (iv) developing and licensing Naqi Operator Vigilance and Naqi Wheelchair Control applications.

As of the date of this Offering Circular, we continue to develop the Naqi Earbuds and Naqi Framework and have not commenced revenue-generating operations. We anticipate sharing prototypes of the Naqi Earbuds and Naqi Framework during the fourth quarter of 2022, aiming for the first commercial (minimum viable product) release of these products by mid 2023.

Commercialization Strategy

Once development of the Naqi Earbuds and Naqi Framework is complete, our commercialization strategy will entail three objectives: (i) integrating the Naqi Earbud and Naqi Framework into all IoT environments, initially piloting accessibility/mobility applications for wheelchairs and operator safety applications for industries which utilize heavy equipment, including the automotive industry, with other applications to follow based on the customer demand; (ii) licensing the Naqi Earbud and Naqi Framework platform directly to customers and to the partner ecosystem for them to develop their own applications; and (iii) developing our cloud platform to analyze Big Data.

Integrate the Naqi Earbud and Naqi Framework into Various IoT Environments

Our technologies can potentially help individuals living with quadriplegia, those who have lost one or many limbs as well as those living with neuromuscular disorders who are challenged with normal everyday tasks. Our first pilot deliverable will be integrating the Naqi Earbud and Naqi Framework into wheelchairs and subsequently into various other IoT environments, such as operator safety, accessibility/mobility, Apple HomeKit AR/VR gaming and others, allowing users to be mobile as well as interact with common devices without the need for mouth-based assistive technologies (e.g., Sip-Puff straws), complex ocular-retinal sensors, voice recognition or proprietary control mechanisms.  All the user data (unanimous) will be collected on the Naqi Cloud platform for market analysis.

License Naqi Earbuds and the Naqi Framework

We intend to license, as applicable, the Naqi Earbuds and Naqi Framework in the form of APIs and SDKs in the smart earbud, gaming and e-sports, military, defense and intelligence, operator vigilance and personal wellness and activity tracking markets. See "-Proposed Markets" for a description of our objectives in each market.

Develop Our Cloud Platform

We intend to develop a cloud platform, called Naqi Cloud, that will enable users to integrate into a wide array of IoT solutions as well as operate within public environments such as airports, shopping centers and restaurants.  We plan to design Naqi Cloud to accommodate hands-free, silent, secure payments at retailers as well as provide opt-in audible marketing based on geo-locations ("GPS").  When customers wear Naqi Earbuds, they will join a worldwide earbud network that will provide audible information to the user, essentially creating an audible augmented reality environment for our users.  This can provide a real-world physical marketing model, similar to Google's AdWord service within the Internet world.  Advertisers will have the ability to bid on impressions based on the likes and preferences of Naqi Earbud users, which in turn entice users to travel-to or walk-into their establishments.  The algorithms for this segment of our business will be carefully designed to fall tightly into an "opt-in" method of notices to our users.  Naqi Cloud revenue will consist of monthly subscriptions for an assortment of IoT integrations, gaming console integrations, delivered audible "suggestions" and "advertisements" as well as affiliate fees received by our worldwide advertising partners.

 


Technologies

Naqi Framework

The Naqi Framework is our patented methodology enabling OEMs of wearable devices to create user interfaces ("UIs") that are capable of discreet and inconspicuous user input and navigation. The Naqi Framework consists of three unique structures: Runes, Plaques and Crypts:

Runes

Runes are three-dimensional line patterns that can be associated to any computer execution, function, procedure, command, macro or process.  These three-dimensional line patterns are constructed with two or more directional commands that include up, down, left, right, forward and back.  Runes can be a set of imagined directions (Mu Rhythms) and captured with either invasive or non-invasive Electroencephalography ("EEG") / Brain-Computer Interface ("BCI") solutions or they can be a set of micro-gestural movements, captured by motion and gyroscopic sensors within the Naqi Earbud. When compared to traditional operating system structures, Runes would serve a similar function to computer icons within a Graphical User Interface ("GUI").

Plaques

Plaques are two-dimensional regions that are organized along the Z-axis of the Rune and are considered a subset of the Rune, organizing closely-related commands.  When compared to traditional operating system structures, Plaques would serve a similar function as file folders with a GUI.

Crypts

The complete set of possible Runes and Plaques along the user's Z-axis is referred to as a Crypt.  When compared to traditional operating system structures, Crypts would most closely resemble a root directory of a hard drive (i.e., C:\). Whether a user chooses to capture brain waves or micro gestures, the Naqi Framework will provide an "invisible operating system" to control his/her environment.

Naqi Earbud

Once development is complete, we intend Naqi Earbuds to be a smart earbud consisting of the circuitry necessary to capture a user's micro-gestural input, eliminating the need for complex bio-training often found within invasive and non-invasive BCI solutions.  Although micro-gestural input and brainwave-controlled input are both discreet input methodologies, micro-gestural input is universal from person to person, is far more accurate and can be captured within a small earbud wearable, unlike a full scalp EEG headset or brain implant required for BCI technologies that are limited to providing basic directional input into information systems.  We anticipate that Naqi Earbuds will create a paradigm shift within the smart earbud market where smart earbuds evolve from being music and phone call receivers to being an invisible outbound control system to your connected world.

Initial Proposed Target Markets

The Company plans to primarily compete in various IoT markets, including (i) the smart earbud market; (ii) the wheelchair market; (iii) the IoT device makers market; (iv) the gaming and e-sports market; (v) the military, defense and intelligence market; (vi) the operator vigilance market; and (vii) the personal wellness and activity tracking market.

Smart Earbud Market

Our initial strategy within the smart earbud market is to license the Naqi Earbud design to major smart earbud OEMs.  The worldwide smart earbud market is approximately USD 25.32 billion in 2020 and is expected to grow at a compound annual growth rate of 36.1% from 2021 to 2028.1  The smart earbud market is currently utilizing a "once-and-done" revenue model:  consumers purchase a set of smart earbuds and will not spend any more money until they purchase another set of smart earbuds.  Naqi Earbuds will enable earbud OEMs to create residual revenue models by creating integrations into devices, services and platforms that mean the most to its consumers. These integrations can be offered to consumers as monthly subscriptions. We plan to manufacture Naqi Earbuds until we solidify a partnership with a leading smart earbud OEM.  Therefore, we have the ability to generate revenue while identifying proper industry partnerships.

_________________________________________
1 Grand View Research. "True Wireless Stereo Earbuds Market Size, Share & Trends Analysis Report By Price Band" (July 2021).


Wheelchair Market

Naqi Earbuds will initially focus on "assistive" integrations.  We will help those living with paralysis, loss of limbs or neuromuscular disorders that prevent them from interacting with their devices and/or IoT environment in an easy, discreet and natural manner.  Follow-up integrations will focus on common residential and commercial IoT environments.  As a first step, the we are exploring possible partnerships with leading wheelchair manufacturers. This partnership will result in the world's first wheelchair that is controlled by smart earbuds, an achievement that will help many millions around the world.  We also plan to license our technologies to other device and wearable manufacturers who wish to incorporate them within their platforms.

IoT Device Makers

We plan to monetize our integrations with common IoT ecosystems such as Apple HomeKit, Amazon Alexa and Google Home in the form of modest monthly subscriptions to an end-user's mobile account.  Finally, we will license our technologies through the use of application programming interfaces and software development kits, allowing developers around the world to invent their own "Naqi Enabled" product or service.  The integrations, user data, geographical data and user-specific options will be managed via our planned "Naqi Cloud" platform which will essentially create a worldwide, real-time network of Naqi Earbud users.

Gaming and E-Sports Market

Our initial strategy within the gaming and e-sports market is to license the Naqi Framework to OEMs of console systems, most notably within the XBox and PlayStation ecosystems.  Utilizing the Naqi Framework will enable such OEMs to develop UIs that are capable of discreet and inconspicuous user input and navigation, enable users to control their gaming environment in a hands-free, voice-free and highly responsive manner.

Military, Defense and Intelligence Market

Our initial strategy within the military, defense and intelligence market is to license the Naqi Framework to OEMs and government agencies, enabling invisible hands-free, voice-free and look-free input to military platforms, including vehicles, aircraft, drones, weapon optics and robotics.  We intend also to incorporate a strong focus on clandestine and invisible communications between users and groups of users, essential for advanced intelligence applications and Close-Quarters Combat (CQC) applications. We are currently exploring relationships with U.S. Department of Defense contractors who will represent us within the government contracting arena when we are ready to acquire a segment of this market.

Operator Vigilance Market

Our initial strategy within the operator vigilance market with a focus on detecting driver fatigue and driver attentiveness while operating electric vehicles, specifically while using autonomous and/or driver assisted modes.  We will also focus on operator fatigue and operator attentiveness for locomotive operators.  Our Naqi Vigilance system, when used in conjunction with our Naqi Earbud (or a Naqi-enabled earbud from another smart earbud OEM), will have an ability to determine whether a driver-operator is fatigued, impaired or paying proper attention to the road/track, as well as whether the driver-operator is following best practices.  Our Naqi Vigilance system can detect whether a driver-operator is looking through the front windshield, is looking out of the side windows too long, is staring at his/her cell phone or if he/she is blinking too often, yawning too often and/or if his/her head is bobbing, all of which can indicate fatigue and possibly impairment.  Additionally, we are working to detect Alpha, Theta and Delta waves from the inner ear canal, which would be additional objective indications that a driver-operator is approaching sleep or sleeping.

Unlike more common video-centric artificial intelligence ("AI") -based vigilance systems, Naqi Vigilance will have the advantage of reading physical bio signals indicating fatigue.  In addition, we will have the ability to know where someone's face is looking and create best-practice templates based on the cockpit layout of the vehicle and geospatial information based on the road or track.  Therefore, this data can be used for training purposes as well as driver rating systems.  The Naqi Earbud telemetry and information collected from a driver-operator's bio signals will be streamed to our Naqi Cloud Platform in an encrypted and secure manner that will guarantee "chain-of-custody" and integrity of the data, should it be subpoenaed in a court of law.


Personal Wellness and Activity Tracking

Our initial strategy with respect to the personal wellness and activity tracking market, which is expected to grow to $138.7 billion by 2028,2 is to offer integrations with the Naqi Earbuds, incorporating motion tracking, EEG and EMG sensors as well as ECG heartrate sensors, PPG pulse sensors, optical pulse oximetry sensors and temperature sensors. With current wrist-worn activity trackers, users must manually engage certain advanced heartrate features such as ECG heart rate, atrial fibrillation (A-fib) detection, and Heart Rate Variability (HRV) by touching relevant sensors on the watch with their opposing hand. With a Naqi Earbud in each ear, users may be able to passively track their heartrate, A-fib, and heartrate variability in real-time for hours every day without having to manually activate this feature and with both hands free. This has major implications for fitness, workout recovery, stress monitoring and many other wellness applications. Additionally, we can leverage our cloud capabilities to offer employer-based wellness programs for major enterprises, like current offerings from Fitbit and other major activity tracker companies. This can be a source of high-volume earbud orders as well as recurring revenue streams with large corporate customers.

Revenue Model

Once we commercialize our products and services, we anticipate three primary sources of revenue:

  • licensing of the Naqi Earbud technology platform and/or direct Naqi Earbud sales;
  • monthly subscriptions for integrations of our technologies into devices, services and platforms; and
  • royalties for applications generated by software sales that originate from the use of Naqi's API/SDK within our developer ecosystem.

In addition, we anticipate generating revenue through various partnership models, whereby we engage with :

  • solution partners, where we license our technologies to such partners and sell Naqi Earbuds directly to customers, with such partners selling Naqi-based applications to customers;
  • independent software vendor resellers, where such resellers sell Naqi-based applications to customers, as well as license our technologies and resell Naqi Earbuds to customers;
  • OEM partners, where such partners embed our technologies into their products which they build, support and sell independently, generating royalties;
  • value added resellers, where such resellers license our technologies and/or resell Naqi Earbuds to customers and provide related services such as consulting, implementation and maintenance; and
  • value added cloud resellers, where such resellers license our technologies and/or resell Naqi Earbuds to customers and provide related services such as consulting, implementation and maintenance using an outsourced hosted Naqi cloud model.

We will explore other strategic partnerships on a case-by-case basis.

Planned Technology Infrastructure

Our technologies depend on the successful development of the following infrastructure: (i) the Naqi Cloud; (ii) the Naqi Appstore; (iii) the Naqi Mobile Network; and (iv) the Naqi Mobile App.

_________________________________________
2 Grand View Research. "True Wireless Stereo Earbuds Market Size, Share & Trends Analysis Report By Price Band" (July 2021).


Naqi Cloud

Naqi User Profiles

Naqi Cloud will be able to determine spending habits (what user buys and average purchase amount), rate the Naqi VIP level of the user (the more often they buy and the more they spend, the higher the VIP rating), frequency of location/establishment visits, times of days as well as days of week most active (hot/cold temperature ratings).  Users will also be able to determine whether to opt-in or opt-out of the Naqi EcoSystem (defined below), determine preferences relating to types of proactive contacts (food, shopping deals, vehicles, etc., frequency of proactive audio cue contacts as well as geographic boundaries and limitations of proactive contacts.  Finally, we need to create a way for users to choose whether or not to allow businesses to push Runes and Plaques to their Naqi Mobile App that are specific to their location or specific to their activity.

Naqi Profile Data Collection

General consumer behavior, general consumer location, action vs time/day-stamps, consumer decision making patterns (classifications), consumer spending (ratings based on classification), conversion ratios / stats of Naqi EcoSystem ads.  This data collection will be fed into a central database of Naqi EcoSystem "Big Data."  We can also use this data collection for micro-region (In-home) predictive behavior patterns, such as controlling in-home IoT devices. Naqi is committed to comply with Data Protection regulations of all governments where Naqi products and services are marketed.

Naqi EcoSystem "Big Data"

Collect data based on population density of Naqi users (defined home location), real-time population densities as well as predicted population densities and patterns.  Large population analytics, predictive analytics, real-world buying profile stats/analytics based on country, region, day or time.  Naqi EcoSystem "Big Data" could be sold as a service to other retailers and marketing agencies, for example.  We will consider creating an online control center, a powerful data dashboard for people-based commerce stats/analytics of a particular country, region or locale.

Health Tracker

Utilizing the Naqi Earbuds, users could track daily steps as well as distance walked, jogged, ran, etc.  We can probably also track calories burned, meals eaten and possibly allow users to set weight loss goals.  Based on this data, we can filter ad suggestions that fit the lifestyle the user wants to live.  If someone walks into a McDonalds, for example, Naqi could send an audio cue such as, "Definitely not a good choice for your diet goals, you might want to consider a salad."  This health tracker function could also feature a hands-free (and possibly voice-free) "CALL HELP" option for 911, police, firefighters, local caregivers or family members (group VOIP call).

Security Feature

A security feature utilizing the Naqi Earbuds could include a reverse 911-style system that audibly warns our clients of exact locations and types of incidents that could be a threat, including the exact direction and distance of a threat.  Threats could include fire, rioting, active shooter, terrorist scenario, chemical / biological hazard, etc, and direct users exactly what to do, where to go and convey the level of urgency to our Naqi clients in real-time.  We can use this feature to relay information on emergency response of all agencies as well as audible re-assurance of the situation and real-instructions on how to survive.  Imagine having something like a virtual SWAT team leader or a virtual Fire Chief talking to you in real-time with data that's specific to you and your situation based on an active threat scenario.  We could also share Naqi Big Data with police, fire, FBI and HLS (FREE) so they know how many Naqi users are in a building, school, city block, geo-spatial area.  We can work with these stakeholders to create best-practices that could be relayed to users on-demand, on their own time, prior to an emergency taking place.

Naqi App Store (APIs/SDKs)

We will post a full library of APIs and SDKs within our App Store and will allow the world to invent their own applications using our earbuds and framework.  Developers will be able to define their own price per download and Naqi will retain a percentage of revenue collected for each download, in-app purchase as well as monthly licensing (should that apply).


Naqi Mobile Network

When earbuds are being worn, users come online within the Naqi environment via the Naqi Mobile App.  Each earbud user is a node in a world-wide Naqi environment (think of a World Wide Web of earbuds).  Bluetooth, Wi-fi, GPS data as well as cell data will be used to capture user information, including location, frequently visited businesses / restaurants, buying patterns, spending habits / limits / classifications, common IoT controls used based on location / business / geo-data, etc.

Naqi Mobile App

Framework

The Naqi framework enables hands-free, voice-free and sometimes look-free control of a user's IoT environment via a local device or Naqi Cloud. Naqi Rune and Plaque Control can also enable invisible and silent one-to-one or group communications.

Profile Setup

The Naqi app will allow users to save profile-specific information and preferences. This allows the user to customize their experience with the app and the Naqi framework.

EcoSystem

The Naqi app will furnish a software marketplace where third-party developers can share or sell applications based on the Naqi Framework. Users can choose to enable or disable third-party applications to customize their experience.

Accessibility

The Naqi app and framework will provide several features with implications for assistive mobility, assistive communication, and assistive human-computer-interface. The framework may be used to control various forms of personal mobility devices, such as powered wheelchairs. It can also be used to provide a form of hands-free/look-free human-computer-interface for moving a mouse cursor on a screen or triggering digital buttons in assistive communication apps.

Competition

The smart earbud, gestural input, brain-computer interface and non-tactile input industries are characterized by rapid technological developments and a high degree of competition. Access to patents and other protection for technology and products, the ability to commercialize technological developments, access to necessary capital, access to market channels and the ability to obtain necessary approvals for testing, manufacturing and commercialization will impact our potential success.

We will be competing with the largest technology firms in the world that may be applying novel biotechnology, signal analysis, sensor development and computing logic to their products and services.  These companies, as well as academic institutions, government agencies and private research organizations, also compete with us in research and development, product development, and market and brand development. Additionally, these companies and entities all compete for highly-qualified scientific personnel and consultants, and capital from investors.

Key competitors include (i) AAVAA; (ii) CTRL-Labs; and (iii) Neuralink.

AAVAA

Founded 2019 in Montréal, Canada, AAVAA is a startup company which utilizes brain-computer interface, artificial intelligence and acoustic technologies to allow users to focus their audio enhancement devices on the sounds they want to hear by paying attention to them. Their audio processing software simultaneously enhances those attended sounds and suppresses background noise. The platform can be implemented in different form factors, such as in-ear earbuds, headphones, and AR/VR sets.


CTRL-Labs

Founded 2015 in New York, New York, CTRL-labs developed an electromyography-based armband that reads nerve signals that travel from the brain to the fingers. The signals are translated into desired intentions, enabling thought-to-text and moving objects. The company uses neuroanatomy to identify individual muscle fibers and interpret the activity of neurons that control those muscle fibers. Bloomberg reports it was acquired by Facebook in 2019 for between $500 million and $1 billion.

Neuralink

Founded 2016 in San Francisco, Neuralink is a neurotechnology company developing implantable brain-machine interfaces and founded by Elon Musk and others. It uses a "sewing machine-like" device to implant very thin conductive threads into the brain and demonstrated a system that read information from a lab rat via 1,500 electrodes. In April 2021, Neuralink demonstrated a monkey playing the game "Pong" using the Neuralink implant. Neuralink is valued at over $500 million.3

For a description of risks related to competition, see "Risk Factors - Risks Related to our Business and Industry - The smart earbud, gestural input, brain-computer interface and non-tactile input industries are competitive, and we may be unable to compete with companies with greater financial or technical resources than us, which could negatively affect our operations."

Product Development Partners

Currently, we have a broad network of partners helping us to develop our hardware and software infrastructure. This includes partners based in India which provide hardware, firmware and software design services related to the internal printed circuit board of the Naqi Earbud. They also provide industrial design, mechanical design and vendor management for the physical design of the Naqi earbud, including EEG and EMG sensor technology consultation and sensor fabrication services.

We have also partnered with North American companies which provides software design services for the Naqi Framework, API/SDK and digital audio, wireless communications and IoT technology consultation services.

Our business is not substantially dependent on contracts with any of the product development partners referenced above.

Intellectual Property

The following is a summary of patents held in connection with the Naqi Earbud technologies:

Country

 

Filing Date

 

Serial Number

 

Issue Date

 

Patent Number

 

Status

 

 

 

 

 

 

 

 

 

 

 

United States

 

1/23/2017

 

62/449,158

 

N/A

 

N/A

 

Expired

 

 

 

 

 

 

 

 

 

 

 

United States

 

1/22/2018

 

15/877,206

 

4/30/2019

 

10,275,027

 

Issued

 

 

 

 

 

 

 

 

 

 

 

WIPO

 

1/22/2018

 

PCT/US2018/014736

 

N/A

 

N/A

 

Expired

 

 

 

 

 

 

 

 

 

 

 

India

 

1/22/2018

 

201917029654

 

N/A

 

N/A

 

Published

 

 

 

 

 

 

 

 

 

 

 

Europe

 

1/22/2018

 

18741177.2

 

N/A

 

N/A

 

Published

 

 

 

 

 

 

 

 

 

 

 

Canada

 

1/22/2018

 

3.051,095

 

N/A

 

N/A

 

Pending

 

 

 

 

 

 

 

 

 

 

 

Hong Kong

 

1/22/2018

 

62020007447.9

 

N/A

 

N/A

 

Pending

 

 

 

 

 

 

 

 

 

 

 

United States

 

3/18/2019

 

16/356,701

 

3/31/2020

 

10,606,354

 

Issued

 

 

 

 

 

 

 

 

 

 

 

Hong Kong

 

10/9/2019

 

19130623.2

 

N/A

 

N/A

 

Published

                     

United States

 

3/30/2020

 

16/834,085

 

12/15/2020

 

10,866,639

 

Issued

 

 

 

 

 

 

 

 

 

 

 

United States

 

12/8/2020

 

17/114,737

 

N/A

 

N/A

 

Pending

_________________________________________
3 PitchBook. https://www.crunchbase.com/organization/neuralink/company_financials (accessed December 14, 2021).



The following is a summary of patents held in connection with the Naqi Framework technologies:

Country

 

Filing Date

 

Serial Number

 

Issue Date

 

Patent Number

 

Status

 

 

 

 

 

 

 

 

 

 

 

United States

 

10/2/2013

 

61/886,045

 

N/A

 

N/A

 

Expired

 

 

 

 

 

 

 

 

 

 

 

United States

 

6/4/2014

 

14,295,733

 

8/2/2016

 

9,405,366

 

Issued

 

 

 

 

 

 

 

 

 

 

 

Europe

 

10/1/2014

 

18210066.9

 

8/5/2020

 

3467625

 

Issued

 

 

 

 

 

 

 

 

 

 

 

Europe

 

10/1/2014

 

14187255.6

 

12/5/2018

 

2857935

 

Issued

 

 

 

 

 

 

 

 

 

 

 

Israel

 

10/1/2014

 

234924

 

3/1/2018

 

234924

 

Issued

 

 

 

 

 

 

 

 

 

 

 

Germany

 

10/1/2014

 

14187255.6

 

12/5/2018

 

2857935

 

Issued

 

 

 

 

 

 

 

 

 

 

 

France

 

10/1/2014

 

14187255.6

 

12/5/2018

 

2857935

 

Issued

 

 

 

 

 

 

 

 

 

 

 

United Kingdom

 

10/1/2014

 

14187255.6

 

12/5/2018

 

2857935

 

Issued

 

 

 

 

 

 

 

 

 

 

 

United States

 

6/20/2016

 

15/186,910

 

11/13/2018

 

10,126,816

 

Issued

 

 

 

 

 

 

 

 

 

 

 

United States

 

9/26/2018

 

16/142,279

 

10/20/2020

 

10,809,803

 

Issued

 

 

 

 

 

 

 

 

 

 

 

United States

 

10/19/2020

 

17/073,717

 

N/A

 

N/A

 

Published

 

 

 

 

 

 

 

 

 

 

 

Hong Kong

 

10/1/2014

 

19130623.2

 

2/19/2021

 

HK40007483

 

Issued

 

 

 

 

 

 

 

 

 

 

 

France

 

10/1/2014

 

18210066.9

 

8/5/2020

 

3467625

 

Issued

 

 

 

 

 

 

 

 

 

 

 

Germany

 

10/1/2014

 

18210066.9

 

8/5/2020

 

3467625

 

Issued

 

 

 

 

 

 

 

 

 

 

 

United Kingdom

 

10/1/2014

 

18210066.9

 

8/5/2020

 

3467625

 

Issued

We have filed trademarks for the following marks, symbols and logos:

  • "NAQI": Canada (#2104471 5/4/2021), USA (#97107612, 11/3/2021 Priority 5/4/2021), World Intellectual Property Organization ("WIPO") trademark to be filed;
  • "NAQI LOGIX": Canada (#2104470 5/4/2021), USA (#97107620, 11/3/2021 Priority 5/4/201) , WIPO (Madrid System) includes countries Australia, Brazil, China, EU, India, Japan, Korea, Malaysia, Norway, Russia, Singapore, Switzerland, UK;
  • "COMMAND YOUR WORLD": Canada (2104472, 5/4/2021), USA (#97107626, 11/3/2021 Priority 5/4/2021), WIPO trademark to be filed; and
  • "Naqi Logo": (Canada #2104469, 5/4/2021), USA (#97107636, 11/3/2021 Priority 5/4/2021), WIPO trademark to be filed.

Employees / Consultants

Our direct personnel consists of one full-time employee, one full-time consultant and nine part-time consultants.  The Company also indirectly employs 33 additional consultants as part of our research and development team.


Regulation

The mass-produced Naqi Earbud product will be subject to certifications needed for consumer electronics and may need other certifications required to sell in specific global markets. The product is planned to comply with Federal Communications Commission ("FCC"), conformité européenne (French for "European Conformity") ("CE"), Waste Electrical and Electronic Equipment Directive (the "WEEE Directive") and the Restriction of Hazardous Substances Directive (the "RoHS Directive") certifications, as well as other certifications where necessary.

FCC

FCC certification is a type of product certification for electronic and electrical goods that are manufactured or sold in the United States. It certifies that the radio frequency emitted from a product is within limits approved by the FCC.

CE

Many products require CE marking before they can be sold in the European Union (the "EU"). CE marking indicates that a product has been assessed by the manufacturer and deemed to meet EU safety, health and environmental protection requirements. It is required for products manufactured anywhere in the world that are then marketed in the EU.

WEEE Directive

The WEEE Directive is the European Community Directive 2012/19/EU on waste electrical and electronic equipment which, together with the RoHS Directive 2011/65/EU, became European Law in February 2003. The WEEE Directive set collection, recycling and recovery targets for all types of electrical goods, with a minimum rate of four kilograms (nine pounds) per head of population per annum recovered for recycling by 2009. The RoHS Directive set restrictions upon European manufacturers as to the material content of new electronic equipment placed on the market.

RoHS Directive

The RoHS Directive, also known as Directive 2002/95/EC, originated in the EU and restricts the use of specific hazardous materials found in electrical and electronic products. All applicable products in the EU market after July 1, 2006 must pass RoHS compliance.

Legal Proceedings

There are currently no legal proceedings against the Company.


DESCRIPTION OF PROPERTY

We do not own any facilities and do not expect to do so in the immediate future. Our mailing address is 1400-1040 West Georgia Street, Vancouver, BC V6E 4H1, Canada, and all of the Company's personnel operate virtually from remote locations.


MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of the Company's financial condition and results of operations should be read together with its financial statements and related notes appearing elsewhere in this Offering Circular. Some of the information contained in this discussion and analysis or set forth elsewhere in this Offering Circular, including information with respect to the Company's plans and strategy for its business and related financing, includes forward-looking statements involving risks and uncertainties and should be read together with the "Risk Factors" section of this Offering Circular for a discussion of important factors which could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.

Company Overview

The Company was incorporated on August 4, 2020, pursuant to the laws of the Province of British Columbia and is domiciled in the Province of British Columbia. The Company engages in the business of (i) developing the Naqi Earbuds, smart earbuds that will enable users to control their IOT  environment without looking at, speaking to or touching the devices being controlled, and the Naqi Framework, which enables OEMs of wearable devices to create user interfaces that are capable of discreet and inconspicuous user input and navigation; (ii) commercializing the Naqi Earbuds and Naqi Framework; (iii) developing and licensing Naqi Earbud and Naqi Framework integrations into common information systems, such as residential and commercial IoT systems and potentially leading gaming systems; and (iv) developing and licensing Naqi Operator Vigilance and Naqi Wheelchair Control applications.

As of the date of this Offering Circular, we continue to develop the Naqi Earbuds and Naqi Framework and have not commenced revenue-generating operations. We anticipate sharing prototypes of the Naqi Earbuds and Naqi Framework during the fourth quarter of 2022, aiming for the first commercial (minimum viable product) release of these products by mid 2023.

As a British Columbia incorporated and Canadian resident company, the Company's financial statements are prepared using IFRS accounting principles, which are different from the accounting principles under U.S. GAAP. IFRS is an internationally recognized body of accounting principles that are used by many companies outside of the United States to prepare their financial statements. Regulation A permits Canadian issuers to prepare and file their financial statements in accordance with IFRS rather than U.S. GAAP.  U.S. investors who are not familiar with IFRS may misunderstand certain information presented in our financial statements. Accordingly, we suggest that readers of the Company's financial statements familiarize themselves with the provisions of IFRS accounting principles in order to better understand the differences between these two sets of principles.

Operating Results

Operating Results for the Nine months ended March 31, 2022

The tables below set out certain selected financial information regarding the operations of the Company for the periods indicated. The selected financial information has been prepared in accordance with IFRS and should be read in conjunction with the Company's consolidated financial statements and related notes for the nine months ended March 31, 2022.

    Nine months ended
March 31, 2022
 
    ($, reviewed)  
Revenue   -  
Loss and comprehensive loss   2,349,035  
Basic net loss per Common Share   0.05  

    As at March 31, 2022  
    ($, reviewed)  
Total assets   853,600  

To date, the Company has not generated any revenues from its planned operations. For the nine months ended March 31, 2022, the Company reported a net loss of $2,349,035, or $0.05 per share, attributable to operating expenses consisting primarily of consulting fees and salaries ($603,741), research & development ($764,552) and share based compensation ($400,980). The Company anticipates that operating expenses will continue to rise as the Company continues to develop its business operations.

The Company's total assets as at March 31, 2022 were $853,600, consisting primarily of cash, intangible assets and patents, as compared to $1,794,145 for the period from August 4, 2020 (date of inception) to June 30, 2021. This decrease in total assets was attributable to the amortization of patents and use of cash in the day-to-day operations of the Company on research & development, consulting fees, salaries, and professional fees, as described under "- Liquidity and Capital Resources" below.

Operating Results for the Period from August 4, 2020 (Date of Inception) to June 30, 2021

The tables below set out certain selected financial information regarding the operations of the Company for the periods indicated. The selected financial information has been prepared in accordance with IFRS and should be read in conjunction with the Company's consolidated financial statements and related notes for the period from August 4, 2020 (date of inception) to June 30, 2021.

    Period from August
4, 2020 (date of
inception) to
June 30, 2021
 
    ($, audited)  
       
Revenue   -  
       
Loss and comprehensive loss   719,027  
       
Basic and diluted net loss per Common Share   0.05  



    As at June 30, 2021  
    ($, audited)  
       
Total assets   1,794,145  

To date, the Company has not generated any revenues from its planned operations. For the period from August 4, 2020 (date of inception) to June 30, 2021, the Company reported a net loss of $719,027, or $0.05 per share, from operating expenses, primarily consisting of Research and development ($201,769), Professional fees ($362,682) and Consulting fees and salaries ($134,625).

The Company's total assets as at June 30, 2021 were $1,794,145, consisting of cash, prepaids and receivables of $1,120,845 and intangible assets.

Liquidity and Capital Resources

As at March 31, 2022, the Company had $116,774 in cash. Currently, the Company's working capital requirements are approximately $165,000 per month. To date, in order to fund its ongoing operations, the Company has completed the following issuances of Common Shares: 

  • On June 8, 2021, the Company issued 7,586,678 Common Shares [pursuant to a private placement] at an offering price of $0.25 per share. The aggregate gross proceeds were approximately $1,989,320.

Our total capital as at March 31, 2022, which reflects the above transactions, is set forth in the table below.

    As at March 31, 2022  
    ($, reviewed)  
Cash and cash equivalents   (116,774 )
Net (cash and cash equivalents)   (116,774 )
Total stockholders deficit   (696,665 )
Total deficiency   (696,665 )

On October 29, 2021, the Company commenced a non-brokered private placement of up to $1,500,000 principal amount of convertible notes (the "Notes").  The Company has issued $643,000 of convertible notes as of March 31, 2022, and has received funding but not yet issued an additional $127,050 as of the date of this Offering Circular. Simple interest will accrue on the principal amount of the Notes at 8% per annum. The Notes, plus any accrued interest payable, shall automatically be converted into units ("Units") of the Company.

Each Unit consists of one Common Share and one warrant, exercisable into an additional Common Share (the "Warrants"). Conversion of the Units will occur at such time as the Company completes a subsequent equity offering involving an issuance of Common Shares ("Subsequent Financing"). This Offering would constitute a Subsequent Financing. The conversion price for the Common Share component of the Note will be at a 20% discount to the Subsequent Financing price, which under this Offering is $2.00, thereby resulting in a conversion price of $1.60 per Common Share.

Each Warrant will entitle the holder to purchase an additional Common Share at a price that is at a 20% premium ("Warrant Exercise Price") to the Subsequent Financing price for a period of 24 months from the date of issuance of the Warrants, which shall be the closing date of the Subsequent Financing. Based on the terms of this Offering, the Warrants would be priced at $2.40 per Warrant. In the event the Company completes a going public transaction and the Common Shares trade at a 75% premium to the Warrant Exercise price (reflecting a share price of $4.20) for a period of 30 trading days, then the Warrants will automatically be exercised into Common Shares.


Since the Company has not commenced revenue generating operations, we may require additional capital for the development of our business operations and commercialization of the products we are currently developing or may develop in the future. See "Risk Factors - We may not have adequate capital to fund our business and may need substantial additional funding to continue operations. We may not be able to raise capital when needed, if at all, which would force us to delay, reduce or eliminate our product development programs or commercialization efforts and could cause our business to fail."

As of June 30, 2021 and March 31, 2022, the Company had no material commitments for capital expenditures.

Plan of Operations

As of the date of this Offering Circular, we continue to develop the Naqi Earbuds and Naqi Framework and have not commenced revenue-generating operations. We anticipate sharing prototypes of the Naqi Earbuds and Naqi Framework during the fourth quarter of 2022, aiming for the first commercial (minimum viable product) release of these products by mid 2023.

Our technologies and services offerings are described in greater detail in "Description of Business" above together with a detailed description of our entire business.

Trend Information

The Company is currently developing the Naqi Earbuds and Naqi Framework and has not commenced revenue-generating operations. As a result, we are unable to identify and comment on significant recent trends in production, sales and inventory, the state of the order book and costs and selling prices since the latest financial year, nor are we able to identify and comment on any known trends, uncertainties, demands, commitments or events that are reasonably likely to have a material effect on the Company's net sales or revenues, income from continuing operations, profitability, liquidity or capital resources, or that would cause reported financial information not necessarily to be indicative of future operating results or financial condition.

Investors should review statements made in this Offering Circular under "Risk Factors" and "Description of Business" for additional information about the Company.


DIRECTORS, EXECUTIVE OFFICERS AND SIGNIFICANT EMPLOYEES

The following table sets out the Company's executive officers, significant personnel and directors as of the date of this Offering Circular:

Name

 

Position

 

Age

 

Term of Office

 

Approximate Hours
per Week for Part-
Time Personnel

 

 

 

 

 

 

 

 

 

Executive Officers:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mark Godsy

 

Chief Executive
Officer

 

66

 

August 2020

 

20

 

 

 

 

 

 

 

 

 

Osman Sinan Tumer

 

Chief Operating
Officer

 

71

 

April 2021

 

28

 

 

 

 

 

 

 

 

 

David Segal

 

Chief Innovation Officer

 

45

 

April 2021

 

n/a

 

 

 

 

 

 

 

 

 

Significant Employees:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Zavier Alexander

 

Director of Product Management

 

36

 

October 2021

 

n/a

 

 

 

 

 

 

 

 

 

Directors:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mark Godsy

 

Director

 

66

 

August 2020

 

n/a

 

 

 

 

 

 

 

 

 

Gary Roshak

 

Director

 

61

 

October 2021

 

n/a

 

 

 

 

 

 

 

 

 

Sue Ozdemir

 

Director

 

49

 

October 2021

 

n/a

 

 

 

 

 

 

 

 

 

John Occhipinti

 

Director

 

56

 

October 2021

 

n/a

 

 

 

 

 

 

 

 

 

Sam Sullivan

 

Director

 

62

 

March 2022

 

n/a

With the exception of Zavier Alexander, all of the above-listed officers and significant employees are serving the Company under consulting agreements.

There is no arrangement or understanding between the persons described above and any other person pursuant to which the person was selected to his or her office or position.

Certain Relationships

Except as set forth above and in our discussion below in "Interest of Management and Others in Certain Transactions," none of our directors, executive officers or significant employees have been involved in any transactions with us or any of our directors, executive officers, significant employees, affiliates or associates that are required to be disclosed pursuant to the rules and regulations of the SEC.


Business Experience

Mark Godsy, Chief Executive Officer

Mark Godsy is our Chief Executive Officer. Mr. Godsy has 30 years of experience in the technology industry, and his previous positions include co-founder of ID Biomedical and Angiotech Pharmaceutical and CEO and now Chairman with Exro Technologies.

Mr. Godsy received a Bachelor of Arts from the University of British Columbia and a law degree from McGill University.

Osman Sinan Tumer, Chief Operating Officer

Osman Sinan Tumer is our Chief Operating Officer. Mr. Tumer has 40 years of experience in the field of Information Technologies, and his previous positions include Head of Global Research Operations with SAP Labs, Senior Director of Co-Innovation Lab with SAP Labs, Head of International Research Policy with SAP Labs, Senior Manager with Arthur Andersen/Price Waterhouse and Director of Application Development with Ralston Purina Company.

Mr. Tumer received a master's degree in Systems Engineering from the Georgia Institute of Technology and a Master of Science degree in Computer Sciences at the Georgia Institute of Technology

David Segal, Chief Innovation Officer

David Segal is our Chief Innovation Officer. Mr. Segal has 21 years of experience within the Computer Science sector and his previous positions include Vice President of U.S. Sales with Digital Samba S.L., President with SpiderWeb Communications Inc. and President with CyberGrad Inc.  Mr. Segal is also a Corporate Faculty at the Harrisburg University of Science & Technology.

Zavier Alexander, Director of Product Management

Zavier Alexander is our Director of Product Management. Mr. Alexander has 13 years of experience in wearable biosensor and consumer electronics product design and his previous positions include Design Manager / Creative Lead with NeuroSky Inc. and Design Consultant as an independent contractor.

Mr. Alexander received a Bachelor of Fine Arts in Industrial Design from the Academy of Art University in San Francisco, California.

Involvement in Certain Legal Proceedings

To our knowledge, none of our current directors, executive officers or significant employees have, during the past ten years:

  • been convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
  • had any bankruptcy petition filed by or against the business or property of the person, or of any partnership, corporation or business association of which he or she was a general partner or executive officer, either at the time of the bankruptcy filing or within two years prior to that time;

  • been subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, his involvement in any type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or to be associated with persons engaged in any such activity;

  • been found by a court of competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;

  • been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or


  • been the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Securities Exchange Act of 1934, as amended (the Exchange Act)), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

We are not currently a party to any legal proceedings, the adverse outcome of which, individually or in the aggregate, we believe will have a material adverse effect on our business, financial condition or operating results.

Family Relationships

There are no familial relationships among any of our directors, officers or significant employees.


COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS

For the period from August 4, 2020 (date of inception) to June 30, 2021, we compensated our three highest paid officers and directors as follows:

Name

 

Position

 

Cash Compensation

 

Other
Compensation

 

Total Compensation

 

 

 

 

 

 

 

 

 

Executive Officers:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mark Godsy

 

Chief Executive
Officer

 

$25,000

 

$0

 

$25,000

 

 

 

 

 

 

 

 

 

Osman Sinan Tumer

 

Chief Operating
Officer

 

$18,750

 

$0

 

$18,750

 

 

 

 

 

 

 

 

 

David Segal

 

Chief Innovation Officer

 

$18,750

 

$0

 

$18,750

Director and Executive Officer Compensation

We have five directors. We currently do not pay our directors any cash compensation for their services as directors.

Personnel Agreements, Arrangements or Plans

Except as otherwise disclosed in this Offering Circular, as of the date of this Offering Circular, the Company has not entered into any plan or arrangement with any of its directors or executive officers concerning compensation to be made in the future.


SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN SECURITYHOLDERS

The following table shows the beneficial ownership of the Common Shares as of the date of this Offering Circular held by (i) each person known to us to be the beneficial owner of more than 10% of any class of our voting securities; (ii) each director who is the beneficial owner of more than 10% of any class of our voting securities; (iii) each executive officer who is the beneficial owner of more than 10% of any class of our voting securities; and (iv) all directors and executive officers as a group. As of March 31, 2022, there were 48,473,874 Common Shares issued and outstanding. As of the date of this Offering Circular, there are 48,473,874 Common Shares issued and outstanding.

Beneficial ownership is determined in accordance with the rules of the SEC, and generally includes voting power and/or investment power with respect to the securities held. Common Shares subject to options and warrants currently exercisable or which may become exercisable within 60 days of the date of this Offering Circular, are deemed outstanding and beneficially owned by the person holding such options or warrants for purposes of computing the number of shares and percentage beneficially owned by such person, but are not deemed outstanding for purposes of computing the percentage beneficially owned by any other person. Except as indicated in the footnotes to this table, the persons or entities named have sole voting and investment power with respect to all the Common Shares shown as beneficially owned by them.

Unless otherwise stated, the business address of each benefit holder identified in the table below is Naqi Logix Inc., 1400-1040 West Georgia Street, Vancouver, BC V6E 4H1, Canada.

Name of Beneficial Holder

 

Amount and Nature of
Beneficial Ownership

 

Percent of Class(1)

 

 

 

 

 

Mark Godsy

 

7,199,401 Common
Shares

 

14.9%

____________________

(1) This Offering Statement does not contemplate that any of our current listed shareholders will acquire any additional Common Shares as part of this Offering.


INTEREST OF MANAGEMENT AND OTHERS IN CERTAIN TRANSACTIONS

Transactions with Related Persons

On April 12, 2021, the Company received a loan of $129,149 from a shareholder under a convertible promissory note for cash received of $78,000 and expense paid on behalf of the Company of $51,149. The note was non-interest bearing, unsecured, and was due on April 12, 2023. The note was initially recorded at management's estimate of fair value of $129,149 and was automatically converted on June 8, 2021 upon the completion of the June 8, 2021 qualified financing at the contractually-agreed mandatory conversion price of $0.25 per common share.

Except as set forth above, there has not been, nor is there currently proposed, any transaction in which we are or were a participant and the amount involved exceeds the lesser of $120,000 or 1% of the total assets since August 4, 2020 (date of inception), and in which any of our directors, executive officers, holders of more than 10% of the Common Shares or any immediate family member of any of the foregoing had or will have a direct or indirect material interest, other than compensation arrangements, which include equity and other compensation, termination, change in control, consulting and other arrangements, which are described under "Compensation of Directors and Executive Officers."

Review, Approval and Ratification of Related Party Transactions

Given our small size and limited financial resources, we have not adopted formal policies and procedures for the review, approval or ratification of transactions, such as those described above, with our executive officer(s), director(s) and significant shareholders. We intend to establish formal policies and procedures in the future, once we have sufficient resources and have appointed additional directors, so that such transactions will be subject to the review, approval or ratification of the Board, or an appropriate committee thereof. On a moving forward basis, our directors will continue to approve any related party transaction.


SECURITIES BEING OFFERED

The following is a summary of the rights of our share capital as provided in our Notice of Articles (the "Notice") and Articles (the "Articles"). For more detailed information, please see our Notice and Articles that have been filed as exhibits to the Offering Statement of which this Offering Circular is a part.

General

The Company's authorized capital consists of (i) an unlimited number of Voting Common Shares, without par value; and (ii) an unlimited number of Non-Voting Common Shares, without par value.

As of the date of this Offering Circular, the Company has 48,473,874 Common Shares issued and outstanding.

Rights, Preferences and Restrictions Attaching to The Common Shares

Voting Common Shares

Our Articles provide the following rights, privileges, restrictions and conditions attaching to our Common Shares:

  • One vote for each Common Share held at all meetings of shareholders.

  • The right to receive notice of and to attend all meeting of shareholders of the Company, except meetings at which only the holders of a specified class of shares (other than the Common Shares) are entitled to attend.

  • The right to vote on all matters submitted to a vote or consent of shareholders of the Company, expect matters upon which only the holders of a specified class of shares (other than the Common Shares) are entitled to vote.

  • The right to receive dividends, if, as, and when declared by the Board, which the holders of the Common Shares and Non-Voting Common Shares shall participate equally with respect to dividends without preference or priority.

  • In the event of any liquidation, dissolution or winding-up of the Company or other distribution of assets of the Company among its shareholders for the purpose of winding up its affairs, subject to the rights, privileges, restrictions and conditions attaching to any other class of shares of the Company, all of the property and assets of the Company available for distribution to the holders of Common Shares and the Non-Voting Common Shares shall be paid or distributed equally, share for share, to the holders of the Common Shares and the Non-Voting Common Shares.

Non-Voting Common Shares

Our Articles provide the following rights, privileges, restrictions and conditions attaching to our Non-Voting Common Shares:

  • Except as required under the Business Corporations Act (British Columbia) (the “BCBCA”), the holders of Non-Voting Common Shares are not entitled to receive notice or, or at attend or to vote at, any meeting of the shareholders of the Company.

  • The right to receive dividends, if, as, and when declared by the Board, which the holders of the Common Shares and Non-Voting Common Shares shall participate equally with respect to dividends without preference or priority.

  • In the event of any liquidation, dissolution or winding-up of the Company or other distribution of assets of the Company among its shareholders for the purpose of winding up its affairs, subject to the rights, privileges, restrictions and conditions attaching to any other class of shares of the Company, all of the property and assets of the Company available for distribution to the holders of Common Shares and the Non-Voting Common Shares shall be paid or distributed equally, share for share, to the holders of the Common Shares and the Non-Voting Common Shares

The Articles may be altered by the affirmative vote of the holders of not less than two-thirds of the outstanding Common Shares.


With the exception of special resolutions (e.g., resolutions in respect of fundamental changes to the Company, including: change of the Company's name, the sale of all or substantially all of the Company's assets, a merger or other arrangement or an alteration to the Company's authorized capital that is not allowed by resolution of the directors) that require the approval of holders of two-thirds of the outstanding Common Shares entitled to vote at a meeting, either in person or by proxy, resolutions to approve matters brought before a meeting of our shareholders require approval by a simple majority of the votes cast by shareholders entitled to vote at a meeting, either in person or by proxy.

Shareholder Meetings

The Articles provide that the location of a meeting of shareholders shall be determined by the Board and may be within or outside British Columbia. The Company must hold an annual general meeting of shareholders within 18 months after the date of inception and, after that, at least once in each calendar year and not more than 15 months after the last annual reference date. For the purpose of determining shareholders entitled to receive notice of or vote at meetings of shareholders, the directors may set in advance a date as the record date for that determination, provided that such date shall not precede by more than 60 days or, if we are a public company, 21 days, and otherwise 10 days, the date on which the meeting is to be held.

Under the BCBCA shareholders holding in the aggregate at least 1/20 of the issued shares of the Company that carry the right to vote at a general meeting of shareholders may requisition a meeting of shareholders. Only shareholders entitled to vote at the meeting, our directors and our auditor are entitled to be present at a meeting of shareholders. The court may, on its own motion or on the application of the Company, a director, or a shareholder entitled to vote at a meeting, order that a meeting of shareholders be called, held and conducted in the manner the court considers appropriate. The court may make such an order if it impracticable for any reason for the Company to call or conduct a meeting of shareholders in the manner required under the BCBCA or the Articles, if the Company fails to hold a meeting of shareholders if accordance with the BCBCA or for any other reason the court considers appropriate.

Pursuant to our Articles, the quorum for the transaction of business at a meeting of our shareholders is two persons who are, or who represent by proxy, shareholders who, in the aggregate, hold at least five percent of the issued shares entitled to be voted at the meeting.

Fully Paid and Non-Assessable

Provided that the consideration in respect of the Common Shares has been fully paid, and the Company has received all required corporate and other approvals, as applicable, in respect of the issuance of the Common Shares, all outstanding Common Shares are, and the Common Shares to be outstanding upon completion of this Offering will be, duly authorized, validly issued, fully paid and non-assessable.

Resale Restrictions

The Common Shares will be transferable following the termination of any transfer hold periods under applicable law.

The securities to be issued in connection with this Offering will be subject to a statutory hold period in Canada in accordance with Section 2.5(2)(3)(ii) of National Instrument 45-102 - Resale of Securities, and will contain the following legend until the end of such period: "Unless permitted under securities legislation, the holder of this security must not trade the security before the date that is 4 months, and a day after the later of (i) [insert the distribution date], and (ii) the date the issuer became a reporting issuer in any province or territory."

Investors in this Offering should consult with their own professional advisers with respect to restrictions on the transferability of the securities offered hereunder.

Warrants

The Company launched a convertible note private placement on October 29, 2021, raising $643,000 as of date of this Offering Circular. The Notes convert into units of the Company, with each Unit consisting of one Common Share and one Warrant, which provides the Unit holder the ability to purchase one Common Share of the Company at a pre-established price. The volume of Warrants will be established upon closing of this Offering as Note holders are required to convert their Units upon closing. Please refer to "Management's Discussion and Analysis of Financial Condition and Results of Operations-Liquidity and Capital Resources" beginning on page 37 for additional details.


As of March 31, 2022, the Company had issued no warrants.

Shareholder Agreements

The Company has three shareholder agreements in place: (i) a shareholder rights agreement (the "Shareholder Agreement"); (ii) a right of first refusal and co-sale agreement (the "Right of First Refusal and Co-Sale Agreement"); and (iii) a voting agreement (the "Voting Agreement") (each, a "Shareholder Agreement" and collectively, the "Shareholder Agreements"), each of which is summarized in greater detail below and attached as an exhibit hereto. Each of the Company's current shareholders has been required to execute the Shareholder Agreements. All incoming investors pursuant to this Offering are required to sign an adoption agreement to the Voting Agreement as a condition of acquiring Common Shares. Your subscription agreement ("Subscription Agreement") will include an adoption agreement for the Voting Agreement as a schedule, which must be completed and returned to the Company along with the signed Subscription Agreement. The Voting Agreement will terminate in connection with the closing of a future initial public offering or other going public transaction involving the Common Shares.

The Shareholder Rights Agreement

The Shareholder Rights Agreement provides the Company's shareholders with a number of rights and ensures the Company operates according to best practices. The Shareholder Rights Agreement establishes the right of owners of over 5% of the Company's issued and outstanding shares ("Major Shareholders") to receive financial statements from the Company unless waived. All other shareholders of the Company may receive such financial statements following their delivery of a written request to the Company. The Shareholder Rights Agreement provides that, subject to the terms of the Shareholder Rights Agreement and applicable law, the Company shall first offer any new securities of the Company to each Major Shareholder, and each Major Shareholder shall have right to participate in such offering of new securities up to the percentage of the Common Shares then held by such Major Shareholder. The Major Shareholders are not required to purchase the additional securities but can do so at their option. The Shareholder Rights Agreement provides for additional standard covenants of the Company including: (i) director and officer insurance; (ii) protection of the Company's IP and confidential information; and (iii) meetings of the Board.

The Right of First Refusal and Co-Sale Agreement

The Right of First Refusal and Co-Sale Agreement regulates the mechanics of sales and transfers of the Common shares. The right of first refusal provides that where a shareholder proposes to transfer shares of the Company, the Company shall have a right of first refusal to purchase all or any portion of such shares that such shareholder may propose to transfer at the same price and on the same terms and conditions as those offered to the prospective transferee. The Major Shareholders shall have a secondary refusal right to purchase all or any portion of the shares proposed to be transferred but not purchased by the Company pursuant to its right of first refusal. The right of co-sale provides that if any shares to be transferred to a proposed transferee and they are not purchased pursuant to the right of first refusal by the Company (or the secondary refusal right by the Major Shareholders, as applicable), each Major Shareholder may elect to exercise its right of co-sale and participate in the proposed share transfer on a pro-rata basis on the same terms and conditions in the proposed transfer. The right of first refusal (and secondary refusal right) and the right of co-sale shall not apply to certain "exempt" transfers, which include: (i) in the case of a shareholder that is an entity, to transfers to its shareholders, members, partners or other equity holders; (ii) repurchases of shares by the Company where such repurchase is pursuant to an agreement containing vesting and/or repurchase provisions approved by a majority of the Board; and (iii) in the case of a shareholder that is a natural person, upon a transfer of shares made for bona fide estate planning purposes. Shareholders are prohibited from transferring shares to any competitor or any customer, distributor or supplier of the company if such transfer would place the Company at a competitive disadvantage with respect to such customer, distributor or supplier. The Right of First Refusal and Co-Sale Agreement further provides for a prohibition on the sale of the Company's shares for 180 days (or such other period as may be requested by the Company or an underwriter to accommodate regulatory restrictions) following the closing of a going public transaction. A transfer of shares that is not made in compliance with the agreement shall be null and void, shall not be recorded on the books of the Company or with its transfer agent and shall not be recognized by the Company.

The Voting Agreement

The Voting Agreement provides certain shareholders with the right to, among other things, designate the election of certain members of the Board and sets forth how shareholders are to vote their respective shares in connection with the sale of the Company.  Mark Godsy is entitled to designate up to seven director nominees, and each shareholder is required to vote their shares in favor of the election of such director nominees. Further, the Voting Agreement provides that any corporate action that is approved by the Board but which also requires shareholder approval, whether by special resolution or ordinary resolution, as applicable, shareholders are obligated to vote their shares in favor of such corporate action. The Voting Agreement establishes a drag-along right, which requires a minority shareholder to sell their shares in the context of a Board approved sale of the Company if more than 66 2/3% of shareholders approve such sale of the Company.


Voting Trust Agreement

Certain shareholders of the Company have entered into voting trust agreements with the Company (the "Voting Trust Agreements"), whereby each such shareholder deposits its shares in a voting trust and such shares can be voted by the Chief Executive Officer of the Company appointed from time to time. In connection with entering into the Voting Trust Agreements, the shareholders delivered to the Chief Executive Officer an irrevocable power of attorney. Pursuant to the power of attorney, the Chief Executive Officer is entitled to deliver a proxy at shareholder meetings to vote the shares of such shareholders and is entitled to execute on behalf of such shareholders, any resolution or other instrument in writing to be executed by the voting shareholders of the Company, including any agreement among the shareholders of the Company.

Share Reserve

We have reserved 9,694,775 Non-Voting Common Shares for issuance pursuant to awards under the Plan, which is equal to approximately 20% of our issued and outstanding Non-Voting Common Shares. The number of Non-Voting Common Shares available for issuance pursuant to awards granted under the Plan will increase as the number of issued and outstanding Non-Voting Common Shares of the Company increases. In general, Non-Voting Common Shares subject to awards granted under the Plan that are exercised, terminated or cancelled, or returned to the Company for any reason, shall be available for issuance pursuant to subsequent awards granted pursuant to the plan.

Administration

Our Board, or a committee of the Board designated by the Board, will administer the Plan. Subject to the terms of the Plan, the Board has the power to determine when and how awards will be granted, which employees, directors or consultants will receive awards, the type and terms of the awards granted, including the number of Non-Voting Common Shares subject to each award and the vesting schedule of the awards, if any, and to interpret the terms of the Plan and the award agreements, among other things. The Board also has the authority to accelerate the time at which an award may vest or be exercised, to approve forms of award agreements to be used under the Plan and amend the terms of any award agreement, and to amend, suspend or terminate the Plan at any time.

The Board will determine the provisions, terms and conditions of each award granted pursuant to the Plan, including vesting schedules, forfeiture or repurchase provisions, forms of payment (cash, shares, or other consideration) upon settlement of the award, payment contingencies and satisfaction of any performance criteria.

Stock Options and Incentive Stock Options

The Plan allows for the grant of incentive stock options that qualify under Section 422 of the Internal Revenue Code, and non-incentive stock options. Prior to an initial public offering, the exercise price of all options granted under the Plan will be determined by the Board, and in effect on the day of grant. Post IPO, the Board will establish the exercise price at the time each option is granted, which exercise price must in all cases be not less than the price required by the applicable regulatory authorities. The term of an option may not exceed 10 years, except that with respect to any employee who owns more than 10% of the voting power of all classes of our outstanding stock or any parent or subsidiary corporation as of the grant date, the term must not exceed five years, and the exercise price must equal at least 110% of the fair market value of the common share on the grant date. The Board will determine the terms of stock option awards pursuant to the Plan, including, without limitation, the permitted method(s) of payment for Non-Voting Common Shares upon the exercise of an option award, and vesting terms. After the continuous service of an option recipient terminates, the recipient's awards may be exercised, to the extent vested at the time of such termination, during the period of time specified in the recipient's award agreement, which generally will be the period of time ending on the earlier of (i) the date that is 90 days following the termination of the recipient's continuous service and (ii) the expiration of the term of the option. If the recipient does not exercise the option within the applicable time period, the option will terminate.


Restricted Share Units

The Plan allows for the grant of restricted share units ("RSUs"). RSUs are awards that will result in payment to a recipient at the end of a specified period only if the vesting criteria established by the Board are achieved or the award otherwise vests. Upon vesting and exercise of the award, an RSU may be settled by the delivery of Non-Voting Common Shares, their cash equivalent, any combination thereof or any other form of consideration, as determined by the Board and set forth in the applicable award agreement. The Board may determine the consideration, if any, to be paid by the recipient upon exercise of an RSU and delivery of each Non-Voting Common Share subject to the RSU. The Board may impose whatever conditions to vesting, or restrictions and conditions to payment, that it determines to be appropriate. The Board may set restrictions based on the achievement of specific performance goals or on the continuation of service or employment, or any other restrictions or conditions it deems appropriate. Upon termination of the continuous service of an RSU recipient, any unvested portion of the recipient's RSU award will be forfeited, except as otherwise provided in the applicable award agreement.

Transferability of Awards

The Plan does not allow for the transfer of awards granted under the Plan except as otherwise provided in the applicable award agreement or as otherwise expressly consented to by the Board.

Certain Adjustments

In the event of certain changes in our capitalization, the Board will make appropriate and proportionate adjustments to one or more of the number of Non-Voting Common Shares that are covered by outstanding awards, the exercise or purchase price of Non-Voting Common Shares covered by outstanding awards, and the numerical share limits contained in the Plan.

Corporate Transactions

The Plan provides that in the event of a corporate transaction such as a "Sale of the Company", as such term is defined in the Plan, the Board may take one or more of the following actions with respect to awards granted under the Plan: (i) cause the conversion or exchange of each outstanding option into common shares on a net issuance basis in accordance with a pre-defined formula; (ii) cause the conversion or exchange of each outstanding option into options, rights or other securities of substantially equivalent value (or greater value) as determined by the Board in its discretion, in an entity participating in or resulting from such liquidity event; (iii) accelerate the vesting, in whole or in part, of outstanding awards such that the outstanding options shall be fully vested and exercisable contemporaneously with the completion of the transaction resulting in the liquidity event; (iv) determine that any or all outstanding options will be purchased by the Company or an entity related to the Company at the liquidity event price less the exercise price for the option shares available to be purchased under such options; (v) cancel any or all of such outstanding unvested options.

Plan Amendments and Termination

The Board has the authority to amend, suspend or terminate the Plan at any time, without shareholder approval Notwithstanding the foregoing, subject to the discretion of the Board, the termination of this Plan shall have no effect on outstanding Awards, which shall continue in effect in accordance with their terms and conditions and the terms and conditions of the Plan.

Penny Stock Regulation

The SEC has adopted regulations that generally define "penny stock" to be any equity security that has a market price of less than $5.00 per share or an exercise price of less than $5.00 per share. Such securities are subject to rules that impose additional sales practice requirements on broker-dealers who sell them. For transactions covered by these rules, the broker-dealer must make a special suitability determination for the investor in such securities and have received the investor's written consent to the transaction prior to the investment. Additionally, for any transaction involving a penny stock, unless exempt, the rules require the delivery, prior to the transaction, of a disclosure schedule prepared by the SEC relating to the penny stock market. The broker-dealer also must disclose the commissions payable to both the broker-dealer and the registered representative, current quotations for the securities and, if the broker-dealer is the sole market-maker, the broker-dealer must disclose this fact and the broker-dealer's presumed control over the market. Finally, among other requirements, monthly statements must be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks. As the Common Shares immediately following this Offering may be subject to such penny stock rules, investors in this Offering may find it more difficult to sell the Common Shares in the secondary market.


Absence of Public Market

We are an alternative reporting company under Regulation A, Tier 2 of the Securities Act. There is no public trading market for the Common Shares. No application is currently being prepared for the Common Shares to be listed on a securities exchange or quoted on an alternative trading system.  As a result, the Common Shares sold in this Offering may not be listed on a securities exchange or quoted on an alternative trading system for an extended period of time, if at all. (See "Risk Factors" beginning on page 12).


WHERE YOU CAN FIND MORE INFORMATION

We have filed with the SEC an Offering Statement on Form 1-A pursuant to Regulation A promulgated under the Securities Act with respect to the Common Shares offered hereby. This Offering Circular, which constitutes a part of the Offering Statement, does not contain all of the information set forth in the Offering Statement or the exhibits and schedules filed therewith. For further information about us and the Common Shares offered hereby, we refer you to the Offering Statement and the exhibits and schedules filed therewith. Statements contained in this Offering Circular regarding the contents of any contract or other document that is filed as an exhibit to the Offering Statement are not necessarily complete, and each such statement is qualified in all respects by reference to the full text of such contract or other document filed as an exhibit to the Offering Statement. We are required to file periodic reports, proxy statements, and other information with the SEC pursuant to the Securities Exchange Act of 1934. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet website that contains reports, proxy statements and other information about issuers, including us, that file electronically with the SEC. The address of this site is www.sec.gov.


PART F/S

INDEX TO FINANCIAL STATEMENTS

NAQI LOGIX INC.

 

Page

 

 

Audited Financial Statements of Naqi Logix Inc. for the Period from August 4, 2020 (Date of Inception) to June 30, 2021 F-2
   
Independent Auditor's Report F-3

 

 

Unaudited Financial Statements of Naqi Logix Inc. for the Nine months ended March 31, 2022

F-20



Naqi Logix Inc.

Financial Statements

For the period from inception on August 4, 2020 (inception) to June 30, 2021

(Expressed in US Dollars)



Tel: 604-688-5421

BDO Canada LLP

Fax: 604-688-5132

1100 - Royal Centre

www.bdo.ca

1055 West Georgia Street

 

Vancouver, BC V6E 3P3 Canada

 

 

 


 

Independent Auditor's Report

 

Shareholders and Board of Directors

Naqi Logix Inc.

Opinion on the Financial Statements

We have audited the accompanying financial statements Naqi Logix Inc. (the "Company"), which comprise the statement of financial position as of June 30, 2021, the related statements of loss and comprehensive loss, changes in equity, and cash flows for the period from inception on August 4, 2020 (inception) to June 30, 2021, and the related notes to the financial statements.

In our opinion, the accompanying financial statements present fairly, in all material respects, the financial position of Naqi Logix Inc. as at June 30, 2021, its financial performance and its cash flows for the period from inception on August 4, 2020 (inception) to June 30, 2021 in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board.

Basis for Opinion

We conducted our audits in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditor's Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Substantial Doubt About the Company's Ability to Continue as a Going Concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As described in Note 1 to the financial statements, the Company is a development stage business, expects to incur further losses in the future and has not generated any revenues or profits as of June 30, 2021. These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Our opinion is not modified with respect to this matter.

Responsibilities of Management for the Financial Statements

Management is responsible for the preparation and fair presentation of these financial statements in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board; and for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of the financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued or available to be issued.

BDO Canada, LLP, a Canadian limited liability partnership, is a member of BDO International Limited, a UK company limited by guarantee, and forms part of the international BDO network of independent member firms.

BDO is the brand name for the BDO network and for each of the BDO Member Firms.


Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.

In performing an audit in accordance with GAAS, we:

  • Exercise professional judgment and maintain professional skepticism throughout the audit.

  • Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.

  • Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control. Accordingly, no such opinion is expressed.

  • Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements.

  • Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

Chartered Professional Accountants

Vancouver, British Columbia

December 29, 2021



Naqi Logix Inc.

Statement of Financial Position

(Expressed in US dollars)


    As at June 30  
    2021  
    $  
Assets      
       
Current      
Cash   1,112,045  
Prepaid expenses   810  
GST receivable   7,990  
    1,120,845  
Non-current      
Intangible assets (Note 4)   673,300  
       
Total Assets   1,794,145  
       
Liabilities      
       
Current      
Accounts payable & accrued liabilities (Notes 6 and 9)   542,755  
Total liabilities   542,755  
       
Shareholders' Equity      
Share capital (Note 6)   1,970,377  
Common share reserve   40  
Accumulated deficit   (719,027 )
    1,251,390  
       
Total Liabilities and Shareholders' Equity   1,794,145  

Nature of operations and going concern - Note 1

Subsequent events - Note 12

APPROVED BY THE DIRECTOR

 

 

 

"Mark Godsy"

  Director

 

  Director




Naqi Logix Inc.
Statements of Loss and Comprehensive Loss
For the period from August 4, 2020 (inception) to June 30, 2021
(Expressed in US dollars)


    2021  
    $  
Office and administrative expenses      
    Consulting fees and salaries (Note 8)   134,625  
    Research and development expenses   201,769  
    Office and other   1,363  
    Professional fees   362,682  
    Marketing and communications   9,758  
    Rent   1,818  
Loss before other items   (712,016 )
       
    Foreign exchange loss   (7,052 )
    Interest and bank charges   41  
       
Net loss and comprehensive loss for the period   (719,027 )
       
Loss per share      
    Basic and diluted   (0.05 )
       
Weighted average number of shares outstanding      
    Basic and diluted   15,262,750  



Naqi Logix Inc.
Statements of Cash Flows
For the period from August 4, 2020 (inception) to June 30, 2021
(Expressed in US dollars)



    2021  
    $  
Cash (used in) provided by:      
       
Operating activities      
Net loss for the period ended June 30, 2021   (719,027 )
       
Changes in non-cash working capital items      
    Prepaid expenses   (810 )
    GST receivable   (7,990 )
    Accounts payable and accrued liabilities   593,904  
       
Cash used in operating activities   (133,923 )
       
Investing activities      
Acquisition of patents   (218,251 )
Acquisition of intangibles   (455,049 )
Cash used in investing activities   (673,300 )
       
Financing activities      
Issuance of shares   1,989,360  
Cash received pursuant to convertible promissory note   78,000  
Share issuance costs   (148,092 )
Cash provided by financing activities   1,919,268  
       
Increase in cash   1,112,045  
       
Cash - beginning   -  
       
Cash - ending   1,112,045  

Supplemental cash flow information - Note 9



Naqi Logix Inc.
Statements of Changes in Equity
For the period from August 4, 2020 (inception) to June 30, 2021
(Expressed in US dollars)


    Number of
common
shares
    Share
capital
    Common
share reserve
    Accumulated
deficit
    Total  
    #     $     $     $     $  
                               
Opening Balance, August 4, 2020   -     -     -     -     -  
                               
Shares to be issued to founders (Note 6)   -           36     -     36  
Shares to be issued to giftees (Note 6)   -           4     -     4  
Shares issued pursuant to private placements (Note 6)   7,586,678     1,989,320     -     -     1,989,320  
Shares issued for debt (Note 5, 6, 8 and 9)   516,596     129,149     -     -     129,149  
Share issuance costs (Note 6)   370,600     (148,092 )   -     -     (148,092 )
Net and comprehensive loss for the period   -     -     -     (719,027 )   (719,027 )
                               
Balance, June 30, 2021   8,473,874     1,970,377     40     (719,027 )   1,251,390  



Naqi Logix Inc.
Notes to the Financial Statements
For the period from August 4, 2020 (inception) to June 30, 2021
(Expressed in US dollars)

1. Nature of operations and going concern

Naqi Logix Inc. (the "Company") was incorporated pursuant to the provisions of the Business Corporations Act of British Columbia on August 4, 2020.

The Company's principal activities include developing revolutionary technology and a platform that transforms our inconspicuous micro-gestures into instant commands to control all the devices where we work, live or play.  Naqi is an early-stage technology company that focuses its research and development on novel, next-generation voice-free, hands-free and look-free device control methodologies that include micro-gestural, electromyography (EMG) and electroencephalography (EEG) input.  Naqi Logix Inc. is currently developing smart earbuds that will enable users to control information systems, devices and platforms in a completely non-tactile, invisible and silent manner.

These financial statements have been prepared on a going concern basis, which assumes that the Company will be able to meet its obligations and continue its operations for the next twelve months. As at June 30, 2021, the Company had an accumulated deficit of $719,027, and it expects to incur further losses in the development of the business. These factors indicate the existence of material uncertainties that may cast significant doubt upon the Company's ability to continue as a going concern. As a result, the Company may be unable to realize its assets and discharge its liabilities in the normal course of business. The Company's ability to continue as a going concern is dependent on its ability to obtain necessary financing to meet its corporate expenditures and discharge its liabilities in the normal course of business. Although the Company was successful in obtaining financing during the period ended June 30, 2021, there can be no assurance that it will be able to obtain adequate financing in the future or that such financing will be on terms advantageous or acceptable to the Company.

In March 2020, the World Health Organization declared coronavirus COVID-19 a global pandemic. This contagious disease outbreak, which has continued to spread, and any related adverse public health developments, has adversely affected workforces, economies, and financial markets globally, potentially leading to an economic downturn. This may impact the Company's ability to raise capital.

Should the Company be unable to continue as a going concern, asset realization values may be substantially different from their carrying values. These financial statements do not give effect to adjustments that would be necessary to carrying values, and classification of assets and liabilities should the Company be unable to continue as a going concern. Such adjustments could be material.

The Company's corporate office is located at Suite 1000-355 Burrard Street, Vancouver, British Columbia, Canada, V6E 2K3.

2. Basis of preparation

Statement of compliance

These financial statements have been presented in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB') and interpretations of the International Financial Reporting Interpretations Committee ("IFRIC"). These financial statements represent the Company's first presentation of the financial results and financial position under IFRS. The policies applied in these financial statements are based on IFRS issued and effective as of June 30, 2021, including IFRS 1, First Time Adoption of International Financial Reporting Standards. As the Company was incorporated on August 4, 2020, no optional exemption has been applied. The Board of Directors approved the financial statements for issue on December 29, 2021.

Basis of measurement and functional currency

These financial statements have been prepared on a historical cost basis except for financial instruments measured at fair value. These financial statements are presented in US dollars, which is the functional currency of the Company.


Naqi Logix Inc.
Notes to the Financial Statements
For the period from August 4, 2020 (inception) to June 30, 2021
(Expressed in US dollars)

3. Accounting policies

These financial statements have been prepared using the following accounting policies:

Cash

Cash includes cash held in financial institutions.

Financial instruments

a) Classification

The Company classifies its financial instruments in the following categories: at fair value through profit and loss ("FVTPL"), at fair value through other comprehensive income (loss) ("FVTOCI") or at amortized cost. The Company determines the classification of financial assets at initial recognition. The classification of debt instruments is driven by the Company's business model for managing the financial assets and their contractual cash flow characteristics.

Equity instruments that are held for trading are classified as FVTPL. For other equity instruments, on the day of acquisition the Company can make an irrevocable election (on an instrument-by-instrument basis) to designate them as at FVTOCI. Financial liabilities are measured at amortized cost, unless they are required to be measured at FVTPL (such as instruments held for trading or derivatives) or if the Company has opted to measure them at FVTPL.

a) Measurement

Financial assets at FVTOCI

Elected investments in equity instruments at FVTOCI are initially recognized at fair value plus transaction costs. Subsequently they are measured at fair value, with gains and losses recognized in other comprehensive income (loss).

Financial assets and liabilities at amortized cost

Financial assets and liabilities at amortized cost are initially recognized at fair value plus or minus transaction costs, respectively, and subsequently carried at amortized cost less any impairment.

Financial assets and liabilities at FVTPL

Financial assets and liabilities carried at FVTPL are initially recorded at fair value and transaction costs are expensed in the consolidated statements of loss and comprehensive loss. Realized and unrealized gains and losses arising from changes in the fair value of the financial assets and liabilities held at FVTPL are included in the consolidated statements of loss and comprehensive loss in the period in which they arise. Where management has opted to recognize a financial liability at FVTPL, any changes associated with the Company's own credit risk will be recognized in other comprehensive loss.


Naqi Logix Inc.
Notes to the Financial Statements
For the period from August 4, 2020 (inception) to June 30, 2021
(Expressed in US dollars)

3.  Accounting policies (continued)

Financial instruments (continued)

b) Impairment of financial assets at amortized cost

The Company recognizes a loss allowance for expected credit losses on financial assets that are measured at amortized cost.

At each reporting date, the Company measures the loss allowance for the financial asset at an amount equal to the lifetime expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition. If at the reporting date, the financial asset has not increased significantly since initial recognition, the Company measures the loss allowance for the financial asset at an amount equal to the twelve month expected credit losses. The Company shall recognize in the statements of loss and comprehensive loss, as an impairment gain or loss, the amount of expected credit losses (or reversal) that is required to adjust the loss allowance at the reporting date to the amount that is required to be recognized.

c) Derecognition

Financial assets

The Company derecognizes financial assets only when the contractual rights to cash flows from the financial assets expire, or when it transfers the financial assets and substantially all of the associated risks and rewards of ownership to another entity. Gains and losses on derecognition are generally recognized in the consolidated statements of loss and comprehensive loss.

Financial liabilities

The Company derecognizes financial liabilities only when its obligations under the financial liabilities are discharged, cancelled or expired. Generally, the difference between the carrying amount of the financial liability derecognized and the consideration paid and payable, including any non-cash assets transferred or liabilities assumed, is recognized in profit or loss.

Share capital

The Company's common shares, and any future offerings of share warrants and options are classified as equity instruments. Incremental costs directly related to the issue of new shares or options are shown in equity as a deduction from the proceeds. For equity offerings of units consisting of a common share and warrant, when both instruments are classified as equity, the Company does not bifurcate the proceeds between the common share and the other equity instruments.

The Company issues shares under repurchase arrangements whereby these shares are initially recorded as common share reserve as unreleased shares subject to a repurchase option held by the Company.  These shares are released into share capital over an agreed period of time (vesting period) for no additional consideration.  The common shares issued under these repurchase arrangements are measured at their fair value on the date that the Company enters into the repurchase agreements.

Income taxes

Income taxes comprises both current and deferred tax. Income tax is recognized in the statement of loss except to the extent that it relates to items recognized in other comprehensive income or directly in equity, in which case the income tax is also recognized in other comprehensive income or directly in equity.

Current income taxes are the expected taxes payable on the taxable income for the period, using tax rates enacted or substantively enacted at the end of the reporting period, and any adjustment to taxes payable in respect of previous periods.

The Company accounts for potential future net tax assets which are attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and which are measured using tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be settled. When the future realization of income tax assets is not considered to be probable, no net asset is recognized. No potential income tax assets of the Company have been recognized.


Naqi Logix Inc.
Notes to the Financial Statements
For the period from August 4, 2020 (inception) to June 30, 2021
(Expressed in US dollars)

3.  Accounting policies (continued)

Loss per share

Basic loss per share is calculated by dividing the net loss for the period available to common shareholders by the weighted average number of shares outstanding during the period. Diluted earnings per share reflect the potential dilution of securities that could share in earnings of an entity. The Company uses the treasury stock method of calculating fully diluted loss per share amounts, whereby any proceeds from the exercise of stock options or other dilutive instruments are assumed to be used to purchase common shares at the average market price during the period. Basic and diluted loss per share are the same for the periods presented.  Contingently issuable shares are treated as outstanding and are included in the calculation of basic and diluted loss per share only from the date when all necessary conditions are satisfied (ie the events have occurred). Shares that are issuable solely after the passage of time are not contingently issuable shares and are included in the calculation of basic and diluted loss per share.

Leases

The main provision of IFRS 16 is the recognition of lease assets and lease liabilities on the consolidated statement of financial position. Under IFRS 16, a lessee is required to do the following: (i) recognize a right-of-use asset and a lease liability, initially measured at the present value of the lease payments, on the consolidated statement of financial position; and (ii) recognize a front-loaded pattern of expense for most leases, even when cash rentals are constant, as the right-of-use asset is depreciated and the lease liability is accreted using the effective interest method. IFRS 16 also requires qualitative disclosures along with specific quantitative disclosures. The Company does not have any material lease obligations as at June 30, 2021.

Intangible assets

Intangible assets are measured at cost less accumulated amortization and accumulated impairment losses. Costs incurred for licenses and patents are capitalized and amortized from the date of capitalization on a straight-line basis over the their remaining estimated lives of 20 years.

Research and development

The Company is engaged in research and development activities. Research costs are expensed as incurred.  Development costs are expensed, unless all of the following can be demonstrated:

  • The technical feasibility of completing the intangible asset so that it will be available for use or sale;
  • The intention to complete the intangible asset and use or sell it;
  • The ability to use or sell the intangible asset;
  • How the intangible asset will generate probable future economic benefits;
  • The availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and
  • The ability  to  measure  reliably  the  expenditures  attributable  to  the  intangible  asset  during  its  development.

Development costs that meet the above criteria are capitalised at cost as deferred development costs. Deferred development costs have finite useful lives and are carried at cost less accumulated amortization and accumulated impairment losses.

Impairment of long-lived assets

The Company evaluates the carrying value of long-lived assets at the end of each reporting period to determine whether there is any indication of impairment.


Naqi Logix Inc.
Notes to the Financial Statements
For the period from August 4, 2020 (inception) to June 30, 2021
(Expressed in US dollars)

3.  Accounting policies (continued)

An impairment loss is recorded when it is determined that the carrying amount is no longer recoverable and exceeds its fair value calculated using the discounted cash flows related to the asset or asset group.  The recoverable amount is the higher of an asset's or cash generating unit's fair value less costs to sell and value in use.  In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset.  For an asset that does not generate largely independent cash flows, the recoverable amount is determined for the cash-generating unit to which the asset belongs.

An impairment loss is recognized when the carrying amount of an asset, or its cash generating unit, exceeds its recoverable amount.  A cash generating unit is the smallest identifiable group of assets that generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

Impairment losses are recognized in profit or loss in the period in which an impairment is identified.  Impairment losses are reversed in subsequent periods if there is a change in the estimates used to determine the recovered amount since the impairment was recognized.

Critical judgments in applying accounting policies

The critical judgments that the Company's management has made in the process of applying the Company's accounting policies with the most significant effect on the amounts recognized in the Company's financial statements are as follows:

Going concern

In preparing these financial statements on a going concern basis, as is disclosed in Note 1 of these consolidated financial statements, Management's critical judgment is that the Company will be able to meet its obligations and continue its operations for the next twelve months.

Estimated useful lives of intangible assets

The estimated useful lives of intangible assets are based on management's intentions, historical experience, internal plans and other factors as determined by management. The useful lives are reviewed on an annual basis and any revisions to the useful lives are accounted for prospectively.

Key sources of estimation uncertainty

The preparation of financial statements requires that the Company's management make assumptions and estimates of effects of uncertain future events on the carrying amounts of the Company's assets and liabilities at the end of the reporting period.  Actual results may differ from those estimates as the estimation process is inherently uncertain. Actual future outcomes could differ from present estimates and assumptions, potentially having material future effects on the Company's consolidated financial statements. Estimates are reviewed on an ongoing basis and are based on historical experience and other facts and circumstances. Revisions to estimates and the resulting effects on the carrying amounts of the Company's assets and liabilities are accounted for prospectively.

The significant assumptions about the future and other major sources of estimation uncertainty as at the end of the reporting period that have a significant risk of resulting in a material adjustment to the carrying amounts of the Company's assets and liabilities are as follows:

a) Deferred income taxes

Deferred income tax assets and liabilities are measured using enacted or substantively enacted tax rates at the reporting date in effect for the period in which the temporary differences are expected to be recovered or settled. The effect on deferred income tax assets and liabilities of a change in tax rates is recognized as part of the provision for income taxes in the period that includes the enactment date. The recognition of deferred income tax assets is based on the assumption that it is probable that taxable profit will be available against which the deductible temporary differences can be utilized.


Naqi Logix Inc.
Notes to the Financial Statements
For the period from August 4, 2020 (inception) to June 30, 2021
(Expressed in US dollars)

Accounting standards issued but not yet effective

There are no accounting pronouncements with future effective dates that are applicable or are expected to have a material impact on the Company's financial statements.

4. Intangible assets

Cost

Total

 

 

$

 

Opening Balance

-

 

Acquisition of Naqi Technology

311,787

 

Acquisition of Rotamach Technology

361,513

 

Balance, June 30, 2021

673,300

 

Naqi Logics LLC Asset Purchase Agreement

On April 12, 2021, the Company entered into an arms-length asset purchase agreement (the "APA") to purchase the patents, vendor technology, vendor intellectual property and know-how (the "Purchase Assets") from Naqi Logics LLC ("LLC") (the "Naqi Technology").


Naqi Logix Inc.
Notes to the Financial Statements
For the period from August 4, 2020 (inception) to June 30, 2021
(Expressed in US dollars)

4. Intangible assets (continued)

Pursuant to the APA, the Company agreed to pay a purchase price of $311,787 in cash.

Also pursuant to the APA, the Company entered into a royalty agreement with LLC for a royalty payable to LLC of up to $5,000,000 (the "LLC Royalty Agreement"). Under the LLC Royalty Agreement, the Company has agreed to pay at the end of each calendar quarter, 2.5% of Net Revenues up to $300,000 per calendar quarter.  Upon the fulfillment of royalty payments of $300,000, the LLC royalty will automatically increase to 5% of Net Revenues, which will continue until the Company has paid an aggregate LLC royalty equal to $5,000,000.  As at June 30, 2021, the Company has not earned any revenues nor accrued any royalty liability.

The LLC Royalty liability assumed upon the acquisition of the Naqi Technology has been recorded at management's estimate of its fair value of $nil on the acquisition date.  Management has also estimated the fair value of the LLC Royalty liability at $nil at June 30, 2021.

Harrisburg University Independent Contractor and Royalty Agreement

On April 12, 2021, the Company signed an independent contractor agreement with Harrisburg University of Science and Technology (the "University Royalty Agreement"). As partial consideration for the University providing certain services, if and when revenue is earned, the Company will pay at the end of each calendar quarter, 2.5% of Net Revenues up to $300,000.  Upon the fulfillment of royalty payments of $300,000 the obligation to pay University Royalties will cease completely.  Management has recorded the assumption of the liability under the University Royalty Agreement at $nil on April 12, 2021 and as at June 30, 2021.

Smart Rotamach Private Limited Technology Purchase Agreement

On April 14, 2021, the Company entered into a technology purchase agreement (the "TPA") with an unrelated party to purchase the Rotomach Technology and all related information and material that relates to sensing, monitoring, measuring and interpreting user information for cash of $361,513.

5. Shareholder convertible promissory note

On April 12, 2021, the Company received a loan of $129,149 from a shareholder (Note 8) under a convertible promissory note for cash received of $78,000 and expense paid on behalf of the Company of $51,149. The note was non-interest bearing, unsecured, and was due on April 12, 2023. The note was initially recorded at management's estimate of fair value of $129,149 and was automatically converted on June 8, 2021 upon the completion of the June 8, 2021 qualified financing (Note 6) at the contractually-agreed mandatory conversion price of $0.25 per common share.

6. Share capital

a) Authorized: Unlimited common shares without par value.

b) Shares issued

Common shares: 48,473,874.

During the period ended June 30, 2021, the Company:

a) Issued 25,637,530 common shares to founders for proceeds of $26 and 3,950,274 commons shares to giftees for proceeds of $4. These common shares are subject to a repurchase agreement under which they are initially issued as unreleased shares, to be released to the recipient shareholders on an agreed timeline as long as the current CEO remains as a service provider to the Company.  In the event there is a change in control of the Company, all of these common shares are released.  These shares are subject to release on the basis that 16.67% vest 6 months after issuance.  The remaining common shares vest in equal instalments of 2.7% monthly over the next 29 months, with a final 2.78% vesting in the 36th month after issuance;


Naqi Logix Inc.
Notes to the Financial Statements
For the period from August 4, 2020 (inception) to June 30, 2021
(Expressed in US dollars)

b) Issued 10,412,196 founders common shares to the shareholders of LLC for proceeds of $10. These common shares are subject to a repurchase agreement under which they are initially issued as unreleased shares, to be released to the recipient shareholders as long as those shareholders continue as service providers to the Company.  In the event there is a change in control of the Company, all of these common shares are released.  16.67% of the common shares issued to these shareholders vest 6 months after their issuance.  The remaining common shares vest in equal instalments of 2.7% monthly over the next 29 months, with a final 2.78% vesting in the 36th month after issuance.

c) Completed a qualified financing through a series of non-brokered private placements by issuing 7,586,678 common shares for gross proceeds of $1,989,320;

d) The Company issued 370,600 and paid $148,092 in cash for share issuance costs related to the issuance of these shares; and

e) Issued 516,596 common shares with a fair value of $129,149 to settle the convertible promissory note (Note 5).

The 40,000,000 founders and giftee common shares were issued as described above in (a) and (b) are considered unreleased common shares subject to vesting under the terms as summarized.  At June 30, 2021 the unreleased common shares are expected to vest as follows:

Fiscal year of release   Number of
released common
shares
    Common share
reserve to be
transferred to
share capital
 
          $  
2022   17,147,158     17  
2023   13,333,334     13  
2024   9,519,508     10  
Total unreleased shares at June 30, 2021   40,000,000     40  

7. Income taxes

A reconciliation between the Company's income tax provision computed at statutory rates to the reported income tax provision is as follows:

    June 30  
    2021  
    $  
Loss for the period before income tax recovery   (719,027 )
Average statutory rate   27.00%  
       
Income tax recovery based on statutory rates   (194,000 )
Change in non-recognized deferred tax assets   194,000  
Income tax recovery   -  

Deferred income tax assets are only recognized to the extent that the realization of tax benefits is determined to be probable.  As at June 30, 2021, the Company has not recognized the benefit of the following deductible temporary differences:



Naqi Logix Inc.
Notes to the Financial Statements
For the period from August 4, 2020 (inception) to June 30, 2021
(Expressed in US dollars)


    June 30
2021
 
    $  
Deferred tax assets      
    Losses carried forward   194,000  
    Share issuance costs   40,000  
    Unrecognized deferred tax assets   (234,000 )
Total deferred tax assets   -  

As at June 30, 2021, the Company has estimated non-capital losses for Canadian income tax purposes of $700,000 that may be carried forward to reduce taxable income derived in future years. The Canadian non-capital losses expire in 2041.

8. Related party transactions

In addition to the related party transaction disclosed in Note 5, the Company entered into the following related party transactions during the period.

The Company's related parties consist of the Company's director and officers, and any companies associated with them. During the period ended June 30, 2021, consulting fees and salaries of $62,500 were paid to the CEO, CIO, COO, and director of the Company.

As at June 30, 2021, $62,500 was owing to directors, officers or their related companies, which is included in accounts payable and accrued liabilities.

On April 1, 2021, the Company entered into a sublease agreement with Shackelford Pharma Inc., in which an officer of the Company also holds an officer position.  The sublease allows the Company to utilize 50% of the premises for a monthly rent amount of CAD $745.  This lease is excluded from lease liability as defined under IFRS 16 due to its low value.

Key management includes directors and executive officers of the Company. During the period ended June 30, 2021, no compensation other than that disclosed above was paid or payable for key management services.

9. Supplemental cash flow information

Investing and financing activities that do not have a direct impact on the current cash flows are excluded from the cash flow statements.

During the period ended June 30, 2021 there were the following non-cash investing and financing transactions:

f) $51,149 of expenses were incurred and settled
by advances under the shareholder convertible promissory note (Note 5).

g) Issued 516,596 common shares to settle shareholder convertible promissory note in the amount of $129,149 (Note 6).

10. Financial instruments

Classification of financial instruments

The Company's financial instruments consist of cash and accounts payable and accrued liabilities. These financial instruments are classified as financial assets and liabilities at amortized cost and are reported at amortized cost.

The classification of the financial instruments as well as their carrying values as at June 30, 2021 is shown in the table below:


Naqi Logix Inc.
Notes to the Financial Statements
For the period from August 4, 2020 (inception) to June 30, 2021
(Expressed in US dollars)


At June 30, 2021   Assets -
Amortized cost
    Liabilities -
Amortized cost
    Total  
    $     $     $  
Financial assets                  
Cash   1,112,045     -     1,112,045  
Total financial assets   1,112,045     -     1,112,045  
Financial liabilities                  
Accounts payable   -     542,754     542,754  
Total financial liabilities   -     542,754     542,754  

Classification of financial instruments

Financial instruments measured at fair value are classified into one of three levels in the fair value hierarchy according to relative reliability of the inputs used to estimate fair values. The three levels of the fair value hierarchy are:

Level 1 - unadjusted quoted prices in active markets for identical assets and liabilities;

Level 2 - inputs other than quoted prices that are observable for the asset or liability either directly or indirectly; and

Level 3 - inputs that are not based on observable market data.

The fair values of financial assets and liabilities approximate the carrying values due to their relatively short-term nature.

10. Financial instruments (continued)

Financial and capital risk management

The Company thoroughly examines the various financial instruments and risks to which it is exposed and assesses the impact and likelihood of those risks. These risks include foreign currency risk, interest rate risk, credit risk, and liquidity risk. Where material, these risks are reviewed and monitored by the Board of Directors.

The Board of Directors has overall responsibility for the determination of the Company's risk management objectives and policies. The overall objective of the Board is to set policies that seek to reduce risk as far as possible without unduly affecting the Company's competitiveness and flexibility.

Discussions of risks associated with financial assets and liabilities are detailed below:

a) Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The risk that the Company will realize a cash loss is limited as the Company's liabilities are either non-interest bearing or have fixed interest rates. The Company considers this risk to be immaterial.

b) Credit risk

Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations.  Credit risk arises from cash held with banks and financial institutions. The maximum exposure to credit risk is equal to the carrying value of the financial assets. The Company considers credit risk with respect to its cash to be immaterial as cash is held through large Canadian financial institutions.

c) Liquidity risk

Liquidity risk is the risk that the Company is not able to meet its financial obligations as they become due. The Company manages its liquidity risk by continuously monitoring forecasted and actual cash flows, as well as anticipated investing and financing activities. Accounts payable and accrued liabilities have contractual maturities of 30 days or are due on demand and are subject to normal trade terms. The Company has working capital of $578,090 as at June 30, 2021.


Naqi Logix Inc.
Notes to the Financial Statements
For the period from August 4, 2020 (inception) to June 30, 2021
(Expressed in US dollars)

11. Management of capital

The Company's objectives when managing capital are to safeguard the Company's ability to continue as a going concern. In the management of capital, the Company includes its components of shareholders' equity.

The capital structure of the Company consists of equity attributable to common shareholders, comprised of issued capital and deficit.

The Company maintains and adjusts its capital structure based on changes in economic conditions and the Company's planned requirements. The Company may adjust its capital structure by issuing new equity, issuing new debt, or acquiring or disposing of assets.

The Company does not have a source of revenue. As such, the Company is dependent on external financing to fund its activities. In order to pay for administrative costs and for future development of its technologies, the Company will spend its existing working capital and raise additional amounts as needed.

Management reviews its capital management policies on an ongoing basis.  The Company is not subject to any externally imposed capital requirements. There were no changes to the Company's approach to capital management during the period.

12. Subsequent events

Bridge Loan

In October 2021, the Company initiated a convertible bridge loan financing and has raised $338,000 as at the financial statement date December 29 2021.


 

 

 

Naqi Logix Inc.

Condensed Interim Financial Statements

For the nine month periods ended March 31, 2022

and period from inception on August 4, 2020 to March 31, 2021

(Unaudited)

(Expressed in US Dollars)

 

 

 



Naqi Logix Inc.
Condensed Interim Statements of Financial Position
(Expressed in US dollars)
 

        March 31, 2022     June 30, 2021  
        Unaudited     Audited  
    Notes   $     $  
ASSETS              
Current assets              
  Cash and cash equivalents     116,774     1,112,045  
  Restricted Cash     25,000     -  
  Prepaid expenses     -     810  
  GST receivable     48,529     7,990  
Total current assets     190,303     1,120,845  
Intangible assets 4   663,297     673,300  
Total assets     853,600     1,794,145  
                 
LIABILITIES AND SHAREHOLDERS' EQUITY              
                 
Current liabilities              
  Accounts payable & accrued liabilities 8   707,066     542,755  
Non-current liabilities              
  Convertible debentures 6   843,199     -  
Total liabilities     1,550,265     542,755  
                 
Shareholders' (deficiency)/equity              
  Share capital 7   1,970,391     1,970,377  
  Common share reserve     401,006     40  
  Accumulated deficit     (3,068,062 )   (719,027 )
Total shareholders' (deficiency)/equity     (696,665 )   1,251,390  
                 
Total liabilities and shareholders' (deficiency)/equity   853,600     1,794,145  

Nature of operations and going concern - Note 1

Subsequent events - Note 10

APPROVED BY THE BOARD OF DIRECTORS

 

 

"Mark Godsy"

Director

 

"Gary Roshak"

Director

 

 

 

 

 




Naqi Logix Inc.
Condensed Interim Statements of Loss and Comprehensive Loss
(Unaudited)
(Expressed in US dollars)
 


        For the nine-months
ended March 31, 2022
    For the period from
inception on August 4,
2020 to March 31, 2021
 
    Notes   $     $  
                 
Expenses              
  Consulting fees and salaries     603,741     -  
  Research and development expenses   764,552     18,010  
  Office and other     89,630     29  
  Share-based compensation 7(c)   400,980     -  
  Professional fees     248,219     54,185  
  Rent 8   5,321     -  
  Marketing and communications     18,500     -  
  Amortization and depreciation 4   10,003     -  
Total expenses     2,140,946     72,224  
                 
Loss before other items     2,140,946     72,224  
                 
  Loss on fair value of convertible debt   189,110     -  
  Interest and bank charges     354     68  
  Interest on convertible debt     11,089     -  
  Foreign exchange loss/(gain)     7,536     (112 )
Net loss and comprehensive loss for the period   2,349,035     72,180  
                 
Basic and diluted loss per share     0.05     0.01  
                 
Weighted average number of common shares outstanding, basic and diluted     48,473,874     5,633,875  



Naqi Logix Inc.
Condensed Interim Statements of Cash Flows
(Unaudited)
(Expressed in US dollars)
 


      For the nine-months
ended,

March 31,
    For the period from
inception on August 4,
2020 to March
 
      2022     31, 2021  
  Notes   $     $  
Cash flows used in operating activities              
Loss for the period     (2,349,035 )   (72,180 )
Items not affecting cash:              
Amortization and depreciation 4   10,003     -  
Share-based payment 7   400,980     -  
Loss on fair value of convertible debentures 6   189,110     -  
Interest on convertible debentures 6   11,089     -  
Changes in non-cash working capital items:              
Receivables, prepaids and deposits     (39,729 )   -  
Accounts payable and accrued liabilities     164,311     40,293  
      (1,613,271 )   (31,887 )
               
               
Cash flows provided by financing activities              
Shareholder loan proceeds 5, 8   -     31,869  
Proceed from shares issued to founders & giftees 7   -     29  
Convertible debt issued 6   643,000     -  
      643,000     31,898  
               
               
Net change in cash and cash equivalents and restricted cash for the period     (970,271 )   11  
Cash and cash equivalents and restricted cash, beginning of period     1,112,045     -  
Cash, cash equivalents and restricted cash, end of period     141,774     11  
               
Breakup of cash and cash equivalents and restricted cash;              
Cash and cash equivalents and restricted cash     116,774     11  
Restricted cash     25,000     -  
      141,774     11  



Naqi Logix Inc.
Condensed Interim Statements of Changes in Equity
(Unaudited)
(Expressed in US dollars)
 


      Number of
shares issued
    Share capital     Common Share
Reserve
    Accumulated
deficit
    Total  
  Notes   #     $     $     $     $  
Opening Balance at August 4, 2020 (Unaudited)     -     -     -     -     -  
                                 
Shares to be issued to founders 7   -     -     26     -     26  
Shares to be issued to giftees 7   -     -     3     -     3  
Net and comprehensive loss for the period     -     -     -     (72,180 )   (72,180 )
Balance at March 31, 2021 (Unaudited)     -     -     29     (72,180 )   (72,151 )
                                 
Balance at June 30, 2021 (Audited)     8,473,874     1,970,377     40     (719,027 )   1,251,390  
Shares issued to founders & giftees 7   13,813,825     14     (14 )   -     -  
Share-based compensation 7   -     -     400,980     -     400,980  
Net loss and comprehensive loss     -     -     -     (2,349,035 )   (2,649,035 )
Balance at March 31, 2022 (Unaudited)     22,287,699     1,970,391     401,006     (3,068,062 )   (696,665 )


Naqi Logix Inc.
Notes to the Condensed Interim Financial Statements
(Unaudited)
For the nine months ended March 31, 2022 and 2021
(Expressed in US dollars)

1. Nature of operations and going concern

Naqi Logix Inc. (the "Company") was incorporated pursuant to the provisions of the Business Corporations Act of British Columbia on August 4, 2020.

The Company's principal activities include developing revolutionary technology and a platform that transforms inconspicuous micro-gestures into instant commands to control certain electronic devices.  Naqi is an early-stage technology company that focuses its research and development on novel, next-generation voice-free, hands-free and look-free device control methodologies that include micro-gestural, electromyography (EMG) and electroencephalography (EEG) input.  Naqi Logix Inc. is currently developing smart earbuds that will enable users to control information systems, devices and platforms in a completely non-tactile, invisible and silent manner.

Going concern uncertainty

These condensed interim financial statements of the Company for the nine months ended March 31, 2022 and period from inception on August 4, 2020 to March 31, 2021 ("financial statements") have been prepared on a going concern basis, which assumes that the Company will be able to meet its obligations and discharge liabilities in the normal course of business.

As at March 31, 2022, the Company had an accumulated deficit of $3,068,062, and it expects to incur further losses in the development of the business. These factors indicate the existence of material uncertainties that may cast significant doubt upon the Company's ability to continue as a going concern. As a result, the Company may be unable to realize its assets and discharge its liabilities in the normal course of business. The Company's ability to continue as a going concern is dependent on its ability to obtain necessary financing to meet its corporate expenditures and discharge its liabilities in the normal course of business. Although the Company was successful in obtaining financing during prior periods, there can be no assurance that it will be able to obtain adequate financing in the future or that such financing will be on terms advantageous or acceptable to the Company. 

In March 2020, the World Health Organization declared coronavirus COVID-19 a global pandemic. This contagious disease outbreak, which has continued to spread, and any related adverse public health developments, has adversely affected workforces, economies, and financial markets globally, potentially leading to an economic downturn. This may impact the Company's ability to raise capital.

Should the Company be unable to continue as a going concern, asset realization values may be substantially different from their carrying values. These financial statements do not give effect to adjustments that would be necessary to carrying values, and classification of assets and liabilities should the Company be unable to continue as a going concern. Such adjustments could be material.

The Company's corporate office is located at Suite 1400-1040 West Georgia Street, Vancouver, British Columbia, Canada, V6E 4H1.

2. Basis of preparation

Statement of compliance
These interim financial statements have been prepared in accordance with International Accounting Standard 34, Interim Financial Reporting ("IAS 34") using accounting policies consistent with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB"). These should be read in conjunction with the Company's last annual financial statements as at and for the year ended June 30, 2021 ("last annual financial statements"). The accounting policies applied by the Company in these condensed interim financial statements are the same as those applied in the last annual financial statements.


Naqi Logix Inc.
Notes to the Condensed Interim Financial Statements
(Unaudited)
For the nine months ended March 31, 2022 and 2021
(Expressed in US dollars)

2. Basis of preparation (continued)

Statement of compliance (continued)
These condensed interim financial statements do not include all of the information required for full annual financial statements. However, selected explanatory notes are included to explain events and transactions that are significant to an understanding of changes in the Company's financial position and performance since the last annual financial statements.  The Board of Directors approved the financial statements for issue on June 30, 2022.

Basis of measurement and functional currency
These financial statements have been prepared on a historical cost basis except for financial instruments measured at fair value. These financial statements are presented in US dollars, which is the functional currency of the Company.

3. New Standards, interpretations and amendments

The accounting policies adopted in the preparation of the condensed interim financial statements are consistent with those followed in the preparation of the Company's annual financial statements for the year ended June 30, 2021 except for the adoption of new standards effective as of July 1, 2021.  The Company has not early adopted any standard, interpretation or amendment that has been issued but is not yet effective.

Several amendments apply for the first time in fiscal 2022, but do not have an impact on the condensed interim financial statements of the Company.

4. Intangible assets

Cost   Total  
    $  
Opening Balance   -  
Acquisition of Naqi Technology   311,787  
Acquisition of Rotamach Technology   361,513  
Balance, June 30, 2021   673,300  

Naqi Logics LLC Asset Purchase Agreement
On April 12, 2021, the Company entered into an arms-length asset purchase agreement (the "APA") to purchase the patents, vendor technology, vendor intellectual property and know-how (the "Purchase Assets") from Naqi Logics LLC ("LLC") (the "Naqi Technology"). 

Pursuant to the APA, the Company agreed to pay a purchase price of $311,787 in cash.

Also pursuant to the APA, the Company entered into a royalty agreement with LLC for a royalty payable to LLC of up to $5,000,000 (the "LLC Royalty Agreement"). Under the LLC Royalty Agreement, the Company has agreed to pay at the end of each calendar quarter, 2.5% of Net Revenues up to $300,000 per calendar quarter.  Upon the fulfillment of royalty payments of $300,000, the LLC royalty will automatically increase to 5% of Net Revenues, which will continue until the Company has paid an aggregate LLC royalty equal to $5,000,000.  As at March 31, 2022, the Company has not earned any revenues nor accrued any royalty liability.

The LLC Royalty liability assumed upon the acquisition of the Naqi Technology has been recorded at management's estimate of its fair value of $nil on the acquisition date.  Management has also estimated the fair value of the LLC Royalty liability at $nil at March 31, 2022 and June 30, 2021.


Naqi Logix Inc.
Notes to the Condensed Interim Financial Statements
(Unaudited)
For the nine months ended March 31, 2022 and 2021
(Expressed in US dollars)

4. Intangible assets (continued)

Harrisburg University Independent Contractor and Royalty Agreement
On April 12, 2021, the Company signed an independent contractor agreement with Harrisburg University of Science and Technology (the "University Royalty Agreement"). As partial consideration for the University providing certain services, if and when revenue is earned, the Company will pay at the end of each calendar quarter, 2.5% of Net Revenues up to $300,000.  Upon the fulfillment of royalty payments of $300,000 the obligation to pay University Royalties will cease completely.  Management has recorded the assumption of the liability under the University Royalty Agreement at $nil on April 12, 2021 and as at March 31, 2022 and June 30, 2021.

Smart Rotamach Private Limited Technology Purchase Agreement
On April 14, 2021, the Company entered into a technology purchase agreement (the "TPA") with an unrelated party to purchase the Rotamach Technology and all related information and material that relates to sensing, monitoring, measuring and interpreting user information for cash of $361,513.

    Intellectual
Property
    Patents     Total  
    $     $     $  
Cost                  
Opening Balance, August 4, 2020   -     -     -  
Additions   455,049     218,251     673,300  
Balance, June 30, 2021   455,049     218,251     673,300  
Additions   -     -     -  
Balance, March 31, 2022   455,049     218,251     673,300  
                   
Accumulated amortization                  
Opening Balance, August 4, 2020   -     -     -  
Amortization   -     -     -  
Balance, June 30, 2021   -     -     -  
Amortization   -     10,003     10,003  
Balance, March 31, 2022   -     10,003     10,003  
                   
Carrying amount                  
At June 30, 2021   455,049     218,251     673,300  
At March 31, 2022   455,049     208,248     663,297  

5. Shareholder convertible promissory note

On April 12, 2021, the Company received a loan of $129,149 ($31,869 was received during the nine months ended March 31, 2021) from a shareholder (Note 8) under a convertible promissory note for cash received of $78,000 and expense paid on behalf of the Company of $51,149. The note was non-interest bearing, unsecured, and was due on April 12, 2023. The note was initially recorded at management's estimate of fair value of $129,149 and was automatically converted on June 8, 2021 upon the completion of the June 8, 2021 qualified financing (Note 6) at the contractually agreed mandatory conversion price of $0.25 per common share.


Naqi Logix Inc.
Notes to the Condensed Interim Financial Statements
(Unaudited)
For the nine months ended March 31, 2022 and 2021
(Expressed in US dollars)

6. Convertible debentures

The Company issued $338,000 in convertible debentures in December 2021, $265,000 in February 2022, and $40,000 in in March 2022.

The convertible debentures bear interest at 8% per annum and are due and payable two years from the date issued ("Maturity Date"). Accrued interest on the convertible debentures as at March 31, 2022 is $11,089.

The loans are convertible under the following conditions:

a) Mandatory Conversion Upon Qualified Financing ("Conversion A"): In the event the Company consummates an equity financing of an aggregate consideration amount in excess of $1 million, all outstanding principal and interest on issued convertible debentures shall automatically convert into 1 common share and 1 warrant as obtained by dividing the outstanding principal and interest by the Conversion Price (price per share multiplied by the discount rate). Any issued warrants will be subject to accelerated expiration if for a period of thirty days they trade at or above the warrant exercise price or the common shares trade at a 75% premium to the warrant exercise price.

b) Mandatory Conversion - Going Public ("Conversion B"): In the event the Company consummates a going public transaction ("IPO") at a common share listing price in excess of the Common Issue Price (a price of US$3.00 per Common Share) multiplied by the discount rate ("Mandatory Conversion Price"), all outstanding principal and interest will convert into common shares in an amount calculated as total outstanding principal and interest divided by the common share listing price pursuant to the IPO.

c) Optional Conversion - Change of Control ("Conversion C"): If the Company consummates a change of control, defined as a single or series of transactions where the Company sells substantially all its assets or disposes of greater than 50% voting power, the holder has the option to either convert all outstanding principal and interest into common shares by dividing total principal and interest by the Common Issue Price, or receiving all outstanding principal and interest in cash.

d) Optional Conversion - At Maturity Date ("Conversion D"): If the convertible notes have not been converted prior to maturity, the holder has the rights to convert any outstanding principal and interest into common shares as obtained by dividing total principal and interest by the Common Issue Price or alternatively receive the total principal and interest in cash.

Management concluded that the convertible debentures are a hybrid financial instrument with an embedded derivative liability being the conversion feature entitling the holder to convert the notes to Units should the Company complete a Subsequent Financing (Conversion A). The Company has elected to designate the entire convertible debenture hybrid financial instrument at its fair value through profit or loss at each reporting date. 

Management estimated the fair value of the convertible debentures at March 31, 2022 by considering each of the conversion features of the instrument as two components;

(1) simple interest straight-debt; and

(2) equity conversion feature of common stock and/or warrants.


Naqi Logix Inc.
Notes to the Condensed Interim Financial Statements
(Unaudited)
For the nine months ended March 31, 2022 and 2021
(Expressed in US dollars)

6. Convertible debentures (continued)

Management then calculated a probability-weighted fair value based on the likelihood of each conversion scenario occurring.  Management considered the probability of each conversion option as follows:

 Conversion A: A probability weighting of 85% was applied. Management considers this outcome to be highly probable based on management's current plans and outlook.

 Conversion B: A probability weighting of 5% was applied as this scenario is considered to be less likely given Conversion A is likely to transpire first and consequently, this conversion feature will expire unexercised.

 Conversion C: A probability weighting of 5% was applied to Conversion C as this scenario is also considered unlikely because management does not intend or expect to enter into a change of control transaction.

 Conversion D: A probability weighting of 5% was also applied to Conversion D since this scenario is predicated on neither Conversion A, B or C occurring prior to maturity and as above, Conversion A is considered highly probable.

Each conversion feature was independently valued using either the Discounted Cash Flow ("DCF") and/or the Binomial Option Pricing Model ("BOPM") method as deemed appropriate. The valuation of each Conversion Option is detailed below.

Valuation of Conversion A
Conversion A is a mandatory conversion, and therefore the value of the conversion is equal to the Fair Value of the warrants and share units which would be issued to the holder under this scenario multiplied by the probability of scenario occurrence.  Management has used the BOPM valuation technique to value the warrants with the following inputs:

Share price

variable

Exercise price

share price x 1.2

Expected volatility

130%

Term

2 years

Risk free rate

2.27%

Expected dividend yield

0%

The number of warrants issued is correlated to the share price at the dates the warrants are issued and the outstanding principal and interest at that date.  Therefore, the share prices does not impact the fair value of the warrants.  The fair value of the shares and warrants are discounted from the expected issuance date at a discount rate of 46.66%

Valuation of Conversion B
Under Conversion B, the holder is entitled to the outstanding principal and interest as at the IPO date. Therefore, the value of the shares which would be issued are equal to the accumulated P&I on each of the Notes as at the conversion date, present valued to the Valuation Date at a discount rate of 46.66%.

Valuation of Conversion C and D
Conversion C and D permit a conversion to common shares at a set price of $3.00 per share at the option of the holder. Therefore, if the share price is greater than $3.00 at the time of this event, the holder would elect to convert to common shares, and if the value is less, the holder would elect to be repaid the principal and interest.

Management used a binomial model to calculate the possible share prices from the last known share price to the maturity of each of the Notes. The last known share price was based on a capital raise at $0.25 per share on June 8, 2021. The value of the conversion option at each date was calculated as the higher of the share value on conversion, or the accrued principal and interest at that date. The weighted average probability of each value is then discounted from the date of the binomial step to the Valuation Date at a rate of 46.66%.


Naqi Logix Inc.
Notes to the Condensed Interim Financial Statements
(Unaudited)
For the nine months ended March 31, 2022 and 2021
(Expressed in US dollars)

Conclusion
Applying the probability weighting summarized above to the Fair Values of each of the conversion options, the fair value of the convertible debentures has been estimated at $832,110 at March 31, 2022.

7. Share capital

a) Authorized: Unlimited common shares without par value.

b) Shares issued

Common shares: 48,473,874.

During the period ended March 31, 2021, the Company:

a) Issued 25,637,530 common shares to founders for proceeds of $26 and 3,011,322 common shares to giftees for proceeds of $3. These common shares are subject to a repurchase agreement under which they are initially issued as unreleased shares, to be released to the recipient shareholders on an agreed timeline as long as the current CEO remains as a service provider to the Company.  In the event there is a change in control of the Company, all of these common shares are released.  These shares are subject to release on the basis that 16.67% vest 6 months after issuance.  The remaining common shares vest in equal instalments of 2.7% monthly over the next 29 months, with a final 2.78% vesting in the 36th month after issuance;

During the period from April 1, 2021 to June 30, 2021, the Company:

b) Issued 938,952 common shares to giftees for proceeds of $1. These common shares are subject to a repurchase agreement under which they are initially issued as unreleased shares, to be released to the recipient shareholders on an agreed timeline as long as the current CEO remains as a service provider to the Company.  In the event there is a change in control of the Company, all of these common shares are released.  These shares are subject to release on the basis that 16.67% vest 6 months after issuance.  The remaining common shares vest in equal instalments of 2.7% monthly over the next 29 months, with a final 2.78% vesting in the 36th month after issuance;

c) Issued 10,412,196 founders common shares to the shareholders of LLC for proceeds of $10. These common shares are subject to a repurchase agreement under which they are initially issued as unreleased shares, to be released to the recipient shareholders as long as those shareholders continue as service providers to the Company.  In the event there is a change in control of the Company, all of these common shares are released.  16.67% of the common shares issued to these shareholders vest 6 months after their issuance.  The remaining common shares vest in equal instalments of 2.7% monthly over the next 29 months, with a final 2.78% vesting in the 36th month after issuance.

d) Completed a qualified financing through a series of non-brokered private placements by issuing 7,586,678 common shares for gross proceeds of $1,989,320.  The Company issued 370,600 and paid $148,092 in cash for share issuance costs related to the issuance of these shares; and

e) Issued 516,596 common shares with a fair value of $129,149 to settle the convertible promissory note (Note 5).


Naqi Logix Inc.
Notes to the Condensed Interim Financial Statements
(Unaudited)
For the nine months ended March 31, 2022 and 2021
(Expressed in US dollars)

7. Share capital (continued)

b) Shares issued (continued)

The 40,000,000 founders and giftee common shares were issued as described above in (a), (b) and (c) are considered unreleased common shares subject to vesting under the terms as summarized.  In the nine-month period ended March 31, 2022 13,813,825 common shares were released and as at March 31, 2022, 26,186,175 unreleased common shares are expected to vest as follows:

Fiscal year of release   Number of
unreleased
common shares
    Common share reserve
to be transferred to
share capital
 
          $  
2022   3,333,333     3  
2023   13,333,334     13  
2024   9,519,508     10  
Total unreleased shares at March 31, 2022   26,186,175     26  

c) Stock options

The Company has an incentive share option plan (the "Plan").  Under the Plan a total of 9,694,775 of the Company's outstanding common shares are reserved for the issuance of share options to directors, officers, employees, and consultants. The terms of each option award are fixed by the directors at the time of grant. Share options awarded have a maximum term of ten years. Share options vest over various time periods from the grant date to ten years at the discretion of the board of directors.

A summary of the Company's share options outstanding at March 31, 2022, including the changes during the period, is as follows:

    Share options     Weighted
average exercise
price
 
          $  
Opening Balance, August 4, 2020   -     -  
Granted   -     -  
Balance, June 30, 2021   -     -  
Granted   3,450,000     1.60  
Forfeited   (77,778 )   1.60  
Balance, March 31, 2022   3,372,222     1.60  

The weighted average remaining contractual life of stock options outstanding as of March 31, 2022 is 9.32 years.


Naqi Logix Inc.
Notes to the Condensed Interim Financial Statements
(Unaudited)
For the nine months ended March 31, 2022 and 2021
(Expressed in US dollars)

7. Share capital (continued)

c) Stock options (continued)

    March 31, 2022  
Risk-free interest rate (average)   1.20%  
Estimated volatility (average)   137%  
Expected life (average)   10  
Fair value of shares (average) $ 0.25  
Forfeiture rate (average)   2.25%  
Dividend rate (average)   0.00%  

During the nine months ended March 31, 2022 $400,980 was recorded to share-based compensation expense.

8. Related party transactions

The Company considers a person or entity a related party if they are a member of key management personnel, including their close relatives, an associate or joint venture, those having significant influence over the Company, as well as entities that are controlled by related parties. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.

The Company entered into the following related party transactions during the nine-month period ended March 31, 2022 and the period from inception on August 4, 2020 to March 31, 2021:

(i) Transactions with Key Management Personnel:

The following amounts were incurred with respect to Key Management Personnel; being the Company's CEO, COO and CIO:

    Nine months ended
March 31, 2022
    For the period from
inception on August 4,
2020 to March 31, 2021
 
    $     $  
Consulting fees to key management personnel   225,000     -  
Share-based compensation   80,774     -  
    305,774     -  

(ii) Transactions with Directors:

The following amounts were incurred with respect to non-executive directors of the Company:

    Nine months ended
March 31, 2022
    For the period from
inception on August 4,
2020 to March 31, 2021
 
    $     $  
Directors' fee   -     -  
Share-based compensation   135,910     -  
    135,910     -  


Naqi Logix Inc.
Notes to the Condensed Interim Financial Statements
(Unaudited)
For the nine months ended March 31, 2022 and 2021
(Expressed in US dollars)

8. Related party transactions (continued)

As at March 31, 2022, $61,500 (2021 - $31,869) was owing to directors, officers or their related companies, which is included in accounts payable and accrued liabilities. 

On April 1, 2021, the Company entered into a twelve-month sublease agreement with Shackelford Pharma Inc., in which an officer of the Company also holds an officer position.  The sublease allows the Company to utilize 50% of the premises for a monthly rent amount of CAD $745.  This lease is excluded from lease liability as defined under IFRS 16 due to its low value.

Key management includes directors and executive officers of the Company. During the nine months ended March 31, 2022 and the period from inception on August 4, 2020 to March 31, 2021, no compensation other than that disclosed above was paid or payable for key management services.

9. Financial instruments

Classification of financial instruments

The Company's financial instruments consist of cash and accounts payable, accrued liabilities and convertible debentures. These financial instruments are classified as financial assets and liabilities at amortized cost and are reported at amortized cost.

The fair values of financial assets and liabilities approximate the carrying values due to their relatively short-term nature.

Financial and capital risk management

The Company thoroughly examines the various financial instruments and risks to which it is exposed and assesses the impact and likelihood of those risks. These risks include foreign currency risk, interest rate risk, credit risk, and liquidity risk. Where material, these risks are reviewed and monitored by the Board of Directors.

The Board of Directors has overall responsibility for the determination of the Company's risk management objectives and policies. The overall objective of the Board is to set policies that seek to reduce risk as far as possible without unduly affecting the Company's competitiveness and flexibility.

Discussions of risks associated with financial assets and liabilities are detailed below:

a) Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The risk that the Company will realize a cash loss is limited as the Company's liabilities are either non-interest bearing or have fixed interest rates. The Company considers this risk to be immaterial.

b) Credit risk

Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations.  Credit risk arises from cash held with banks and financial institutions. The maximum exposure to credit risk is equal to the carrying value of the financial assets. The Company considers credit risk with respect to its cash to be immaterial as cash is held through large Canadian financial institutions.

c) Liquidity risk

Liquidity risk is the risk that the Company is not able to meet its financial obligations as they become due. The Company manages its liquidity risk by continuously monitoring forecasted and actual cash flows, as well as anticipated investing and financing activities. Accounts payable and accrued liabilities have contractual maturities of 30 days or are due on demand and are subject to normal trade terms. The Company has negative working capital of $516,762 as at June 30, 2022.


Naqi Logix Inc.
Notes to the Condensed Interim Financial Statements
(Unaudited)
For the nine months ended March 31, 2022 and 2021
(Expressed in US dollars)

10. Subsequent events

On June 1, 2022, the Company received a loan of $98,612(CAD$125,000) from a shareholder under an unsecured, non-interest bearing demand promissory note for cash received.


PART III - EXHIBITS

Exhibit No.

 

Description

 

 

 

Exhibit 2.1†

 

Certificate of Incorporation of Naqi Logix Inc.

 

 

 

Exhibit 2.2†

 

Certificate of Change of Name.

 

 

 

Exhibit 2.3†

 

Bylaws of Naqi Logix Inc.

 

 

 

Exhibit 3.1†

 

Form of Shareholder Rights Agreement of Naqi Logix Inc.

 

 

 

Exhibit 3.2†

 

Form of Right of First Refusal and Co-sale Agreement of Naqi Logix Inc.

 

 

 

Exhibit 3.3†

 

Form of Voting Agreement of Naqi Logix Inc.

 

 

 

Exhibit 4.1*

 

Form of Subscription Agreement.

 

 

 

Exhibit 5.1†

 

Form of Voting Trust Agreement.

 

 

 

Exhibit 6.1†

 

Broker-dealer Agreement dated January 17, 2022 between Naqi Logix Inc. and Dalmore Group, LLC.

 

 

 

Exhibit 10.1*

 

Power of Attorney (included on signature page hereto).

 

 

 

Exhibit 11.1*

 

Consent of BDO.

 

 

 

Exhibit 12.1*

 

Opinion of Osler, Hoskin & Harcourt.

† Previously filed.

* Filed herewith.


SIGNATURES

Pursuant to the requirements of Regulation A, the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form 1-A and has duly caused this offering statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Toronto, Province of British Columbia, Canada, on June 30, 2022.

 

NAQI LOGIX INC.

 

 

 

 

/s/ Mark Godsy

 

 

 

 

Name:

Mark Godsy

 

 

 

 

Title:

Chief Executive Officer

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Mark Godsy his or her true and lawful attorney-in-fact and agent, with full power of substitution, for her or him and in her or his name, place and stead, in any and all capacities, to sign any and all amendments to this Form 1-A offering statement, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and ratifying and confirming all that said attorney-in-fact and agent or her or his substitute or substitutes may lawfully do or cause to be done by virtue hereof.

This offering statement has been signed by the following persons in the capacities and on the dates indicated.

By: /s/ Mark Godsy   June 30, 2022
Name: Mark Godsy    
Title: Chief Executive Officer and Director
(Principal Executive Officer)
   
     
By: /s/ Florence Tan   June 30, 2022
Name: Florence Tan    
Title: Head of Finance
(Principal Financial Officer and Principal Accounting Officer)
   
     
By: /s/ Osman Tumer   June 30, 2022
Name: Osman Tumer    
Title: Chief Operating Officer    
     
By: /s/ David Segal   June 30, 2022
Name: David Segal    
Title: Chief Innovation Officer    
     
By: /s/ John Occhipinti   June 30, 2022
Name: John Occhipinti    
Title: Director    
     
By: /s/ Gary Roshak   June 30, 2022
Name: Gar Roshak    
Title: Director    
     
By: /s/ Sue Ozdemir   June 30, 2022
Name: Sue Ozdemir    
Title: Director    
     
By: /s/ Sam Sullivan   June 30, 2022
Name: Sam Sullivan    
Title: Director    


EX1A-4 SUBS AGMT 3 exhibit4-1.htm EXHIBIT 4.1 Naqi Logix Inc.: Exhibit 4.1 - Filed by newsfilecorp.com

NAQI LOGIX INC.

SUBSCRIPTION AGREEMENT

INSTRUCTIONS TO SUBSCRIBER

1. All subscribers must complete all the information in the boxes on page 2 of this Agreement and sign where indicated with an "X".

2. If you are resident in Canada or otherwise subject to Canadian securities laws, and you are subscribing as an "accredited investor" (as defined under applicable Canadian securities laws) you must complete and sign Exhibit "A" - Accredited Investor Certificate, together with a completed Appendix A to Exhibit "A", and Appendix B to Exhibit "A", if applicable. Exhibit "A" does not have to be completed by U.S. Purchasers1.

3. If you are a U.S. Purchaser, you must complete and sign Exhibit "B" - United States Purchaser Questionnaire as attached to the Subscription Agreement.

4. If you are resident outside of Canada and the United States, you must complete and sign "Exhibit "C" - International Investor Certificate as attached to the Subscription Agreement.

5. All subscribers must complete all the information the Exhibit "D" - AML Certificate as attached to this Agreement and sign where indicated.

6. All subscribers must complete and sign Exhibit "A" - Adoption Agreement to Right of First Refusal and Co-Sale Agreement attached to Schedule "A"- Right of First Refusal and Co-Sale Agreement of this Agreement.

7. All subscribers must complete and sign Exhibit "A" - Adoption Agreement to the Shareholder Rights Agreements attached to Schedule "B"- Shareholder Rights Agreement of this Agreement.

8. All subscribers must complete and sign Exhibit "A" - Adoption Agreement to the Voting Agreement attached to Schedule "C"-Voting Agreement of this Agreement. Make payment to the Issuer pursuant to the instructions provided by Novation Solutions Inc. dba Dealmaker ("Dealmaker"), the technology agent engaged by the Issuer in connection with this offering to process this subscription agreement.

_______________________________________________

1A "U.S. Purchaser" means a subscriber for Shares that (a) was in United States, (b) any person that receives or received an offer of the Shares while in the United States, and (c) any person that is in the United States at the time the buy order was made or this Agreement was executed or delivered; provided, however, that "U.S. Purchaser shall not include any persons excluded from the definition of "U.S. person" pursuant to Rule 902(k)(2)(vi) of Regulation S or persons holding accounts excluded from the definition of "U.S. person" pursuant to Rule 902(k)(2)(i) of Regulation S, solely in their capacities as holders of such accounts.


NAQI LOGIX INC.

PRIVATE PLACEMENT SUBSCRIPTION AGREEMENT

The undersigned (the "Subscriber") hereby irrevocably subscribes for and agrees to purchase from Naqi Logix Inc. (the "Issuer") that number of Voting Common shares of the Issuer (the " Shares") set out below at a price of US$2.00 per Share (the "Offering"). The Subscriber must invest a minimum of $1,500.00; however, the Issuer reserves the right to waive this minimum in its sole discretion. The Subscriber agrees to be bound by the terms and conditions set forth in the attached "Terms and Conditions of Subscription for Shares".

 

Full legal name of Subscriber (including middle name(s), for individuals):

Number of securities: Voting Common Shares

Aggregate Subscription Price: $0.00 USD

   
  TYPE OF OWNERSHIP:
(Name of Subscriber) If the Subscriber is individual:            If the Subscriber is not an individual:
   
By:  
(Authorized Signature)  Individual
   Joint Tenant
(Official Capacity or Title, if the Subscriber is not  Tenants in Common
an individual)  Community Property
   
   
(Name of individual whose signature appears
above if different than the name of the Subscriber
printed above.)
If interests are to be jointly held:
  Name of the Joint Subscriber:
   
  Social Security Number of the Joint Subscriber:
   
(Subscriber's Residential Address, including
Province/State and Postal/Zip Code)
Check this box if the securities will be held in a custodial account: ☐
  Type of account:
   
Taxpayer Identification Number EIN of account:
   
  Address of account provider:
(Telephone Number)  
   

(Offline Investor)

(E-Mail Address)

 

 


ACCEPTANCE

The Issuer hereby accepts the subscription as set forth above on the terms and conditions contained in this Subscription Agreement (including the Terms and Conditions and Exhibits attached hereto).

Dated as of

Naqi Logix Inc.

By:

Authorized Signing

Officer


TERMS AND CONDITIONS OF SUBSCRIPTION FOR VOTING COMMON SHARES OF

NAQI LOGIX INC.

1. SUBSCRIPTION

1.1 On the basis of the representations and warranties and subject to the terms and conditions set forth herein, the Subscriber hereby irrevocably subscribes for and agrees to purchase the number of Shares set forth on page 2 hereof at a price per Share of US$2.00 (such subscription and agreement to purchase being the "Subscription") for aggregate proceeds of the Subscription Amount shown on page 2 of this subscription agreement (the "Agreement"), which is tendered herewith, on the basis of the representations and warranties and subject to the terms and conditions set forth in this Agreement. The Subscriber must invest a minimum of $1,500.00; however, the Issuer reserves the right to waive this minimum in its sole discretion.

1.2 The Issuer hereby agrees to sell the Shares to the Subscriber on the basis of the representations and warranties and subject to the terms and conditions set forth in this Agreement. Subject to the terms of this Agreement, the Agreement will be effective upon its acceptance by the Issuer.

2. PAYMENT

2.1 The Subscription Amount must accompany this Subscription and shall be made pursuant to the instructions provided on Dealmaker. The Subscriber authorizes the Issuer to treat the Subscription Amount as an interest free loan until the closing of the Offering (the "Closing") and the Subscriber authorizes the Issuer to release the Subscription Amount to the Issuer prior to the Closing.

2.2 The Subscriber acknowledges and agrees that this Agreement, the Subscription Amount and any other documents delivered in connection herewith will be held by or on behalf of the Issuer. In the event that this Agreement is not accepted by the Issuer for whatever reason, which the Issuer expressly reserves the right to do, the Subscription Amount (without interest thereon) and any other documents delivered in connection herewith will be returned to the Subscriber at the address of the Subscriber as set forth on page 2 of this Agreement.

3. DOCUMENTS REQUIRED FROM ISSUER AND SUBSCRIBER

3.1 The Subscriber must complete, sign and return to the Issuer the following documents:

(a) an executed copy of this Agreement;

(b) if the Subscriber is resident in Canada or otherwise subject to Canadian securities laws (a "Canadian Purchaser"), the Accredited Investor Certificate, attached hereto as Exhibit A;

(c) if the Subscriber is a U.S. Purchaser (as that term is defined in Exhibit B), a United States Purchaser Questionnaire (the "U.S. Questionnaire") attached hereto as Exhibit B;

(d) if the Subscriber is resident outside of Canada and the United States, the International Investor Certificate as attached hereto as "Exhibit "C";

(e) the AML Certificate, attached hereto Exhibit "D";


 

(f) Exhibit "A" - Adoption Agreement to Right of First Refusal and Co-Sale Agreement attached to Schedule "A"- Right of First Refusal and Co-Sale Agreement of this Agreement;

(g) Exhibit "A" - Adoption Agreement to the Shareholder Rights Agreements attached to Schedule "B"- Shareholder Rights Agreement of this Agreement;

(h) Exhibit "A" - Adoption Agreement to the Voting Agreement attached to Schedule "B"-Voting Agreement of this Agreement; and

(i) such other supporting documents that the Issuer or its legal counsel may require.

3.2 The Subscriber shall complete, sign and return to the Issuer as soon as possible, on request by the Issuer, any additional documents, questionnaires, notices and undertakings as may be required by any regulatory authorities and applicable law.

3.3 Both parties to this Agreement acknowledge and agree that Osler, Hoskin & Harcourt LLP and Nauth LPC have acted as counsel only to the Issuer and is not protecting the rights and interests of the Subscriber. The Subscriber acknowledges and agrees that the Issuer, Osler, Hoskin & Harcourt LLP and Nauth LPC have given the Subscriber the opportunity to seek, and are hereby recommending that the Subscriber obtain, independent legal advice with respect to the subject matter of this Agreement and, further, the Subscriber hereby represents and warrants to the Issuer, Osler, Hoskin & Harcourt LLP and Nauth LPC that the Subscriber has sought independent legal advice or waives such advice.

4. ACKNOWLEDGEMENTS AND AGREEMENTS OF SUBSCRIBER

4.1 The Subscriber acknowledges and agrees that:

(a) the decision to execute this Agreement and acquire the Shares agreed to be purchased hereunder has not been based upon any oral or written representation as to fact or otherwise made by or on behalf of the Issuer;

(b) the Subscriber understands and agrees that the Issuer and others will rely upon the truth and accuracy of the acknowledgements, representations, warranties, covenants and agreements contained in this Agreement and the exhibits attached hereto, as applicable, and agrees that if any of such acknowledgements, representations and agreements are no longer accurate or have been breached, the Subscriber shall promptly notify the Issuer;

(c) all of the information which the Subscriber has provided to the Issuer is correct and complete as of the date this Agreement is signed, and if there should be any change in such information prior to the Closing, the Subscriber will immediately provide the Issuer with such information;

(d) the Issuer is entitled to rely on the representations and warranties of the Subscriber contained in this Agreement and the exhibits attached hereto, as applicable, and the Subscriber will hold harmless the Issuer from any loss or damage it or they may suffer as a result of the Subscriber's failure to correctly complete this Agreement or the exhibits attached hereto, as applicable;

(e) the Subscriber has been advised to consult the Subscriber's own legal, tax and other advisors with respect to the merits and risks of an investment in the Shares and with respect to applicable resale restrictions, and it is solely responsible (and the Issuer is not in any way responsible) for compliance with:


(i) any applicable laws of the jurisdiction in which the Subscriber is resident in connection with the distribution of the Shares hereunder, and

(ii) applicable resale restrictions;

(f) the Subscriber understands and agrees that there may be material tax consequences to the Subscriber of an acquisition or disposition of the Shares, and that the Issuer gives no opinion and makes no representation with respect to the tax consequences to the Subscriber under federal, state, provincial, local or foreign tax law of the Subscriber's acquisition or disposition of the Shares;

(g) the Issuer is not a reporting issuer as that term is defined in applicable securities legislation nor will it become a reporting issuer in any jurisdiction in Canada following completion of the Offering and, as a result:

(i) the Issuer will not be subject to the continuous disclosure requirements under the securities legislation of Canada, including the requirements relating to the production and filing of audited financial statements and other financial information, and

(ii) any applicable hold periods under applicable Canadian securities legislation may never expire, and the Shares may be subject to restrictions on resale for an indefinite period of time;

(h) upon the issuance thereof, and until such time as the same is no longer required under applicable Canadian securities laws and regulations, any certificates representing the Shares will bear legends setting out resale restrictions under applicable securities legislation, and unless permitted under applicable securities legislation, the Shares may not be traded before the date that is four months and a day after (i) the date of closing, and (ii) the date the Issuer became a reporting issuer in any province or territory.

(i) the Issuer will make a notation on its records or give instructions to the registrar and transfer agent of the Issuer, if applicable, in order to implement the restrictions on transfer set forth and described in this Agreement;

(j) the Subscriber is purchasing the Shares as principal and not for the benefit of any other Person, or is deemed to be purchasing the Shares as principal under applicable securities laws, or if the Subscriber is purchasing as agent or trustee for a beneficial purchaser, such agent or trustee is purchasing the Shares as principal and for the benefit of any other person, or is deemed under applicable securities laws to be purchasing the Shares as principal;

(k) if the Subscriber is resident in, or is otherwise subject to the securities laws of a jurisdiction of Canada, then:

(i) such Subscriber is purchasing the Shares as an "accredited investor" within the meaning of NI 45-106, or as agent for a beneficial purchaser disclosed on page 2 of this Agreement, and such disclosed beneficial purchaser is an "accredited investor" within the meaning of NI 45-106;

(ii) such Subscriber, or the beneficial purchaser for whom such Subscriber is contracting hereunder is, as the case may be, a person, other than an individual or an investment fund, that has net assets of at least $5,000,000 as shown on such Subscriber or beneficial purchaser's most recently prepared financial statements, as applicable, was not, or the beneficial purchaser for whom such Subscriber is contracting was not, as the case may be, created or used solely to purchaser or hold securities as an accredited investor in paragraph (m) of the definition of "accredited investor" in NI 45-106; and

 


(iii) such Subscriber has completed, executed and delivered a certificate in the form attached as Exhibit A, hereto, together with a complete Appendix A to Exhibit "A" and, if applicable, Appendix B to Exhibit "A";

(l) unless the Subscriber is a U.S. Purchaser, the Subscriber, has not received or been provided with or had delivered a prospectus, registration statement, offering memorandum (within the meaning of applicable securities laws) or any document purporting to describe the business and affairs of the Issuer which has been prepared for review by prospectus purchasers to assist in making an investment decision in respect of the Shares; and that the decision to enter into this Subscription Agreement and to purchase the Shares from the Issuer is based entirely upon this Agreement and not upon any other verbal or written representation as to fact or otherwise made by or on behalf of the Issuer;

(m) the Subscriber acknowledges and agrees that there is no ready public market for the Shares and that there is no guarantee that a market for their resale will ever exist. The Subscriber must bear the economic risk of this investment indefinitely and the Issuer has no obligation to list the Shares on any market or take any steps (including registration under the Securities Act of 1933, as amended (the "1933 Act") or the Securities Exchange Act of 1934, as amended) with respect to facilitating trading or resale of the Shares. The Subscriber acknowledges that the Subscriber is able to bear the economic risk of losing the Subscriber's entire investment in the Shares. The Subscriber also understands that an investment in the Issuer involves significant risks and has taken full cognizance of and understands all of the risk factors relating to the purchase of the Shares;

(n) the Issuer has advised the Subscriber that the Issuer is relying on an exemption from the requirements to provide the Subscriber with a prospectus and to sell the Shares through a person registered to sell securities under provincial securities legislation and other applicable Canadian securities laws, as a consequence of acquiring the Shares pursuant to such exemption, certain protections, rights and remedies provided by the applicable securities legislation including the various provincial securities acts, including statutory rights of rescission or damages, will not be available to the Subscriber;

(o) no Canadian securities commission or similar regulatory authority in Canada has reviewed or passed on the merits of any of the Shares;

(p) there is no government or other insurance covering any of the Shares;

(q) there are restrictions under Canadian securities laws on the Subscriber's ability to resell the Shares and it is the responsibility of the Subscriber to find out what those restrictions are and to comply with such restrictions before selling any of the Shares;

(r) this Agreement is not enforceable by the Subscriber unless it has been accepted by the Issuer, and the Subscriber acknowledges and agrees that the Issuer reserves the right to reject any Subscription for any reason whatsoever;


(s) the Issuer is not an investment fund within the meaning of the Securities Act (British Columbia). No commission or finder's fee has been or shall be paid to any director, officer, founder or control person of the Issuer or of an affiliate of the Issuer in connection with the issuance of the Shares hereunder;

(t) if the Subscriber is resident in or subject to the laws of Canada, the Issuer has made sufficient inquiry into and has obtained all relevant information and documentation required in order to assess and accept the Subscriber's qualification as a qualified investor under NI 45-106 - Prospectus Exemptions;

(u) the Subscriber acknowledges that the price of the Shares was set by the Issuer on the basis of the Issuer's internal valuation and no warranties are made as to value;

(v) the Issuer has engaged Dalmore Group LLC, as the broker-dealer (the "Broker-Dealer") to offer the Shares to prospective U.S. Purchasers (as defined in Exhibit B) on a best-efforts basis. The Issuer has agreed to pay the Broker-Dealer selling commissions of one percent (1.0%) of the gross offering proceeds in the United States.

5. REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE ISSUER

5.1 The Issuer represents and warrants to the Subscriber that the following are true as of the Closing (and acknowledges that the Subscriber is relying upon those representations and warranties in connection with the execution and delivery of this Agreement and the completion of the transactions contemplated herein):

(a) The Issuer is a corporation duly organized, validly existing and in good standing under the Business Corporations Act (British Columbia) and has all the necessary corporate power, authority and capacity required: (i) to carry on its business as presently conducted and as presently proposed to be conducted; and (ii) to enter into this Agreement, and to perform its obligations hereunder. The Issuer is duly qualified to transact business and is in good standing under the laws of each jurisdiction in which the failure to so qualify would have a material adverse effect on the business, affairs, operations, assets (including intellectual property and other intangible assets), liabilities (contingent or otherwise), condition (financial or otherwise), property or capital of the Issuer, whether or not arising in the ordinary course of business and whether or not attributable to any change in conditions relating to economic, financial, currency, exchange, market or otherwise (a "Material Adverse Effect").

(b) The execution, delivery and performance by the Issuer of this Agreement has been duly authorized by all necessary corporate action on the part of the Issuer. This Agreement constitutes valid and binding obligations of the Issuer, enforceable against the Issuer in accordance with its terms except as limited by (i) bankruptcy, insolvency, liquidation, reorganization, reconstruction and other similar laws generally affecting the enforceability of creditors' rights; and (ii) the effect of rules of law governing the availability of equitable remedies, and will not violate or conflict with the terms of any restriction, agreement or undertaking of the Issuer.

(c) The execution, delivery and performance of this Agreement by the Issuer and the completion of the transactions contemplated in this Agreement do not and will not result in or constitute a default, breach or violation or an event that, with notice or lapse of time or both, would be a default, breach or violation of: (i) any of the terms, conditions or provisions of the articles of the Issuer or any resolution of the shareholders or directors of the Issuer; (ii) any agreement, instrument, contract, lease, note, indenture, mortgage or purchase order to which it is a party; (iii) any judgement, order, writ or decree of any court or governmental entity; or (iv) any applicable law. The execution, delivery and performance of the Agreement by the Issuer and the completion of the transactions contemplated in this Agreement will not result in the creation of any lien, charge or encumbrance upon any assets of the Issuer or the suspension, revocation, forfeiture or nonrenewal of any material permit or license applicable to the Issuer.


(d) no "bad actor" disqualifying event described in Rule 506(d)(1)(i)-(viii) of the 1933 Act (a "Disqualification Event") is applicable to the Issuer, except for a Disqualification Event as to which Rule 506(d)(2)(ii-iv) or (d)(3), is applicable.

6. REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE SUBSCRIBER

6.1 The Subscriber hereby represents and warrants to and covenants with the Issuer (which representations, warranties and covenants shall survive the Closing) that:

(a) unless the Subscriber is a U.S. Purchaser and has concurrently herewith completed, executed and delivered Exhibit B, the Subscriber is not in the United States, the Subscriber (and any person acting on its behalf) did not receive an offer to purchase the Shares in the United States, and the individuals making the order to purchase the Shares and executing and delivering this Agreement on behalf of the Subscriber were not in the United States when the order was placed and this Agreement was executed and delivered;

(b) no "bad actor" disqualifying event described in Rule 506(d)(1)(i)-(viii) of the 1933 Act (a "Disqualification Event") is applicable to the Subscriber, except for a Disqualification Event as to which Rule 506(d)(2)(ii-iv) or (d)(3), is applicable;

(c) the Subscriber is knowledgeable of, or has been independently advised as to, the applicable laws of the securities regulators having application in the jurisdiction in which the Subscriber is resident which would apply to the offer and sale of the Shares, including any restrictions with respect to the trading in, and the restricted period or statutory hold period applicable to the Shares imposed by the applicable securities laws of the jurisdiction in which the Subscriber resides or to which such Subscriber is subject;

(d) the Subscriber is purchasing the Shares pursuant to an exemption from the prospectus requirement or equivalent requirements under applicable laws or, if such is not applicable, the Subscriber is permitted to purchase the Shares under the applicable laws of the securities regulators in the jurisdiction in which the Subscriber resides without the need to rely on any exemption;

(e) if the Subscriber is not a resident in Canada or the United States;

(i) the applicable laws of the authorities in the jurisdiction in which the Subscriber resides do not require the Issuer to make any filings or seek any approvals of any kind whatsoever from any securities regulator of any kind whatsoever in the jurisdiction in which the Purchaser resides in connection with the offer, issue, sale or resale of any of the Shares;

(ii) the purchase of the Shares by the Subscriber does not trigger:

A. any obligation to prepare and file a prospectus or similar document, or any other report with respect to such purchase in the International Jurisdiction; or


B. any continuous disclosure reporting obligation of the Issuer in the International Jurisdiction; and

(iii) the Subscriber will, if requested by the Issuer, deliver to the Issuer a certificate or opinion of local counsel from the jurisdiction in which the Purchaser resides which will confirm the matters referred to in subparagraphs (i), and (ii) above to the satisfaction of the Issuer, acting reasonably;

(f) the Subscriber has the legal capacity and competence to enter into and execute this Agreement and to take all actions required pursuant hereto and, if the Subscriber is a corporate entity, it is duly incorporated and validly subsisting under the laws of its jurisdiction of incorporation and all necessary approvals by its directors, shareholders and others have been obtained to authorize execution and performance of this Agreement on behalf of the Subscriber;

(g) the entering into of this Agreement and the transactions contemplated hereby do not result in the violation of any of the terms and provisions of any law applicable to, or, if applicable, the constating documents of, the Subscriber or of any agreement, written or oral, to which the Subscriber may be a party or by which the Subscriber is or may be bound;

(h) the Subscriber has duly executed and delivered this Agreement and it constitutes a valid and binding agreement of the Subscriber enforceable against the Subscriber;

(i) the Subscriber has received and carefully read this Agreement;

(j) the Subscriber is aware that an investment in the Issuer is speculative and involves certain risks, including the possible loss of the entire investment;

(k) the Subscriber has made an independent examination and investigation of an investment in the Shares and the Issuer and agrees that the Issuer will not be responsible in any way whatsoever for the Subscriber's decision to invest in the Shares and the Issuer;

(l) the Subscriber is not an underwriter of, or dealer in, any of the Shares, nor is the Subscriber participating, pursuant to a contractual agreement or otherwise, in the distribution of the Shares or any of them;

(m) no person has made to the Subscriber any written or oral representations:

(i) that any person will resell or repurchase any of the Shares,

(ii) that any person will refund the purchase price of any of the Shares, or

(iii) as to the future price or value of any of the Shares; and

(n) the Subscriber acknowledges and agrees that the Issuer shall not consider the Subscriber's Subscription for acceptance unless the undersigned provides to the Issuer, along with an executed copy of this Agreement:

(i) the Accredited Investor Certificate attached hereto as Exhibit A, if applicable;

(ii) the United States Purchaser Questionnaire attached hereto as Exhibit B, if applicable; and


(iii) such other supporting documentation that the Issuer or its legal counsel may request to establish the Subscriber's qualification as a qualified investor.

7. REPRESENTATIONS AND WARRANTIES WILL BE RELIED UPON

7.1 The Issuer and the Subscriber each acknowledge that the acknowledgements, representations and warranties made by it contained herein are made with the intention that they may be relied upon by the parties and their legal counsel in determining (i) the Subscriber's willingness to purchase the Shares and (ii) the Subscriber's eligibility to purchase the Shares under applicable securities legislation, or (if applicable) the eligibility of others on whose behalf it is contracting hereunder to purchase the Shares under applicable securities legislation. The Subscriber further agrees that by accepting delivery of the certificates representing the Shares, it will be representing and warranting that the acknowledgements, representations and warranties contained herein are true and correct as of the date hereof and will continue in full force and effect notwithstanding any subsequent disposition by the Subscriber of such Shares.

8. RESALE RESTRICTIONS

8.1 The Subscriber acknowledges that any resale of the Shares will be subject to resale restrictions contained in Canadian securities legislation applicable to the Issuer, the Subscriber and any proposed transferee.

9. LEGENDING AND REGISTRATION OF SUBJECT SHARES

9.1 The Subscriber hereby acknowledges that upon the issuance thereof, and until such time as the same is no longer required under the applicable securities laws and regulations, the certificates representing any of the Shares will bear a legend in substantially the following form in addition to any legends required pursuant to the Shareholders Agreements:

UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THESE SECURITIES MUST NOT TRADE THE SECURITIES BEFORE THE DATE THAT IS FOUR MONTHS AND ONE DAY AFTER THE LATER OF: (I) THE DATE OF ISSUE, AND (II) THE DATE THE ISSUER BECOMES A REPORTING ISSUER IN ANY PROVINCE OR TERRITORY IN CANADA.

9.2 The Subscriber hereby acknowledges and agrees to the Issuer making a notation on its records or giving instructions to the registrar and transfer agent of the Issuer, if applicable, in order to implement the restrictions on transfer set forth and described in this Agreement.

10. COLLECTION OF PERSONAL INFORMATION

10.1 The Subscriber acknowledges and consents to the fact that the Issuer is collecting the Subscriber's personal information for the purpose of fulfilling this Agreement and completing the Offering. The Subscriber's personal information (and, if applicable, the personal information of those on whose behalf the Subscriber is contracting hereunder) may be disclosed by the Issuer to (a) stock exchanges or securities regulatory authorities, (b) the Issuer's registrar and transfer agent, (c) Canadian tax authorities, (d) authorities pursuant to the Proceeds of Crime (Money Laundering) and Terrorist Financing Act (Canada) and (e) any of the other parties involved in the Offering, including legal counsel, and may be included in record books in connection with the Offering. By executing this Agreement, the Subscriber is deemed to be consenting to the foregoing collection, use and disclosure of the Subscriber's personal information (and, if applicable, the personal information of those on whose behalf the Subscriber is contracting hereunder) for the foregoing purposes and to the retention of such personal information for as long as permitted or required by law or business practice. Notwithstanding that the Subscriber may be purchasing Shares as agent on behalf of an undisclosed principal, the Subscriber agrees to provide, on request, particulars as to the nature and identity of such undisclosed principal, and any interest that such undisclosed principal has in the Issuer, all as may be required by the Issuer in order to comply with the foregoing.

 


Furthermore, the Subscriber is hereby notified that:

(a) the Issuer may deliver to any securities commission having jurisdiction over the Issuer, the Subscriber or this subscription, including any Canadian provincial securities commissions and/or the SEC (collectively, the "Commissions") certain personal information pertaining to the Subscriber, including such Subscriber's full name, residential address and telephone number, the number of shares or other securities of the Issuer owned by the Subscriber, the number of Shares purchased by the Subscriber and the total purchase price paid for such Shares, the prospectus exemption relied on by the Issuer and the date of distribution of the Shares,

(b) such information is being collected indirectly by the Commissions under the authority granted to them in securities legislation,

(c) such information is being collected for the purposes of the administration and enforcement of the securities laws, and

(d) the Subscriber may contact the following public official in British Columbia with respect to questions about the British Columbia Securities Commission's indirect collection of such information at the following address and telephone number:

British Columbia Securities Commission
701 West Georgia Street

P.O. Box 10142, Pacific Centre
Vancouver, B.C. V7Y 1L2

Telephone: 604-899-6854 or 1-800-373-6393 (toll free across Canada)

11. COSTS

11.1 The Subscriber acknowledges and agrees that all costs and expenses incurred by the Subscriber (including any fees and disbursements of any special counsel retained by the Subscriber) relating to the purchase of the Shares shall be borne by the Subscriber.

12. GOVERNING LAW

12.1 This Agreement is exclusively governed by the laws of the Province of British Columbia and the federal laws of Canada applicable thereto. The Subscriber, in its personal capacity and, if applicable, on behalf of each beneficial purchaser for whom it is acting, irrevocably attorns to the exclusive jurisdiction of the courts of the Province of British Columbia.

13. SURVIVAL

13.1 This Agreement, including without limitation the representations, warranties and covenants contained herein, shall survive and continue in full force and effect and be binding upon the parties hereto notwithstanding the completion of the purchase of the Shares by the Subscriber pursuant hereto.


 

14. ASSIGNMENT

14.1 This Agreement is not transferable or assignable.

15. FUNDS

15.1 All funds are set out in U.S. dollars.

16. SEVERABILITY

16.1 The invalidity or unenforceability of any particular provision of this Agreement shall not affect or limit the validity or enforceability of the remaining provisions of this Agreement.

17. ENTIRE AGREEMENT

17.1 Except as expressly provided in this Agreement and in the agreements, instruments and other documents contemplated or provided for herein, this Agreement contains the entire agreement between the parties with respect to the sale of the Shares and there are no other terms, conditions, representations or warranties, whether expressed, implied, oral or written, by statute or common law, by the Issuer or by anyone else.

18. NOTICES

18.1 All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted by electronic mail or facsimile. Notices to the Subscriber and the Issuer shall be directed to the addresses set out in this Agreement.

19. COUNTERPARTS AND ELECTRONIC MEANS

19.1 This Agreement may be executed in any number of counterparts, each of which, when so executed and delivered, shall constitute an original and all of which together shall constitute one instrument. Delivery of an executed copy of this Agreement by electronic mail or facsimile transmission or other means of electronic communication capable of producing a printed copy will be deemed to be execution and delivery of this Agreement as of the date hereinafter set forth.

[End of Subscription Agreement]


EXHIBIT "A"

ACCREDITED INVESTOR CERTIFICATE

TO BE COMPLETED BY ACCREDITED INVESTORS RESIDENT IN OR SUBJECT TO THE LAWS OF A JURISDICTION OF CANADA

The categories listed herein contain certain specifically defined terms. If you are unsure as to the meanings of those terms, or are unsure as to the applicability of any category below, please contact your broker and/or legal advisor before completing this certificate.

TO: NAQI LOGIX INC.

In connection with the purchase of Shares (the "Shares") of Naqi Logix Inc. (the " Issuer"), the undersigned hereby represents, warrants and certifies to the Issuer (and acknowledges that the Issuer is relying thereon) that:

a. the Purchaser (the undersigned or, if the undersigned is purchasing the Shares as agent on behalf of a disclosed beneficial purchaser, such beneficial purchaser being referred to herein as the "Purchaser") is resident in Canada or is subject to the securities laws of a Province or Territory of Canada;

b. the Purchaser is purchasing the Shares as principal for its own account or is deemed under National Instrument 45-106 - Prospectus Exemptions of the Canadian Securities Administrators ("NI 45-106") to be purchasing the Shares as principal, or the purchaser is duly authorized to purchase the Shares and to execute and deliver all documentation in connection with the purchase on behalf of each beneficial purchaser, each of whom is purchasing as principal for its own account, not for the benefit of any other person;

c. the Purchaser is an "accredited investor" within the meaning of NI 45-106 and/or s. 73.3(1) of the Securities Act (Ontario) (the "OSA"), by virtue of satisfying the indicated criterion as set out in Appendix "A" to this certificate, and the undersigned agrees and covenants to provide the Issuer with such reasonable information as the Issuer may request from time to time to confirm that the undersigned qualifies for the category of accredited investor selected in Appendix "A" to this certificate. (YOU MUST ALSO INITIAL OR PLACE A CHECK-MARK ON THE APPROPRIATE LINE IN APPENDIX "A" ATTACHED TO THIS CERTIFICATE);

d. the Purchaser was not created or used solely to purchase or hold securities as an accredited investor as described in paragraph (m) of the definition of "accredited investor" in NI 45-106;

e. if the Purchaser is relying on paragraph (j), (k) or (l) of the definition of "accredited investor", the Purchaser has delivered to the Issuer a completed and executed risk acknowledgment form in form attached hereto as Appendix B; and

f. upon execution of this Exhibit "A" by the Purchaser, this Exhibit "A" and all Appendices thereto shall be incorporated into and form part of the subscription agreement to which this Exhibit "A" is attached.

The undersigned represents and warrants that the above representations and warranties will be true and correct both as of the execution of this certificate and as of the closing time of the purchase and sale of the Shares and acknowledges that they will survive the completion of the issue of the Shares.

The undersigned acknowledges that the foregoing representations and warranties are made by the undersigned with the intent that they be relied upon in determining the suitability of the Purchaser as a purchaser of the Shares and that this certificate is incorporated into and forms part of the subscription agreement and the undersigned undertakes to immediately notify the Issuer of any change in any statement or other information relating to the Issuer set forth herein which takes place prior to the closing time of the purchase and sale of the Shares.



DATED:

 

   

INVESTOR:

(Print Full Name of Entity or Individual)

   

 

By:

   

 

(Signature)

   

 

Name:

   

 

(If signing on behalf of entity)

   

 

Title:

   

 

(If signing on behalf of entity)



APPENDIX "A"

TO ACCREDITED INVESTOR CERTIFICATE

Accredited Investors only: Please check the appropriate box and initial.

 (a) a Canadian financial institution, or a Schedule III bank;

 (b) the Business Development Bank of Canada incorporated under the Business Development Bank of Canada Act (Canada);

 (c) a subsidiary of any Person referred to in paragraphs (a) or (b), if the Person owns all of the voting securities of the subsidiary, except the voting securities required by law to be owned by directors of that subsidiary;

 (d) a Person registered under the securities legislation of a jurisdiction of Canada as an adviser or dealer, other than a Person registered solely as a limited market dealer under one or both of the Securities Act (Ontario) or the Securities Act (Newfoundland and Labrador);

 (e) an individual registered under the securities legislation of a jurisdiction of Canada as a representative of a Person referred to in paragraph (d);

 (e.1) an individual formerly registered under the securities legislation of a jurisdiction of Canada, other than an individual formerly registered solely as a representative of a limited market dealer under one or both of the Securities Act (Ontario) or the Securities Act (Newfoundland and Labrador);

 (f) the Government of Canada or a jurisdiction of Canada, or any crown corporation, agency or wholly owned entity of the Government of Canada or a jurisdiction of Canada;

 (g) a municipality, public board or commission in Canada and a metropolitan community, school board, the Comité de gestion de la taxe scolaire de l'île de Montréal or an intermunicipal management board in Québec;

 (h) any national, federal, state, provincial, territorial or municipal government of or in any foreign jurisdiction, or any agency of that government;

 (i) a pension fund that is regulated by either the Office of the Superintendent of Financial Institutions (Canada) or a pension commission or similar regulatory authority of a jurisdiction of Canada;

 (j) an individual who, either alone or with a spouse, beneficially owns financial assets having an aggregate realizable value that before taxes, but net of any related liabilities, exceeds CDN$1,000,000;

 (j.1) an individual who beneficially owns financial assets having an aggregate realizable value that, before taxes but net of any related liabilities, exceeds $5,000,000;

 (k) an individual whose net income before taxes exceeded CDN$200,000 in each of the two most recent calendar years or whose net income before taxes combined with that of a spouse exceeded CDN$300,000 in each of the two most recent calendar years and who, in either case, reasonably expects to exceed that net income level in the current calendar year;

 (l) an individual who, either alone or with a spouse, has net assets of at least CDN$5,000,000;

 (m) a Person, other than an individual or investment fund, that has net assets of at least CDN$5,000,000 as shown on its most recently prepared financial statements and that has not been created or used solely to purchase or hold securities as an accredited investor;

 (n) an investment fund that distributes or has distributed its securities only to (i) a Person that is or was an accredited investor at the time of the distribution, (ii) a Person that acquires or acquired securities in the circumstances referred to in sections 2.10 (Minimum amount investment) and 2.19 (Additional investment in investment funds) of NI 45-106, or (iii) a Person described in paragraph (i) or (ii) that acquires or acquired securities under section 2.18 (Investment fund reinvestment) of NI 45-106;


 (o) an investment fund that distributes or has distributed securities under a prospectus in a jurisdiction of Canada for which the regulator or, in Québec, the securities regulatory authority, has issued a receipt;

 (p) a trust company or trust corporation registered or authorized to carry on business under the Trust and Loan Companies Act (Canada) or under comparable legislation in a jurisdiction of Canada or a foreign jurisdiction, acting on behalf of a fully managed account managed by the trust company or trust corporation, as the case may be;

 (q) a Person acting on behalf of a fully managed account managed by that Person, if that Person (i) is registered or authorized to carry on business as an adviser or the equivalent under the securities legislation of a jurisdiction of Canada or a foreign jurisdiction, and (ii) in Ontario, is purchasing a security that is not a security of an investment fund;

 (r) a registered charity under the Income Tax Act (Canada) that, in regard to the trade, has obtained advice from an eligibility adviser or an adviser registered under the securities legislation of the jurisdiction of the registered charity to give advice on the securities being traded;

 (s) an entity organized in a foreign jurisdiction that is analogous to any of the entities referred to in paragraphs (a) to (d) or paragraph (i) in form and function;

 (t) a Person in respect of which all of the owners of interests, direct, indirect or beneficial, except the voting securities required by law to be owned by directors, are Persons that are accredited investors;

 (u) an investment fund that is advised by a Person registered as an adviser or a Person that is exempt from registration as an adviser;

 (v) a Person that is recognized or designated by the securities regulatory authority or, except in Ontario and Québec, the regulator as (i) an accredited investor, or (ii) an exempt purchaser in Alberta or Ontario; or

 (w) a trust established by an accredited investor for the benefit of the accredited investor's family members of which a majority of the trustees are accredited investors and all of the beneficiaries are the accredited investor's spouse, a former spouse of the accredited investor or a parent, grandparent, brother, sister, child or grandchild of that accredited investor, of that accredited investor's spouse or of that accredited investor's former spouse.


APPENDIX "B"

FORM 45-106F9

RISK ACKNOWLEDGEMENT FORM FOR

INDIVIDUAL ACCREDITED INVESTORS

WARNING! This investment is risky. Do not invest unless you can afford to lose all the money

you pay for this investment.

Section 1 - TO BE COMPLETED BY THE ISSUER OR SELLING SECURITY HOLDER
1. About your investment
Type of Securities: Voting Common Shares Issuer: Naqi
  Logix
  Inc. (the
  "Issuer")
Purchased from: The Issuer  
Sections 2 to 4 - TO BE COMPLETED BY THE PURCHASER  
2. Risk acknowledgement  
This investment is risky. Initial that you understand that: Your
Initials
Risk of loss - You could lose your entire investment of $  
Liquidity risk - You may not be able to sell your investment quickly - or at all.  
Lack of information - You may receive little or no information about your investment.  
Lack of advice - You will not receive advice from the salesperson about whether this investment is suitable for you unless the salesperson is registered. The salesperson is the person who meets with, or provides information to, you about making this investment. To check whether the salesperson is registered, go to www.aretheyregistered.ca.  
3. Accredited investor status
You must meet at least one of the following criteria to be able to make this investment. Initial the statement that applies to you. (You may initial more than one statement.) The person identified in section 6 is responsible for ensuring that you meet the definition of accredited investor. That person, or the salesperson identified in section 5, can help you if you have questions about whether you meet these criteria. Your
Initials
· Your net income before taxes was more than $200,000 in each of the 2 most recent calendar years, and you expect it to be more than $200,000 in the current calendar year. (You can find your net income before taxes on your personal income tax return.)  
· Your net income before taxes combined with your spouse's was more than $300,000 in each of the 2 most recent calendar years, and you expect your combined net income before taxes to be more than $300,000 in the current calendar year.  
· Either alone or with your spouse, you own more than $1 million in cash and securities, after subtracting any debt related to the cash and securities.  

 

 

 


· Either alone or with your spouse, you have net assets worth more than $5 million. (Your net assets are your total assets (including real estate) minus your total debt.)  
4. Your name and signature
By signing this form, you confirm that you have read this form and you understand the risks of making this investment as identified in this form.
First and Last Name (please print):

Signature:
Date:
Section 5 - TO BE COMPLETED BY THE SALESPERSON
5. Salesperson information
[Instruction: The salesperson is the person who meets with, or provides information to, the purchaser with respect to making this investment. That could include a representative of the issuer or selling security holder, a registrant or a person who is exempt from the registration requirement.]
First and Last Name of Salesperson (please print):
Telephone: Email:
Name of Firm (if registered):
Section 6 - TO BE COMPLETED BY THE ISSUER OR SELLING SECURITY HOLDER
6. For more information about this investment

For more information about this investment / the Issuer:

Naqi Logix Inc.

c/o Osler, Hoskin & Harcourt LLP

1055 West Hastings Street, Suite 1700 Vancouver, BC V6E 2E9

Attention: Mark Godsy

Email: magodsy@shaw.ca

For more information about prospectus exemptions, contact your local securities regulator. You can find contact information at www.securities-administrators.ca.

 

 


EXHIBIT "B"

UNITED STATES PURCHASER QUESTIONNAIRE

TO: Naqi Logix Inc. (the "Corporation")

You are a U.S. Purchaser (as defined below) and (check one of the below):

 an "accredited investor" within the meaning of Rule 501(a) of Regulation D under the 1933 Act (a "U.S. Accredited Investor") meeting one of the requirements in Part A below (please complete Part A); or

 not a U.S. Accredited Investor and the Aggregate Subscription Price is no more than 10% of the greater of your annual income or net worth. You represent that to the extent you have any questions with respect to your status as a U.S. Accredited Investor, or the application of the investment limits, you have sought professional advice.

A "U.S. Purchaser" means a subscriber for Shares that (a) was in United States, (b) any person that receives or received an offer of the Shares while in the United States, and (c) any person that is in the United States at the time the buy order was made or this Agreement was executed or delivered; provided, however, that "U.S. Purchaser shall not include any persons excluded from the definition of "U.S. person" pursuant to Rule 902(k)(2)(vi) of Regulation S or persons holding accounts excluded from the definition of "U.S. person" pursuant to Rule 902(k)(2)(i) of Regulation S, solely in their capacities as holders of such accounts.

Capitalized terms used herein but not otherwise defined have the meaning ascribed to such terms in the Subscription Agreement to which this Exhibit B is attached and forms a part.

Part A

In connection with the purchase of Shares of the Issuer by the undersigned subscriber, or, as the case may be, the disclosed principal on behalf of whom the Investor is contracting for, (the "Investor"), the Investor hereby represents, warrants, covenants and certifies to the Issuer (and acknowledges that the Company and its counsel are relying thereon) that it is a U.S. Accredited Investor that satisfies one or more of the categories of "accredited investor" as indicated below:

 (i) A bank, as defined in Section 3(a)(2) of the U.S. Securities Act;

a savings and loan association or other institution as defined in Section 3(a)(5)(A) of the U.S. Securities Act, whether acting in its individual or fiduciary capacity; a broker or dealer registered pursuant to Section 15 of the United States Securities Exchange Act of 1934; An insurance company as defined in Section 2(a)(13) of the U.S. Securities Act; An investment company registered under the United States Investment Company Act of 1940; or A business development company as defined in Section 2(a)(48) of that Act; a Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301 (c) or (d) of the United States Small Business Investment Act of 1958;A plan established and maintained by a state, its political subdivisions or any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees, if such plan has total assets in excess of US$5,000,000; or an employee benefit plan within the meaning of the United States Employee Retirement Income Security Act of 1974, as amended, in which the investment decision is made by a plan fiduciary, as defined in Section 3(21) of such Act, which is either a bank, savings and loan association, insurance company or registered investment adviser, or an employee benefit plan with total assets in excess of U.S. $5,000,000 or, if a self directed plan, with investment decisions made solely by persons that are Accredited Investors;

 


 (ii) A private business development company as defined in Section 202(a)(22) of the Investment Advisers Act of 1940;

 (iii) an organization described in Section 501(c)(3) of the Internal Revenue Code, a corporation, Massachusetts or similar business trust, partnership, or limited liability company not formed for the specific purpose of acquiring the Shares, with total assets in excess of US$5,000,000;

 (iv) +a director, executive officer or general partner of the issuer of the securities being offered or sold, or any director, executive officer, or general partner of a general partner of that issuer;

 (v) a natural person whose individual net worth, or joint net worth with that person's spouse or spouse equivalent, at the time of his purchase, exceeds US$1,000,000 (Note: for purposes of calculating net worth under this paragraph: (i) the person's primary residence shall not be included as an asset, (ii) indebtedness that is secured by the person's primary residence, up to the estimated fair market value of the primary residence at the time of the sale of the securities, shall not be included as a liability (except that if the amount of such indebtedness outstanding at the time of sale of the securities exceeds the amount outstanding 60 days before such time, other than as a result of the acquisition of the primary residence, the amount of such excess shall be included as a liability) and (iii) indebtedness that is secured by the person's primary residence in excess of the estimated fair market value of the primary residence at the time of sale of the Shares shall be included as a liability);

 (vi) A natural person who had an individual income in excess of US$200,000 in each of the two most recent years or joint income with that person's spouse or spousal equivalent in excess of U.S. $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current year; or

 (vii) A trust, with total assets in excess of US$5,000,000, not formed for the specific purpose of acquiring the securities offered, whose purchase is directed by a sophisticated person as described in Rule 506(b)(2)(ii) of the U.S. Securities Act;

 (viii) An entity in which all of the equity owners are U.S. Accredited Investors;

 (ix) a natural person who holds one of the following licenses in good standing: General Securities

Representative license (Series 7), the Private Securities Offerings Representative license (Series 82), or the Investment Adviser Representative license (Series 65);

 (x) An investment adviser registered pursuant to Section 203 of the Investment Advisers Act of 1940 or registered pursuant to the laws of a state; or

 (xi) An investment adviser relying on the exemption from registering with tthe SEC under Section 203(l) or (m) of the Investment Advisers Act of 1940; or


 (xii) A rural business investment company as defined in Section 384A of the Consolidated Farm and Rural Development Act;

 (xiii) An entity, of a type not listed herein, not formed for the specific purpose of acquiring the securities offered, owning investments in excess of $5,000,000;

 (xiv) A "family office," as defined in Rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940

(17 CFR 275.202(a)(11)(G)-1):

(i) With assets under management in excess of $5,000,000,

(ii) That is not formed for the specific purpose of acquiring the securities offered, and

(iii) Whose prospective investment is directed by a person who has such knowledge and experience in financial and business matters that such family office is capable of evaluating the merits and risks of the prospective investment;

 (xv) A "family client," as defined in rule 202(a)(11)(G)-1 under the Investment Advisers Act of 1940 (17 CFR 275.202(a)(11)(G)-1)), of a family office meeting the requirements in category 23 above and whose prospective investment in the issuer is directed by such family office as referenced above;

 (xvi) A natural person who is a "knowledgeable employee," as defined in rule 3c-5(a)(4) under the Investment Company Act of 1940 (17 CFR 270.3c-5(a)(4)), of the issuer of the securities being offered or sold where the issuer would be an investment company, as defined in Section 3 of such Act, but for the exclusion provided by either Section 3(c)(1) or Section 3(c)(7) of such Act; or

The foregoing representation and warranty is true and accurate as of the date of this certificate and will be true and accurate as of the closing of the Closing and the issuance of the Shares to the Investor. If any such representation or warranty shall not be true and accurate at the closing of the Closing, the undersigned shall give immediate written notice of such fact to the Issuer.

DATED:

INVESTOR:

(Print Full Name of Entity or Individual)

   
 

By:

(Signature)

Name:

(If signing on behalf of entity)

Title:

(If signing on behalf of entity)

 


EXHIBIT "C"

INTERNATIONAL INVESTOR CERTIFICATE

FOR SUBSCRIBERS RESIDENT OUTSIDE OF CANADA AND THE UNITED STATES

TO:

Naqi Logix Inc. (the "Corporation")

The undersigned (the "Subscriber") represents covenants and certifies to the Corporation that:

i. the Subscriber (and if the Subscriber is acting as agent for a disclosed principal, such disclosed principal) is not resident in Canada or the United States or subject to applicable securities laws of Canada or the United States;

ii. the issuance of the securities in the capital of the Corporation under this agreement (the "Securities" ) by the Corporation to the Subscriber (or its disclosed principal, if any) may be effected by the Corporation without the necessity of the filing of any document with or obtaining any approval from or effecting any registration with any governmental entity or similar regulatory authority having jurisdiction over the Subscriber (or its disclosed principal, if any);

iii. the Subscriber is knowledgeable of, or has been independently advised as to, the applicable securities laws of the jurisdiction which would apply to this subscription, if there are any;

iv. the issuance of the Securities to the Subscriber (and if the Subscriber is acting as agent for a disclosed principal, such disclosed principal) complies with the requirements of all applicable laws in the jurisdiction of its residence;

v. the applicable securities laws do not require the Corporation to register the Securities, file a prospectus or similar document, or make any filings or disclosures or seek any approvals of any kind whatsoever from any regulatory authority of any kind whatsoever in the international jurisdiction;

vi. the purchase of the Securities by the Subscriber, and (if applicable) each disclosed beneficial subscriber, does not require the Corporation to become subject to regulation in the Subscriber's or disclosed beneficial subscriber's jurisdiction, nor does it require the Corporation to attorn to the jurisdiction of any governmental authority or regulator in such jurisdiction or require any translation of documents by the Corporation;

vii. the Subscriber will not sell, transfer or dispose of the Securities except in accordance with all applicable laws, including applicable securities laws of Canada and the United States, and the Subscriber acknowledges that the Corporation shall have no obligation to register any such purported sale, transfer or disposition which violates applicable Canadian or United States securities laws; and

viii. the Subscriber will provide such evidence of compliance with all such matters as the Corporation or its counsel may request.

The Subscriber acknowledges that the Corporation is relying on this certificate to determine the Subscriber's suitability as a purchaser of securities of the Corporation. The Subscriber agrees that the representations, covenants and certifications contained to this certificate shall survive any issuance of Securities and warrants of the Corporation to the Subscriber.

The statements made in this Form are true and accurate as of the date hereof.

DATED:



INVESTOR:

(Print Full Name of Entity or Individual)

   
 

By:

(Signature)

Name:

(If signing on behalf of entity) Title:

(If signing on behalf of entity)

 


EXHIBIT "D"

AML Certificate

By executing this document, the client certifies the following:

If an Entity:

1. I am the of the Entity, and as such have knowledge of the matters certified to herein;

2. the Entity has not taken any steps to terminate its existence, to amalgamate, to continue into any other jurisdiction or to change its existence in any way and no proceedings have been commenced or threatened, or actions taken, or resolutions passed that could result in the Entity ceasing to exist;

3. the Entity is not insolvent and no acts or proceedings have been taken by or against the Entity or are pending in connection with the Entity, and the Entity is not in the course of, and has not received any notice or other communications, in each case, in respect of, any amalgamation, dissolution, liquidation, insolvency, bankruptcy or reorganization involving the Entity, or for the appointment of a receiver, administrator, administrative receiver, trustee or similar officer with respect to all or any of its assets or revenues or of any proceedings to cancel its certificate of incorporation or similar constating document or to otherwise terminate its existence or of any situation which, unless remedied, would result in such cancellation or termination;

4. the Entity has not failed to file such returns, pay such taxes, or take such steps as may constitute grounds for the cancellation or forfeiture of its certificate of incorporation or similar constating document;

5. if required, the documents uploaded to the DealMaker portal are true certified copies of the deed of trust, articles of incorporation or organization, bylaws and other constating documents of the Entity including copies of corporate resolutions or by-laws relating to the power to bind the Entity;

6. The Client is the following type of Entity:

7. The names and personal addresses as applicable for the entity in Appendix 1 are accurate.

All subscribers:

Dealmaker Account number: (Offline Investor)

If I elect to submit my investment funds by an electronic payment option offered by DealMaker, I hereby agree to be bound by DealMaker's Electronic Payment Terms and Conditions (the "Electronic Payment Terms"). I acknowledge that the Electronic Payment Terms are subject to change from time to time without notice.

Notwithstanding anything to the contrary, an electronic payment made hereunder will constitute unconditional acceptance of the Electronic Payment Terms, and by use of the credit card or ACH/EFT payment option hereunder, I: (1) authorize the automatic processing of a charge to my credit card account or debit my bank account for any and all balances due and payable under this agreement; (2) acknowledge that there may be fees payable for processing my payment; (3) acknowledge and agree that I will not initiate a chargeback or reversal of funds on account of any issues that arise pursuant to this investment and I may be liable for any and all damages that could ensue as a result of any such chargebacks or reversals initiated by myself.


DATED:

INVESTOR:

(Print Full Name of Investor)

   
 

By:

            (Signature)

Name of Signing Officer (if Entity):

Title of Signing Officer (if Entity):

 


 

Appendix 1 - Subscriber Information

For the Subscriber and Joint Holder (if applicable)

Name

Address

Date of Birth (if an Individual)

Taxpayer Identification Number









For a Corporation or entity other than a Trust (Insert names and addresses below or attach a list)

1. One Current control person of the Organization:

Name

Address

Date of Birth

Taxpayer Identification Number





2. Unless the entity is an Estate or Sole Proprietorship, list the Beneficial owners of, or those exercising direct or indirect control or direction over, more than 25% of the voting rights attached to the outstanding voting securities or the Organization:

Name

Address

Date of Birth

Taxpayer Identification Number













For a Trust (Insert names and addresses or attach a list)

1. Current trustees of the Organization:

Name

Address

Date of Birth

Taxpayer Identification Number















________________________________________________________

 

NAQI LOGIX INC.

RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT

 

________________________________________________________



TABLE OF CONTENTS


      Page
     
1. Definitions 1
     
2. Agreement Among the Company and the Shareholders 5
       
  2.1 Right of First Refusal 5
  2.2 Right of Co-Sale  7
  2.3 Effect of Failure to Comply 9
  2.4 Triggering Events 9
     
3. Exempt Transfers 11
       
  3.1 Exempted Transfers 11
  3.2 Exempted Offerings 11
  3.3 Prohibited Transferees 11
       
4. Legend 11
     
5. Lock-Up 12
       
  5.1 Agreement to Lock-Up  12
  5.2 Stop Transfer Instructions 12
     
6. Miscellaneous 12
       
  6.1 Term 12
  6.2 Share Split 12
  6.3 Ownership 13
  6.4 Dispute Resolution 13
  6.5 Waiver of Jury Trial 13
  6.6 Notices  13
  6.7 Entire Agreement 14
  6.8 Delays or Omissions  14
  6.9 Amendment; Waiver and Termination  14
  6.10 Assignment of Rights  14
  6.11 Severability  15
  6.12 Additional Shareholders  15
  6.13 Governing Law  15
  6.14 Counterparts 15
  6.15 Titles and Subtitles  15
  6.16 No Strict Construction  15
  6.17 Number and Gender 16
  6.18 Aggregation of Shares  16
  6.19 Specific Performance 16
  6.20 Independent Legal Advice 16
  6.21 Conflict with Constating Documents 16

1


RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT

THIS RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT (the "Agreement") is made as of April 12, 2021 by and among Naqi Logix Inc., a corporation existing under the Business Corporations Act (British Columbia) (the "Company") and those shareholders of the Company listed on Schedule A (together with any subsequent shareholders, or any transferees, who become parties hereto pursuant to Section 6.10 or 6.12) (the "Shareholders").

RECITALS

WHEREAS, the Shareholders own all of the outstanding shares in the capital of the Company;

AND WHEREAS, the Shareholders and the Company desire to provide each Shareholder with certain rights in accordance with the terms of this Agreement, including, among other rights, a Right of First Refusal and a Right of Co-Sale.

NOW, THEREFORE, the parties agree as follows:

1. Definitions.

1.1 "Affiliate" means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by or is under common control with such Person, including any general partner, managing member, officer or director of such Person or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, such Person.

1.2 "Articles" means the articles and notice of articles of the Company, as amended from time to time.

1.3 "Associate" means, with respect to any natural person: (a) a body corporate, if such natural person beneficially owns, directly or indirectly, voting securities carrying more than 50% of the voting rights attached to all voting securities of such body corporate; (b) a trust or estate for the benefit of such natural person or one or more of such natural person's Immediate Family Members; (c) a registered retirement savings plan of such natural person; or (d) an Immediate Family Member of such natural person.

1.4 "Board" means the board of directors of the Company.

1.5 "Capital Shares" means (a) Common Shares (whether now outstanding or hereafter issued in any context), (b) Common Shares issued or issuable upon conversion of any other class or series of shares in the capital of the Company, and (c) Common Shares issued or issuable upon exercise or conversion, as applicable, of share options, warrants or other convertible securities of the Company, in each case now owned or subsequently acquired by any Shareholder. For purposes of the number of Capital Shares held by a Shareholder (or any other calculation based thereon), all shares in the capital of the Company convertible into Common Shares, if any, shall be deemed to have been converted into Common Shares at the then applicable conversion ratio.

1


1.6 "Change of Control" means a transaction or series of related transactions in which a Person, or a group of related Persons, acquires from the Shareholders, shares in the capital of the Company representing more than 50% of the outstanding voting power of the Company.

1.7 "Common Shares" means collectively, the Voting Common Shares and the Non-Voting Common Shares.

1.8 "Company Notice" means written notice from the Company notifying the Selling Shareholder that the Company intends to exercise its Right of First Refusal as to some or all of the Transfer Shares with respect to any Proposed Shareholder Transfer.

1.9 "Competitor" means a Person engaged, directly or indirectly (including through any partnership, limited liability company, corporation, joint venture or similar arrangement (whether now existing or formed hereafter)), in substantially the same business as the Company, but shall not include any financial investment firm or collective investment vehicle that, together with its Affiliates, holds less than 20% of the outstanding equity of any Competitor and does not, nor do any of its Affiliates, have a right to designate any members of the board of directors of such Competitor.

1.10 "Constating Documents" means the certificate of incorporation, the certificate of change of name, notice of articles and articles of the Company, together with any amendments thereto or replacements thereof from time to time.

1.11 "Deemed Liquidation Event" means, unless the holders of a majority of the outstanding voting shares in the capital of the Company, elect otherwise by written notice sent to the Company at least 10 days prior to the effective date of any such event:

(a) an amalgamation or arrangement in which:

(a) the Company is a constituent party; or

(b) a subsidiary of the Company is a constituent party and the

Company issues shares in its capital pursuant to such amalgamation or arrangement,

except any such amalgamation or arrangement involving the Company or a subsidiary of the Company in which the shares in the capital of the Company outstanding immediately prior to such amalgamation or arrangement continue to represent, or are converted into or exchanged for shares that represent, immediately following such amalgamation or arrangement, at least a majority, by voting power, of the outstanding voting shares in the capital of (1) the surviving or resulting corporation or (2) if the surviving or resulting corporation is a wholly owned subsidiary of another corporation immediately following such amalgamation or arrangement, the parent corporation of such surviving or resulting corporation; or

(b) the sale, lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions, by the Company or any subsidiary of the Company of all or substantially all the assets of the Company and its subsidiaries taken as a whole, or the sale or disposition (whether by merger or otherwise) of one or more subsidiaries of the Company if substantially all of the assets of the Company and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries, except where such sale, lease, transfer, exclusive license or other disposition is to a wholly owned subsidiary of the Company.

 

2


1.12 "Equity Incentive Plan" means any equity incentive plan, share purchase plan, employee share option plan, or similar arrangement that is approved by the Board as it may be amended from time to time.

1.13 "Founders" means Mark A. Godsy, Vladimiro Cernetig, Gary A. Roshak, Thomas Dean, Almaz Nanjappa, Satya Narayana Jaddu, Scott Dunlop, Brant Pidvidic, Victor Joseph Allgeier, Srinivasa Rao Edara, Amar Pal Gampa, Grace Wiranata, Sai Hardhik Jaddu, Olaf Strassner, Robert Aaron Fashler, David Segal, Robert Thomas Payne, Osman Sinan Tumer and The Harrisburg University of Science and Technology, collectively (for so long as such individual is a Shareholder), and their exempt transferees (pursuant to Section 3.1) that are Shareholders (for so long as they are Shareholders); and "Founder" means any one of them.

1.14 "Holding Company" means a body corporate that is a party to this Agreement and is controlled by an individual that is also a party to this Agreement.

1.15 "including" (or "includes") means including (or includes) without

limitation.

1.16 "Immediate Family Member" means, with respect to a natural person, a child, stepchild, grandchild, parent, stepparent, grandparent, Spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships, of such natural person.

1.17 "Major Shareholder" means any Shareholder holding at least 5% of the votes attached to the outstanding voting shares in the capital of the Company, on an as converted and fully diluted basis.

1.18 "Non-Voting Common Shares" means the Non-Voting Common shares in the capital of the Company.

1.19 "Person" means any individual, corporation, partnership, trust, limited liability company, association or other entity.

1.20 "Principal" means, generally, a Person that is a party to this Agreement who controls a Holding Company;

1.21 "Proposed Shareholder Transfer" means any assignment, sale, offer to sell, pledge, mortgage, hypothecation, encumbrance, disposition of or any other like transfer or encumbering of any Transfer Shares (or any interest therein) proposed by any of the Shareholders.

1.22 "Proposed Transfer Notice" means written notice from a Shareholder setting forth the terms and conditions of a Proposed Shareholder Transfer.

 

3


1.23 "Prospective Transferee" means any person to whom a Shareholder proposes to make a Proposed Shareholder Transfer.

1.24 "Right of Co-Sale" means the right, but not an obligation, of a Major Shareholder to participate in a Proposed Shareholder Transfer by a Shareholder on the terms and conditions specified in the Proposed Transfer Notice.

1.25 "Right of First Refusal" means the right, but not an obligation, of the Company, or its permitted transferees or assigns, to purchase some or all of the Transfer Shares with respect to a Proposed Shareholder Transfer, on the terms and conditions specified in the Proposed Transfer Notice.

1.26 "Secondary Notice" means written notice from the Company notifying the Selling Shareholder and the other Shareholders that the Company does not intend to exercise its Right of First Refusal as to all Transfer Shares with respect to any Proposed Shareholder Transfer.

1.27 "Secondary Refusal Right" means the right, but not an obligation, of each Major Shareholder to purchase up to its pro rata portion (based upon the total number of Capital Shares then held by all Major Shareholders) of any Transfer Shares not purchased pursuant to the Right of First Refusal, on the terms and conditions specified in the Proposed Transfer Notice.

1.28 "Selling Shareholder" means any Shareholder who proposes to make a Proposed Shareholder Transfer.

1.29 "Shareholder Notice" means written notice from a Shareholder notifying the Company and the Selling Shareholder that such Shareholder intends to exercise its Secondary Refusal Right as to a portion of the Transfer Shares with respect to any Proposed Shareholder Transfer.

1.30 "Shareholder Rights Agreement" means the Shareholder Rights Agreement among the Company and its shareholders dated as of the date hereof, as the same may be amended, restated or replaced from time to time.

1.31 "Spouse" means, in relation to any Person who is an individual, any Person to whom that Person is married or with whom that Person is living in a conjugal relationship outside of marriage.

1.32 "Supermajority Holders" means two or more Shareholders of record holding in aggregate, at the time of reference, shares to which are attached more than two-thirds of the votes attached to the outstanding voting shares in the capital of the Company.

1.33 "Transfer Shares" means Capital Shares owned by a Shareholder, or issued to a Shareholder after the date hereof (including in connection with any share split, share dividend, recapitalization, reorganization, or the like).

1.34 "Triggering Event" means, with respect to an individual:

 

4


(a) such individual has his or her employment or engagement terminated for cause or breach, as applicable; or

(b) such individual has his or her employment or engagement

terminated without cause or for convenience, as applicable, or resigns.

1.35 "Undersubscription Notice" means written notice from a Major Shareholder notifying the Company and the Selling Shareholder that such Major Shareholder intends to exercise its option to purchase all or any portion of the Transfer Shares not purchased pursuant to the Right of First Refusal or the Secondary Refusal Right.

1.36 "Voting Agreement" means the Voting Agreement among the Company and its shareholders dated as of the date hereof, as the same may be amended, restated or replaced from time to time.

1.37 "Voting Common Shares" means the Voting Common shares in the capital

of the Company.

2. Agreement Among the Company and the Shareholders.

2.1 Right of First Refusal.

(a) Grant. Subject to the terms of Section 3, each Shareholder hereby unconditionally and irrevocably grants to the Company a Right of First Refusal to purchase all or any portion of Transfer Shares that such Shareholder may propose to transfer in a Proposed Shareholder Transfer, at the same price and on the same terms and conditions as those offered to the Prospective Transferee.

(b) Notice. Each Shareholder proposing to make a Proposed Shareholder Transfer must deliver a Proposed Transfer Notice to the Company and each other Shareholder no later than 30 days prior to the consummation of such Proposed Shareholder Transfer. Such Proposed Transfer Notice shall contain the material terms and conditions (including price and form of consideration) of the Proposed Shareholder Transfer and the identity of the Prospective Transferee. To exercise its Right of First Refusal under this Section 2, the Company must deliver a Company Notice to the Selling Shareholder within 10 days after delivery of the Proposed Transfer Notice. In the event of a conflict between this Agreement and any other agreement that may have been entered into by a Shareholder with the Company that contains a pre-existing right of first refusal, the Company and the Shareholder acknowledge and agree that the terms of this Agreement shall control and the pre-existing right of first refusal shall be deemed satisfied by compliance with Section 2.1(a) and this Section 2.1(b).

(c) Grant of Secondary Refusal Right to Shareholders. Subject to the terms of Section 3, each Shareholder hereby unconditionally and irrevocably grants to the Major Shareholders a Secondary Refusal Right to purchase all or any portion of the Transfer Shares not purchased by the Company pursuant to the Right of First Refusal, as provided in this Section 2.1(c). If the Company does not intend to exercise its Right of First Refusal with respect to all Transfer Shares subject to a Proposed Shareholder Transfer, the Company must deliver a Secondary Notice to the Selling Shareholder and to each Major Shareholder to that effect no later than 10 days after the Selling Shareholder delivers the Proposed Transfer Notice to the Company. To exercise its Secondary Refusal Right, a Major Shareholder must deliver a Shareholder Notice to the Selling Shareholder and the Company within 10 days after the Company's deadline for its delivery of the Secondary Notice.

 

5


(d) Undersubscription of Transfer Shares. If options to purchase have been exercised by the Company and the Major Shareholders with respect to some but not all of the Transfer Shares by the end of the 10-day period specified in the last sentence of Section 2.1(c)) (the "Shareholder Notice Period"), then the Company shall, immediately after the expiration of the Shareholder Notice Period, send written notice to those Major Shareholders who fully exercised their Secondary Refusal Right within the Shareholder Notice Period (the "Exercising Shareholder"). Each Exercising Shareholder shall, subject to the provisions of this Section 2.1(d), have an additional option to purchase all or any part of the balance of any such remaining unpurchased Transfer Shares on the terms and conditions set forth in the Proposed Transfer Notice. To exercise such option, an Exercising Shareholder must deliver an Undersubscription Notice to the Selling Shareholder and the Company within 10 days after the expiration of the Shareholder Notice Period (the "Undersubscription Notice Period"). In the event there are two or more such Exercising Shareholders that choose to exercise the last-mentioned option for a total number of remaining shares in excess of the number available, the remaining shares available for purchase under this Section 2.1(d) shall be allocated to such Exercising Shareholders pro rata based on the number of Transfer Shares such Exercising Shareholders have elected to purchase pursuant to the Secondary Refusal Right (without giving effect to any Transfer Shares that any such Exercising Shareholder has elected to purchase pursuant to the Undersubscription Notice). If the options to purchase the remaining shares are exercised in full by the Exercising Shareholders, the Company shall immediately notify all of the Exercising Shareholders and the Selling Shareholder of that fact.

(e) Forfeiture of Rights. Notwithstanding the foregoing, if the total number of Transfer Shares that the Company and the Major Shareholders have agreed to purchase in the Company Notice, Shareholder Notices and Undersubscription Notices is less than the total number of Transfer Shares, then the Company and the Major Shareholders shall be deemed to have forfeited any right to purchase such Transfer Shares, and the Selling Shareholder shall be free to sell all, but not less than all, of the Transfer Shares to the Prospective Transferee on terms and conditions substantially similar to (and in no event more favourable than) the terms and conditions set forth in the Proposed Transfer Notice, it being understood and agreed that (i) any such sale or transfer shall be subject to the other terms and restrictions of this Agreement, including the terms and restrictions set forth in Sections 2.2 and 6.10(b); (ii) any future Proposed Shareholder Transfer shall remain subject to the terms and conditions of this Agreement, including this Section 2; and (iii) such sale shall be consummated within 60 days after receipt of the Proposed Transfer Notice by the Company and, if such sale is not consummated within such 60 day period, such sale shall again become subject to the Right of First Refusal and Secondary Refusal Right on the terms set forth herein.

(f) Consideration; Closing. If the consideration proposed to be paid for the Transfer Shares is in property, services or other non-cash consideration, the fair market value of the consideration shall be as determined in good faith by the Board and as set forth in the Company Notice. If the Company or any Major Shareholder cannot for any reason pay for the

 

6


Transfer Shares in the same form of non-cash consideration, the Company or such Major Shareholder may pay the cash value equivalent thereof, as determined in good faith by the Board and as set forth in the Company Notice. The closing of the purchase of Transfer Shares by the Company and the Shareholders shall take place, and all payments from the Company and the other Shareholders shall have been delivered to the Selling Shareholder, by the later of (i) the date specified in the Proposed Transfer Notice as the intended date of the Proposed Shareholder Transfer and (ii) 30 days after delivery of the Proposed Transfer Notice.

2.2 Right of Co-Sale.

(a) Exercise of Right. If any Transfer Shares of a Selling Shareholder, which are subject to a Proposed Shareholder Transfer, are not purchased pursuant to Section 2.1 and thereafter are to be sold to a Prospective Transferee, each Major Shareholder may elect to exercise its Right of Co-Sale and participate on a pro rata basis in the Proposed Shareholder Transfer as set forth in Section 2.2(b) and, subject to Section 2.2(d), otherwise on the same terms and conditions specified in the Proposed Transfer Notice. Each Major Shareholder who desires to exercise its Right of Co-Sale (each, a "Participating Shareholder") must give such Selling Shareholder written notice to that effect within 10 days after the Shareholder Notice Period or the Undersubscription Notice Period, as applicable, and upon giving such notice such Participating Shareholder shall be deemed to have effectively exercised the Right of Co-Sale.

(b) Shares Includable. Each Participating Shareholder may include in the Proposed Shareholder Transfer all or any part of such Participating Shareholder's Capital Shares equal to the product obtained by multiplying (i) the aggregate number of Transfer Shares subject to the Proposed Shareholder Transfer by (ii) a fraction, the numerator of which is the number of Capital Shares owned by such Participating Shareholder immediately before consummation of the Proposed Shareholder Transfer, and the denominator of which is the total number of Capital Shares owned, in the aggregate, by all Participating Shareholders immediately prior to the consummation of the Proposed Shareholder Transfer, plus the number of Transfer Shares held by such Selling Shareholder. To the extent one or more of the Participating Shareholders exercise such right of participation in accordance with the terms and conditions set forth herein, the number of Transfer Shares that such Selling Shareholder may sell in the Proposed Shareholder Transfer shall be correspondingly reduced.

(c) Purchase and Sale Agreement. The terms and conditions of any Proposed Shareholder Transfer in accordance with Section 2.2 shall be memorialized in, and governed by, a written purchase and sale agreement with the Prospective Transferee (the "Purchase and Sale Agreement") with customary terms and provisions for such a transaction, and the Participating Shareholders and such Selling Shareholder shall enter into such Purchase and Sale Agreement as a condition precedent to any sale or other transfer in accordance with this Section 2.2.

(d) Allocation of Consideration.

(i) Subject to Section 2.2(d)(ii), the aggregate consideration payable to the Participating Shareholders and such Selling Shareholder shall be allocated based on the number of Capital Shares sold to the Prospective Transferee by each Participating Shareholder and such Selling Shareholder as provided in Section 2.2(b), provided that if a Participating Shareholder wishes to sell any shares convertible into Common Shares, the price set forth in the Proposed Transfer Notice shall be appropriately adjusted based on the conversion ratio of such shares into Common Shares.

 

7


(ii) In the event that the Proposed Shareholder Transfer constitutes a Change of Control, the terms of the Purchase and Sale Agreement shall provide that the aggregate consideration from such transfer shall be allocated to the Participating Shareholders and such Selling Shareholder in accordance with the liquidation preferences set forth in the Articles as if (1) such transfer was a Deemed Liquidation Event and (2) the Capital Shares sold in accordance with the Purchase and Sale Agreement were the only Capital Shares outstanding. In the event that a portion of the aggregate consideration payable to the Participating Shareholder(s) and such Selling Shareholder is placed into escrow, the Purchase and Sale Agreement shall provide that (x) the portion of such consideration that is not placed in escrow (the "Initial Consideration") shall be allocated in accordance with the Articles as if the Initial Consideration were the only consideration payable in connection with such transfer and (y) any additional consideration which becomes payable to the Participating Shareholder(s) and such Selling Shareholder upon release from escrow shall be allocated in accordance with the Articles after taking into account the previous payment of the Initial Consideration as part of the same transfer.

(e) Purchase by Selling Shareholder; Deliveries. Notwithstanding Section 2.2(c), if any Prospective Transferee refuses to purchase securities subject to the Right of Co-Sale from any Participating Shareholder or upon the failure to negotiate in good faith a Purchase and Sale Agreement reasonably satisfactory to the Participating Shareholders, such Selling Shareholder may not sell any Transfer Shares to such Prospective Transferee unless and until, simultaneously with such sale, such Selling Shareholder purchases all securities subject to the Right of Co-Sale from such Participating Shareholder on the same terms and conditions (including the proposed purchase price) as set forth in the Proposed Transfer Notice and as provided in Section 2.2(d)(i); provided, however, if such sale constitutes a Change of Control, the portion of the aggregate consideration paid by such Selling Shareholder to such Participating Shareholder shall be made in accordance with the first sentence of Section 2.2(d)(ii). In connection with such purchase by such Selling Shareholder, such Participating Shareholder shall deliver to such Selling Shareholder a share certificate or certificates, properly endorsed for transfer, representing the Capital Shares being purchased by such Selling Shareholder. Each such share certificate delivered to such Selling Shareholder will be transferred to the Prospective Transferee against payment therefore in consummation of the sale of the Transfer Shares pursuant to the terms and conditions specified in the Proposed Transfer Notice, and such Selling Shareholder shall concurrently therewith remit or direct payment to each such Participating Shareholder the portion of the aggregate consideration to which each such Participating Shareholder is entitled by reason of its participation in such sale as provided in this Section 2.2(e).

(f) Additional Compliance. If any Proposed Shareholder Transfer is not consummated within 60 days after receipt of the Proposed Transfer Notice by the Company, such Selling Shareholder proposing the Proposed Shareholder Transfer may not sell any Transfer Shares unless they first comply in full with each provision of this Section 2. The exercise or election not to exercise any right by any other Shareholder hereunder shall not adversely affect its right to participate in any other sales of Transfer Shares subject to this Section 2.2.

 

8


2.3 Effect of Failure to Comply.

(a) Transfer Void; Equitable Relief. Any Proposed Shareholder Transfer not made in compliance with the requirements of this Agreement shall be null and void ab initio, shall not be recorded on the books of the Company or its transfer agent and shall not be recognized by the Company. Each party hereto acknowledges and agrees that any breach of this Agreement would result in substantial harm to the other parties hereto for which monetary damages alone could not adequately compensate. Therefore, the parties hereto unconditionally and irrevocably agree that any non-breaching party hereto shall be entitled to seek protective orders, injunctive relief and other remedies available at law or in equity (including seeking specific performance or the rescission of purchases, sales and other transfers of Transfer Shares not made in strict compliance with this Agreement).

(b) Violation of First Refusal Right. If any Shareholder becomes obligated to sell any Transfer Shares to the Company or any other Major Shareholder under this Agreement and fails to deliver such Transfer Shares in accordance with the terms of this Agreement, the Company and/or such other Major Shareholder may, at its option, in addition to all other remedies it may have, send to such first Shareholder the purchase price for such Transfer Shares as is herein specified and transfer to the name of the Company or such other Major Shareholder (or request that the Company effect such transfer in the name of such other Major Shareholder) on the Company's books the certificate or certificates representing the Transfer Shares to be sold.

(c) Violation of Co-Sale Right. If any Selling Shareholder purports to sell any Transfer Shares in contravention of the Right of Co-Sale (a "Prohibited Transfer"), each other Shareholder who desires to exercise its Right of Co-Sale under Section 2.2 may, in addition to such remedies as may be available by law, in equity or hereunder, require such Selling Shareholder to purchase from such other Shareholder the type and number of Capital Shares that such other Shareholder would have been entitled to sell to the Prospective Transferee had the Prohibited Transfer been effected in compliance with the terms of Section 2.2. The sale will be made on the same terms, including as provided in Section 2.2(d)(i) and the first sentence of Section 2.2(d)(ii), as applicable, and subject to the same conditions as would have applied had such Selling Shareholder not made the Prohibited Transfer, except that the sale (including the delivery of the purchase price) must be made within 90 days after such other Shareholder learns of the Prohibited Transfer, as opposed to the timeframe prescribed in Section 2.2. Such Selling Shareholder shall also reimburse such other Shareholder for any and all reasonable and documented out-of-pocket fees and expenses, including reasonable legal fees and expenses, incurred pursuant to the exercise or the attempted exercise of such other Shareholder's rights under Section 2.2.

2.4 Triggering Events.

(a) Notwithstanding anything to the contrary in this Agreement, in the case of any Shareholder that has acquired his, her or its Common Shares pursuant to any Equity Incentive Plan, then if such Shareholder who is an individual, or if the Principal of such Shareholder, who is an employee or consultant of the Company or a subsidiary, experiences a Triggering Event, then the Company shall be entitled, subject to the remainder of this Section 2.4(a), to purchase within a period of one year from such Triggering Event, and such Shareholder (or the Shareholder controlled by such terminated Principal) and his, her or its Prospective Transferees (for purposes of this Section 2.4, the "Defaulting Shareholder") shall sell, all or any part thereof, of the Common Shares beneficially owned by such Defaulting Shareholder that were issued pursuant to an Equity Incentive Plan: (X) in the case of (b) in the definition of "Triggering Event", at the price determined in accordance with Section 2.4(c) or (Y) in the case of (a) in the definition of "Triggering Event", for the original issue price of such Common Shares.


 9


(b) Upon the occurrence of a Triggering Event with respect to a Defaulting Shareholder or a Founder:

(a) such Defaulting Shareholder or such Founder shall lose all rights that have been personally granted to such Defaulting Shareholder or Founder under this Agreement (and not all Shareholders or holders of a specific class of Common Shares), the Voting Agreement and the Shareholder Rights Agreement if any; and

(b) such Defaulting Shareholder or such Founder hereby irrevocably appoints the Company or in the case of a Defaulting Shareholder that is a Founder, any other Founder that is not a Defaulting Shareholder, as his, her or its true and lawful proxy and attorney-in-fact, with full power of substitution, to vote and exercise all voting, consent and similar rights of such Defaulting Shareholder or such Founder (including any rights to approve any amendments to this Agreement, the Voting Agreement or the Shareholder Rights Agreement), in a manner consistent with all resolutions passed, consents given or recommendations made by the Board, and/or sign any shareholder resolutions or amendments to shareholder agreements (including this Agreement), with respect to all of the Common Shares that now are or hereafter registered in the name of, and/or beneficially owned by, such Defaulting Shareholder or such Founder, as the case may be. The proxies and powers granted by each such Defaulting Shareholder or such Founder, as the case may be, pursuant to this Section 2.4(b) are coupled with an interest and are given to secure the performance of each Defaulting Shareholder's or such Founder's obligations and duties under this Agreement. Such proxy and power of attorney shall be irrevocable for so long as such Defaulting Shareholder or such Founder holds any Common Shares and shall survive the death, incompetency, disability, bankruptcy or dissolution of such Defaulting Shareholder or such Founder and the subsequent holders of his, her or its Common Shares (except, for greater clarity, with respect to those Common Shares transferred pursuant to Section 2.4(a)).

(c) The purchase price payable for any Common Shares to be transferred at a price determined pursuant to Section 2.4(a) (X) shall be equal to the fair market value of such Common Shares, determined as at the date of the event which gives rise to the right of purchase or sale, in good faith by the Board.

10


3. Exempt Transfers.

3.1 Exempted Transfers. Notwithstanding the foregoing or anything to the contrary herein, the provisions of Sections 2.1 and 2.2 shall not apply: (a) in the case of a Shareholder that is an entity, upon a transfer by such Shareholder to its shareholders, members, partners or other equity holders, (b) to a repurchase of Transfer Shares from a Shareholder by the Company or the Company's Affiliates at a price no greater than that originally paid by such Shareholder for such Transfer Shares and pursuant to an agreement containing vesting and/or repurchase provisions approved by a majority of the Board, or (c) in the case of a Shareholder that is a natural person, upon a transfer of Transfer Shares by such Shareholder made for bona fide estate planning purposes, either during his or her lifetime or on death by will or intestacy to his or her Spouse, child (natural or adopted), any other direct lineal descendant of such Shareholder (or his or her Spouse) or any other Immediate Family Member (all of the foregoing collectively referred to as "family members"), or any other person approved by the Board, or any custodian or trustee of any trust, partnership or limited liability company for the benefit of, or the ownership interests of which are owned wholly by, such Shareholder or any such family members; provided that in the case of clause (a) or (c), such Shareholder shall deliver prior written notice to the Company and the other Shareholders of such transfer and such Transfer Shares shall at all times remain subject to the terms and restrictions set forth in this Agreement, shall be subject to such voting arrangements as may be reasonably required by the Board, and such transferee shall, as a condition to such issuance, deliver a counterpart signature page to this Agreement as confirmation that such transferee shall be bound by all the terms and conditions of this Agreement as a Shareholder (but only with respect to the securities so transferred to the transferee), including the obligations of a Shareholder with respect to Proposed Shareholder Transfers of such Transfer Shares pursuant to Section 2. The parties further confirm, acknowledge and agree that in the case of clause (a) or (c), such Transfer Shares shall at all times remain subject to the provisions of Section 2.4(a) (the "Repurchase Right") and that if a Triggering Event occurs with respect to the Shareholder that effected the relevant Transfer, such Transfer Shares shall remain subject to the Repurchase Right, notwithstanding the Transfer.

3.2 Exempted Offerings. Notwithstanding the foregoing or anything to the contrary herein, the provisions of Section 2 shall not apply to the sale of any Transfer Shares (a) to the public in an offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, or a prospectus filed with any Canadian securities regulatory authorities (an "IPO") or (b) pursuant to a Deemed Liquidation Event.

3.3 Prohibited Transferees. Notwithstanding the foregoing, no Shareholder shall transfer any Transfer Shares to (a) any Competitor or (b) any customer, distributor or supplier of the Company, if the Board should determine that such transfer would result in such customer, distributor or supplier receiving information that would place the Company at a competitive disadvantage with respect to such customer, distributor or supplier.

4. Legend. Each certificate representing Capital Shares held by the Shareholders or issued to any Prospective Transferee in connection with a transfer permitted by this Agreement shall be endorsed with the following legend:

"THE SALE, PLEDGE, HYPOTHECATION OR TRANSFER OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO, AND IN CERTAIN CASES PROHIBITED BY, THE TERMS AND CONDITIONS OF A CERTAIN RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT BY AND AMONG THE SHAREHOLDER, THE CORPORATION AND CERTAIN OTHER HOLDERS OF SHARES IN THE CAPITAL OF THE CORPORATION. COPIES OF SUCH AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE CORPORATION."

 

11


The Company may instruct its transfer agent to impose transfer restrictions on the shares represented by certificates bearing the legend referred to above in this Section 4 to enforce the provisions of this Agreement, and the Company shall promptly do so. The legend shall be removed upon termination of this Agreement at the request of the Shareholder.

5. Lock-Up.

5.1 Agreement to Lock-Up. Each Shareholder shall not, without the prior written consent of the managing underwriter, during the period commencing on the date of the final prospectus relating to the Company's IPO and ending on the date specified by the Company and the managing underwriter (such period not to exceed 180 days), or such other period as may be requested by the Company or an underwriter to accommodate regulatory restrictions on (a) the publication or other distribution of research reports and (b) analyst recommendations and opinions, including the restrictions contained in FINRA Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor provisions or amendments thereto, (i) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any Capital Shares held immediately prior to the effectiveness of the registration statement for the IPO or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Capital Shares, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Capital Shares or other securities, in cash or otherwise. The foregoing provisions of this Section 5 shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, and shall only be applicable to the Shareholders if all officers, directors and holders of more than 1% of the outstanding Common Shares (on a fully-diluted and as-converted to Common Share basis) enter into similar agreements. Subject to applicable law, the underwriters in connection with the IPO are intended third-party beneficiaries of this Section 5 and shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto. Each Shareholder shall execute such agreements as may be reasonably requested by the underwriters in the IPO that are consistent with this Section 5 or that are necessary to give further effect thereto.

5.2 Stop Transfer Instructions. In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect to the Capital Shares of each Shareholder (and transferees and assignees thereof) until the end of such restricted period.

6. Miscellaneous.

6.1 Term. This Agreement (other than Section 5 in the case of clause (a) below) shall automatically terminate upon the earlier of (a) immediately prior to the consummation of an IPO and (b) the consummation of a Deemed Liquidation Event.

6.2 Share Split. All references to numbers of shares in this Agreement shall be appropriately adjusted to reflect any share dividend, split, combination or other recapitalization affecting the Capital Shares occurring after the date of this Agreement.

 

12


6.3 Ownership. Each Shareholder represents and warrants that such Shareholder is the sole legal and beneficial owner of the Capital Shares subject to this Agreement and that no other person or entity has any interest in such shares.

6.4 Dispute Resolution. The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the courts of the Province of British Columbia for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (b) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the courts of the Province of British Columbia, and (c) hereby waive, and agree not to assert, by way of motion, as a defence, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.

6.5 Waiver of Jury Trial. EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE SECURITIES OR THE SUBJECT MATTER HEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.

6.6 Notices. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given upon the earlier of actual receipt or: (a) personal delivery to the party to be notified, (b) when sent, if sent by email or facsimile during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient's next business day, (c) five days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one business day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery, with written verification of receipt. All communications shall be sent to the respective parties at their mailing address, email address or facsimile number as set forth in the corporate records of the Company, as the case may be, or to such mailing address, email address or facsimile number as subsequently modified by written notice given in accordance with this Section 6.6. If notice is given to the Company, it shall be sent to c/o Osler, Hoskin & Harcourt LLP, 1055 West Hastings Street, Suite 1700, Vancouver, British Columbia, V6E 2E9, Attn: Mark Godsy; email: magodsy@shaw.ca; and a copy (which shall not constitute notice) shall also be sent to Osler, Hoskin & Harcourt LLP, 1055 West Hastings Street, Suite 1700, Vancouver, British Columbia, V6E 2E0, Attn. Mark Longo, facsimile: (778) 785-2745; email: mlongo@osler.com.

 

13


6.7 Entire Agreement. This Agreement (including any schedules and exhibits hereto), together with the Shareholder Rights Agreement and the Voting Agreement all as may be amended, modified, restated or replaced from time to time, constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and all other written or oral agreements relating to the subject matter hereof existing between the parties are expressly canceled.

6.8 Delays or Omissions. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non- defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default previously or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.

6.9 Amendment; Waiver and Termination. This Agreement may be amended, modified or terminated (other than pursuant to Section 6.1) and the observance of any term hereof may be waived (either generally or in a particular instance and either retroactively or prospectively) only by a written instrument executed by (a) the Company and (b) the Supermajority Holders, provided that the consent of a particular Shareholder shall be required for any amendment or waiver if such amendment or waiver either (i) is directly applicable to the unique rights of such Shareholder set forth in the Agreement or (ii) adversely affects the rights of such Shareholder in a manner that is different than the effect on the rights of the other Shareholders holding the same class or series, as the case may be, of Capital Shares. Any amendment, modification, termination or waiver so effected shall be binding upon the Company and the Shareholders and all of their respective heirs, attorneys, guardians, estate trustees, executors, trustees, successors (including any successor by reason of amalgamation of any party) and permitted assigns whether or not such party, heir, attorney, guardian, estate trustee, executor, trustee, successor or permitted assign entered into or approved such amendment, termination or waiver. The Company shall give prompt written notice of any amendment, modification or termination hereof or waiver hereunder to any party hereto that did not consent in writing to such amendment, modification, termination or waiver. No waivers of or exceptions to any term, condition or provision of this Agreement, in any one or more instances, shall be deemed to be, or construed as, a further or continuing waiver of any such term, condition or provision. Notwithstanding the foregoing, Schedule A may be amended by the Company from time to time to add information regarding additional Shareholders or to reflect transfers or repurchases of shares in the capital of the Company or changes to the names of the parties without the consent of the other parties hereto.

6.10 Assignment of Rights.

(a) The terms and conditions of this Agreement shall enure to the benefit of and be binding upon the parties and their respective heirs, attorneys, guardians, estate trustees, executors, trustees, successors (including any successor by reason of amalgamation of any party) and permitted assigns. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective heirs, attorneys, guardians, estate trustees, executors, trustees, successors (including any successor by reason of amalgamation of any party) and permitted assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

14


(b) Any heir, attorney, guardian, estate trustee, executor, trustee, successor (including any successor by reason of amalgamation of any party) or permitted assignee of any Shareholder, including any Prospective Transferee who purchases Transfer Shares in accordance with the terms hereof, shall deliver to the Company and the other Shareholders, as a condition to any transfer or assignment, an adoption agreement in the form attached hereto as Exhibit A, pursuant to which such heir, attorney, guardian, estate trustee, executor, trustee, successor (including any successor by reason of amalgamation of any party) or permitted assignee shall confirm their agreement to be subject to and bound by all of the provisions set forth in this Agreement that were applicable to the predecessor or assignor of such heir, attorney, guardian, estate trustee, executor, trustee, successor (including any successor by reason of amalgamation of any party) or permitted assignee of any Shareholder.

(c) Except in connection with an assignment by the Company by operation of law to the acquirer of the Company, the rights and obligations of the Company hereunder may not be assigned under any circumstances.

6.11 Severability. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.

6.12 Additional Shareholders. Notwithstanding anything to the contrary contained herein, if, after the date of this Agreement, the Company enters into an agreement with any Person to issue shares to such Person, then the Company shall cause such Person, as a condition precedent to entering into such agreement, to become a party to this Agreement by executing an adoption agreement in the form attached hereto as Exhibit A, agreeing to be bound by and subject to the terms of this Agreement as a "Shareholder" and thereafter such Person shall be deemed a "Shareholder" for all purposes under this Agreement.

6.13 Governing Law. This Agreement is a contract made under and shall be governed by and construed in accordance with the laws of the Province of British Columbia and the federal laws of Canada applicable therein.

6.14 Counterparts. This Agreement may be executed in counterparts and by means of facsimile, portable document format (PDF), electronic signature or other transmission method, each of which when so executed and delivered shall be an original, but all such counterparts shall together constitute one and the same instrument.

6.15 Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.

6.16 No Strict Construction. The language used in this Agreement is the language chosen by the parties to express their mutual intent, and no rule of strict construction shall be applied against any party.

 

15


6.17 Number and Gender. Unless the context otherwise requires, words importing the singular include the plural and vice versa and words importing gender include all genders.

6.18 Aggregation of Shares. All Capital Shares held or acquired by a Shareholder and its Affiliates and Associates shall be aggregated together for the purpose of determining the availability of any rights under this Agreement and such Shareholder and its Affiliates and Associates may apportion such rights as among themselves in any manner they deem appropriate.

6.19 Specific Performance. In addition to any and all other remedies that may be available at law in the event of any breach of this Agreement, each Shareholder shall be entitled to specific performance of the agreements and obligations of the Company and the other Shareholders hereunder and to such other injunction or other equitable relief as may be granted by a court of competent jurisdiction.

6.20 Independent Legal Advice. The parties acknowledge that they have entered into this Agreement willingly with full knowledge of the obligations imposed by the terms of this Agreement. The parties further acknowledge that they have been afforded the opportunity to obtain independent legal advice and confirm by the execution of this Agreement that they have either done so or waived their right to do so, and agree that this Agreement constitutes a binding legal obligation and that they are estopped from raising any claim on the basis that they have not obtained such advice.

6.21 Conflict with Constating Documents. In the event of any conflict or inconsistency between the provisions of this Agreement and the Company's Constating Documents, the provisions of this Agreement shall prevail and govern to the extent permitted by law. The Shareholders agree that they shall promptly initiate all necessary proceeding, vote their respective Shares and take any such further action as is required by the Shareholders so as to cause the Constating Documents to be amended in order to resolve such conflict or inconsistency in favour of the provisions of this Agreement.

[Signature pages follow]

 

16


SCHEDULE A

SHAREHOLDERS

Name

Redacted

 

Schedule A to the Right of First Refusal and Co-Sale Agreement


Redacted

 

 

 

 

 

 

Schedule A to the Right of First Refusal and Co-Sale Agreement


Redacted

 

 

 

 

 

 

Schedule A to the Right of First Refusal and Co-Sale Agreement


EXHIBIT A

ADOPTION AGREEMENT

THIS ADOPTION AGREEMENT (the "Adoption Agreement") is executed on by the undersigned ("Holder") pursuant to the terms of that certain Right of First Refusal and Co-Sale Agreement dated as of April 12, 2021 (the "Agreement"), by and among Naqi Logix Inc. (the "Company") and its shareholders, as such Agreement may be amended and restated hereafter. Capitalized terms used but not defined in this Adoption Agreement shall have the respective meanings ascribed to such terms in the Agreement. By the execution of this Adoption Agreement, Holder agrees as follows.

1.1 Acknowledgement. Holder acknowledges that Holder is acquiring certain shares in the capital of the Company (the "Shares"), for one of the following reasons (Check the correct box):

☐ in accordance with Section 6.10 of the Agreement, in which case Holder will be a "Shareholder" for all purposes of the Agreement.

☐ in accordance with Section 6.12 of the Agreement, in which case Holder will be a "Shareholder" for all purposes of the Agreement.

1.2 Agreement.  Holder hereby (a) agrees that the Shares, and any other shares in the capital of the Company required by the Agreement to be bound thereby, shall be bound by and subject to the terms of the Agreement and (b) adopts the Agreement with the same force and effect as if Holder were originally a party thereto.

1.3 Notice. Any notice required or permitted by the Agreement shall be given to Holder at the address or the email address listed below Holder's signature hereto.

Holder:

 

Agreed and Accepted:

By:

 

NAQI LOGIX INC.

Name:

 

By:

Title:

 

Name:

Address:

(Offline Investor)

Title:

Email:

Email:



________________________________________________________

 

NAQI LOGIX INC.

SHAREHOLDER RIGHTS AGREEMENT

 

________________________________________________________



TABLE OF CONTENTS


      Page
     
1. Definitions 2
     
2. Information Rights 4
       
  2.1 Delivery of Financial Statements 4
       
3. Rights to Future Equity Issuances 5
       
  3.1 Right of First Offer 5
     
4. Additional Covenants 7
       
  4.1 Insurance 7
  4.2 Employee Agreements 7
  4.3 Employee Shares  7
  4.4 Board Matters  8
  4.5 Successor Indemnification 8
     
5. Miscellaneous 8
       
  5.1 Successors and Assigns  8
  5.2 Termination 8
  5.3 Governing Law  9
  5.4 Counterparts 9
  5.5 Titles and Subtitles  9
  5.6 No Strict Construction  9
  5.7 Number and Gender 9
  5.8 Statutory References 9
  5.9 Notices  9
  5.10 Amendments; Waivers and Termination  9
  5.11 Severability  10
  5.12 Aggregation of Shares  10
  5.13 Additional Shareholders  10
  5.14 Entire Agreement 10
  5.15 Dispute Resolution 10
  5.16 Waiver of Jury Trial 11
  5.17 Delays or Omissions  11
  5.18 Independent Legal Advice 11
  5.19 Conflict with Constating Documents 11


SHAREHOLDER RIGHTS AGREEMENT

THIS SHAREHOLDER RIGHTS AGREEMENT (the "Agreement") is made and entered into as of April 12,2021, by and among Naqi Logix Inc., a corporation existing under the Business Corporations Act (British Columbia) (the "Company") and those shareholders of the Company listed on Schedule A (together with any subsequent shareholders, or any transferees, who become parties hereto pursuant to Sections 3.1, 5.1 or 5.13) (the "Shareholders").

RECITALS

WHEREAS, the Shareholders wish to receive certain information from the Company to participate in future equity offerings by the Company;

AND WHEREAS, the Shareholders and the Company hereby agree that this Agreement shall govern the rights of the Shareholders to receive certain information from the Company and to participate in future equity offerings by the Company, and shall govern certain other matters as set forth in this Agreement;

NOW, THEREFORE, the parties hereby agree as follows:

1. Definitions. For purposes of this Agreement:

1.1 "Affiliate" means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by or is under common control with such Person, including any general partner, managing member, officer or director of such Person or any venture capital fund now or hereafter existing that is controlled by one or more general partners or managing members of, or shares the same management company with, such Person.

1.2 "Associate" means, with respect to any natural person: (a) a body corporate, if such natural person beneficially owns, directly or indirectly, voting securities carrying more than 50% of the voting rights attached to all voting securities of such body corporate; (b) a trust or estate for the benefit of such natural person or one or more of such natural person's Immediate Family Members; (c) a registered retirement savings plan of such natural person; or (d) an Immediate Family Member of such natural person.

1.3 "Board" means the board of directors of the Company.

1.4 "Canadian Securities Law" means the securities laws of each province and territory of Canada, and the rules, instruments, regulations, notices and policies of each securities commission or other securities regulatory authority in each province or territory in Canada.

1.5 "Common Shares" means collectively, the Voting Common Shares and the Non-Voting Common Shares." for BC Companies.

1.6 "Competitor" means a Person engaged, directly or indirectly (including through any partnership, limited liability company, corporation, joint venture or similar arrangement (whether now existing or formed hereafter)), in substantially the same business as the Company, but shall not include any financial investment firm or collective investment vehicle that, together with its Affiliates, holds less than 20% of the outstanding equity of any Competitor and does not, nor do any of its Affiliates, have a right to designate any members of the board of directors of such Competitor.

 

2


1.7 "Constating Documents" means the certificate of incorporation, certificate of change of name, notice of articles and articles of the Company, together with any amendments thereto or replacements thereof from time to time.

1.8 "Deemed Liquidation Event" means, unless the holders of a majority of the outstanding voting shares in the capital of the Company elect otherwise by written notice sent to the Company at least 10 days prior to the effective date of any such event:

(a) an amalgamation or arrangement in which:

(i) the Company is a constituent party; or

(ii) a subsidiary of the Company is a constituent party and the Company issues shares in its capital pursuant to such amalgamation or arrangement,

except any such amalgamation or arrangement involving the Company or a subsidiary of the Company in which the shares in the capital of the Company outstanding immediately prior to such amalgamation or arrangement continue to represent, or are converted into or exchanged for shares that represent, immediately following such amalgamation or arrangement, at least a majority, by voting power, of the outstanding shares in the capital of (1) the surviving or resulting corporation or (2) if the surviving or resulting corporation is a wholly owned subsidiary of another corporation immediately following such amalgamation or arrangement, the parent corporation of such surviving or resulting corporation; or

(b) the sale, lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions, by the Company or any subsidiary of the Company of all or substantially all the assets of the Company and its subsidiaries taken as a whole, or the sale or disposition (whether by merger or otherwise) of one or more subsidiaries of the Company if substantially all of the assets of the Company and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries, except where such sale, lease, transfer, exclusive license or other disposition is to a wholly owned subsidiary of the Company.

1.9 "Derivative Securities" means any securities or rights convertible into, or exercisable or exchangeable for (in each case, directly or indirectly), Common Shares, including options and warrants.

1.10 "Exchange Act" means the United States Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

1.11 "Founders" means Mark A. Godsy, Vladimiro Cernetig, Gary A. Roshak, Thomas Dean, Almaz Nanjappa, Satya Narayana Jaddu, Scott Dunlop, Brant Pidvidic, Victor Joseph Allgeier, Srinivasa Rao Edara, Amar Pal Gampa, Grace Wiranata, Sai Hardhik Jaddu, Olaf Strassner, Robert Aaron Fashler, David Segal, Robert Thomas Payne, Osman Sinan Tumer and The Harrisburg University of Science and Technology, collectively; and "Founder" means any one of them individually.

 

3


1.12 "GAAP" means generally accepted accounting principles in Canada.

1.13 "Immediate Family Member" means, with respect to a natural person, a child, stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships, of such natural person.

1.14 "including" (or "includes") means including (or includes) without

limitation.

1.15 "IPO" means the Company's first underwritten public offering of its

Common Shares.

1.16 "Major Shareholder" means any Shareholder holding at least 5% of the votes attached to the outstanding voting shares in the capital of the Company, on an as converted and fully diluted basis.

1.17 "New Securities" means, collectively, equity securities in the capital of the Company, whether or not currently authorized, as well as rights, options, or warrants to purchase such equity securities, or securities of any type that are, or may become, convertible or exchangeable into or exercisable for such equity securities.

1.18 "Non-Voting Common Shares" means the Non-Voting Common shares in the capital of the Company.

1.19 "Person" means any individual, corporation, partnership, trust, limited liability company, association or other entity.

1.20 "Right of First Refusal and Co-Sale Agreement" means the Right of First Refusal and Co-Sale Agreement among the Company and its Shareholders dated as of the date hereof, as the same may be amended, restated or replaced from time to time.

1.21 "Shareholder Agreements" means: (a) this Agreement; (b) the Voting Agreement; and (c) the Right of First Refusal and Co-Sale Agreement.

1.22 "Supermajority Holders" means two or more Shareholders of record holding in aggregate, at the time of reference, shares to which are attached more than two-thirds of the votes attached to the outstanding shares in the capital of the Company.

1.23 "Voting Agreement" means the Voting Agreement among the Company and its Shareholders dated as of the date hereof, as the same may be amended, restated or replaced from time to time.

1.24 "Voting Common Shares" means the Voting Common shares in the capital of the Company.

 

4


2. Information Rights.

2.1 Delivery of Financial Statements.

(a) The Company shall deliver to each Major Shareholder, provided that the Board has not reasonably determined that such Major Shareholder is a Competitor, as soon as practicable, but in any event within 120 days after the end of each fiscal year of the Company, financial statements of the Company for and as at the end of such fiscal year (including a balance sheet of the Company as at the end of such fiscal year and statements of income, retained earnings and change in cash flow of the Company for such fiscal year), prepared in accordance with GAAP, consistently applied, and accompanied by a review engagement report by independent accountants.

(b) If, for any period, the Company has any subsidiary whose accounts are consolidated with those of the Company, then in respect of such period the financial statements delivered pursuant to the foregoing sections shall be the consolidated and consolidating financial statements of the Company and all such consolidated subsidiaries.

(c) Subject to Section 2.1(d), each Shareholder that is not a Major Shareholder hereby irrevocably confirms that such Shareholder does not wish to receive annual financial statements of the Company.

(d) Notwithstanding Section 2.1(c), each Shareholder that is not a Major Shareholder shall be entitled, so long as the Board has not reasonably determined that such Shareholder is a Competitor, to obtain a copy of the financial statements of the Company that were delivered to the Major Shareholders in accordance with Section 2.1(a) as soon as practicable following delivery of a written request to the Company by such Shareholder.

3. Rights to Future Equity Issuances.

3.1 Right of First Offer. Subject to the terms and conditions of this Section 3.1 and applicable securities laws, if the Company proposes to offer or sell any New Securities, the Company shall first offer such New Securities to each Major Shareholder. A Major Shareholder shall be entitled to apportion the right of first offer hereby granted to it in such proportions as it deems appropriate, among (a) itself, (b) its Associates and Affiliates, and (c) its beneficial interest holders, such as limited partners, members or any other Person having "beneficial ownership," as such term is defined in Rule 13d-3 promulgated under the Exchange Act, of such Major Shareholder ("Shareholder Beneficial Owners"); provided that, each such Associate, Affiliate or Shareholder Beneficial Owner: (i) is not a Competitor, unless such party's purchase of New Securities is otherwise consented to by the Board, and (ii) agrees to enter into the Shareholder Agreements, as a "Shareholder" under each such Shareholder Agreement (provided that, any Competitor shall not be entitled to any rights as a Major Shareholder under Section 2.1 and this Section 3.1).

(a) The Company shall give notice (the "Offer Notice") to each Major Shareholder, stating (i) its bona fide intention to offer such New Securities, (ii) the number of such New Securities to be offered, and (iii) the price and terms, if any, upon which it proposes to offer such New Securities.

 

5


(b) By notification to the Company within 20 days after the Offer Notice is given, each Major Shareholder may elect to purchase or otherwise acquire, at the price and on the terms specified in the Offer Notice, up to that portion of such New Securities that equals the proportion that the Common Shares then held by such Major Shareholder (including all Common Shares then issuable (directly or indirectly) upon conversion and/or exercise, as applicable, of any Derivative Securities then held by such Major Shareholder) bears to the total number of Common Shares then outstanding (assuming full conversion and/or exercise, as applicable, of all Derivative Securities (including any allocated but unexercised options in the capital of the Company)). At the expiration of such 20 day period, the Company shall promptly notify each Major Shareholder that elects to purchase or acquire all the New Securities available to it (each, a "Fully Exercising Shareholder") of the failure of any other Major Shareholder who is not a Founder to do likewise. During the 10 day period commencing after the Company has given such notice, each Fully Exercising Shareholder may, by giving notice to the Company, elect to purchase or acquire, in addition to the number of New Securities specified above, up to that portion of the New Securities for which Major Shareholders who are not Founders were entitled to subscribe for but that were not subscribed for by such Major Shareholders that is equal to the proportion that the Common Shares issued and held, or issuable (directly or indirectly) upon conversion and/or exercise, as applicable, of any Derivative Securities then held, by such Fully Exercising Shareholder bears to the Common Shares issued and held, or issuable (directly or indirectly) upon conversion and/or exercise, as applicable, of any Derivative Securities then held, by all Fully Exercising Shareholders who wish to purchase such unsubscribed New Securities. The closing of any sale pursuant to this Section 3.1(b) shall occur on the later of: (i) 90 days after the date that the Offer Notice is given; and (ii) the date of initial sale of New Securities pursuant to Section 3.1(c).

(c) If all New Securities referred to in the Offer Notice are not elected to be purchased or acquired as provided in Section 3.1(b), the Company may, during the 90-day period following the expiration of the periods provided in Section 3.1(b), offer and sell the remaining unsubscribed portion of such New Securities to any Person or Persons at the same price and upon the same terms as specified in the Offer Notice. If the Company does not enter into an agreement for the sale of the New Securities within such period, or if such agreement is not consummated within 30 days of the execution thereof, the right provided hereunder shall be deemed to be revived and such New Securities shall not be offered unless first reoffered to the Major Shareholders in accordance with this Section 3.1.

(d) The right of first offer in this Section 3.1 shall not be applicable to:

(i) Common Shares or Derivative Securities issued as a dividend or distribution on any shares in the capital of the Company;

(ii) Common Shares or Derivative Securities issued by reason of a share split;

(iii) Common Shares or Derivative Securities issued to employees or directors of, or consultants or advisors to, the Company or any of its subsidiaries pursuant to a plan, agreement or arrangement approved by the Board;

 

6


(iv) Common Shares or Derivative Securities actually issued upon the exercise of other Derivative Securities, or Common Shares actually issued upon the conversion or exchange of Derivative Securities, in each case provided such issuance is pursuant to the terms of such Derivative Security and such Derivative Security was issued in accordance with this Section 3.1;

(v) Common Shares or Derivative Securities issued to banks, equipment lessors or other financial institutions, or to real property lessors, pursuant to a debt financing, equipment leasing or real property leasing transaction approved by the Board;

(vi) Common Shares or Derivative Securities issued to suppliers or third-party service providers in connection with the provision of goods or services pursuant to transactions approved by the Board;

(vii) Common Shares or Derivative Securities issued pursuant to the acquisition of another corporation by the Company by amalgamation, arrangement, purchase of all or substantially all of the assets or shares or other reorganization or to a joint venture agreement, provided that such issuances are approved by the Board; or

(viii) Common Shares or Derivative Securities issued in connection with sponsored research, collaboration, technology license, development, original equipment manufacturer (OEM), marketing or other similar agreements or strategic partnerships approved by the Board.

4. Additional Covenants.

4.1 Insurance. The Company shall use its commercially reasonable efforts to obtain from financially sound and reputable insurers directors and officers liability insurance in an amount and on terms and conditions satisfactory to the Board, and will use commercially reasonable efforts to cause such insurance policies to be maintained until such time as the Board determines that such insurance should be discontinued.

4.2 Employee Agreements. The Company will cause each person now or hereafter employed by it or by any subsidiary of the Company (or engaged by the Company or any subsidiary of the Company as a consultant/independent contractor) and with access to confidential information and/or trade secrets to enter into a nondisclosure and proprietary rights assignment agreement substantially in the form approved by the Board. In addition, the Company shall not amend, modify, terminate, waive, or otherwise alter, in whole or in part, any of the above- referenced agreements or any restricted share agreement between the Company and any employee, without Board approval.

4.3 Employee Shares. Unless otherwise approved by the Board, all future advisors, employees and consultants of the Company who purchase, receive options to purchase, or receive awards of shares in the capital of the Company after the date hereof shall be required to execute restricted share or option agreements, as applicable, providing for (a) vesting of shares or options (as the case may be) over a four year period, with the first 25% of such shares or options (as applicable) vesting on the first anniversary of continued employment or service, and the remaining shares or options (as applicable) vesting in equal monthly installments over the following three years, and (b) the execution and delivery of adoption agreements to the Shareholder Agreements in form and substance satisfactory to the Company as a condition precedent to such employee or consultant becoming a shareholder of the Company. In addition, unless otherwise approved by the Board, the Company shall retain a "right of first refusal" on employee transfers of shares in the capital of the Company until the Company's IPO and shall have the right to repurchase unvested shares at cost upon the cessation of employment or service of a holder of restricted shares.

 

7


4.4 Board Matters. Unless otherwise determined by the vote of a majority of the Board, the Board shall meet at least quarterly in accordance with an agreed-upon schedule. The Company shall reimburse the directors for all reasonable out-of-pocket travel expenses incurred (consistent with the Company's travel policy) in connection with attending meetings of the Board. The Board may establish such committees of the Board as it considers appropriate, each of which shall consist solely of non-management directors.

4.5 Successor Indemnification. If the Company or any of its successors or assignees amalgamates, consolidates with or merges into any other Person and is not the continuing or surviving corporation or entity of such amalgamation, consolidation or merger, then to the extent necessary, proper provision shall be made so that the successors and assignees of the Company assume the obligations of the Company with respect to indemnification of members of the Board as in effect immediately before such transaction, whether such obligations are contained in the Company's Articles or elsewhere, as the case may be.

5. Miscellaneous.

5.1 Successors and Assigns.

(a) The rights under this Agreement may be assigned (but only with all related obligations) by a Shareholder in connection with the transfer of shares in the capital of the Company to a transferee (i) that is an Affiliate or an Associate of such Shareholder; or (ii) that after such transfer, such transferee is a Major Shareholder; provided, however, that (1) the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of such transferee and such shares with respect to which such rights are being transferred; and (2) such transferee agrees by executing an adoption agreement in the form attached hereto as Exhibit A to be bound by and subject to the terms of this Agreement as a Shareholder and thereafter such Person shall be deemed a Shareholder for all purposes under this Agreement.

(b) The terms and conditions of this Agreement shall enure to the benefit of and be binding upon the parties and their respective heirs, attorneys, guardians, estate trustees, executors, trustees, successors (including any successor by reason of amalgamation of any party) and permitted assigns. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective heirs, attorneys, guardians, estate trustees, executors, trustees, successors (including any successor by reason of amalgamation of any party) and permitted assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

8


5.2 Termination. This Agreement (other than Section 4.5) shall terminate and be of no further force or effect (a) immediately before the consummation of the IPO, (b) when the Company first becomes (i) subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act or (ii) a reporting issuer pursuant to applicable Canadian Securities Laws, or (c) upon a Deemed Liquidation Event, whichever event occurs first. Section 4.5 shall survive the termination of this Agreement.

5.3 Governing Law. This Agreement is a contract made under and shall be governed by and construed in accordance with the laws of the Province of British Columbia and the federal laws of Canada applicable therein.

5.4 Counterparts. This Agreement may be executed in counterparts and by means of facsimile, portable document format (PDF), electronic signature or other transmission method, each of which when so executed and delivered shall be an original, but all such counterparts shall together constitute one and the same instrument.

5.5 Titles and Subtitles. The titles and subtitles used in this Agreement are for convenience only and are not to be considered in construing or interpreting this Agreement.

5.6 No Strict Construction. The language used in this Agreement is the language chosen by the parties to express their mutual intent, and no rule of strict construction shall be applied against any party.

5.7 Number and Gender. Unless the context otherwise requires, words importing the singular include the plural and vice versa and words importing gender include all genders.

5.8 Statutory References. A reference to a statute includes all regulations made pursuant to such statute and, unless otherwise specified, the provisions of any statute or regulation which amends, supplements or supersedes any such statute or any such regulation.

5.9 Notices. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given upon the earlier of actual receipt or: (a) personal delivery to the party to be notified, (b) when sent, if sent by email or facsimile during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient's next business day, (c) five days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one business day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery, with written verification of receipt. All communications shall be sent to the respective parties at their mailing address, email address or facsimile number as set forth in the corporate records of the Company, as the case may be, or to such mailing address, email address or facsimile number as subsequently modified by written notice given in accordance with this Section 5.9. If notice is given to the Company, it shall be sent to c/o Osler, Hoskin & Harcourt LLP, 1055 West Hastings Street, Suite 1700, Vancouver, British Columbia, V6E 2E9, Attn: Mark Godsy; email: magodsy@shaw.ca; and a copy (which shall not constitute notice) shall also be sent to Osler, Hoskin & Harcourt LLP, 1055 West Hastings Street, Suite 1700, Vancouver, British Columbia, V6E 2E0, Attn. Mark Longo, facsimile: (778) 785-2745; email: mlongo@osler.com.

 

9


5.10 Amendments; Waivers and Termination. This Agreement may be amended, modified or terminated (other than pursuant to Section 5.2) and the observance of any term hereof may be waived (either generally or in a particular instance and either retroactively or prospectively) only by a written instrument executed by (a) the Company and (b) the Supermajority Holders, provided that the consent of a particular Shareholder shall be required for any amendment or waiver if such amendment or waiver either (A) is directly applicable to the unique rights of such Shareholder set forth in the Agreement or (B) adversely affects the rights of such Shareholder in a manner that is different than the effects on the rights of the other Shareholders holding the same class or series, as the case may be, of shares in the capital of the Company. Any amendment, modification, termination or waiver so effected shall be binding upon the Company and the Shareholders and all of their respective heirs, attorneys, guardians, estate trustees, executors, trustees, successors (including any successor by reason of amalgamation of any party) and permitted assigns whether or not such party, heir, attorney, guardian, estate trustee, executor, trustee, successor or permitted assign entered into or approved such amendment, termination or waiver. The Company shall give prompt written notice of any amendment, modification or termination hereof or waiver hereunder to any party hereto that did not consent in writing to such amendment, modification, termination or waiver. No waivers of or exceptions to any term, condition or provision of this Agreement, in any one or more instances, shall be deemed to be, or construed as, a further or continuing waiver of any such term, condition or provision. Notwithstanding the foregoing, Schedule A hereto may be amended by the Company from time to time to add information regarding additional Shareholders or to reflect transfers or repurchases of shares in the capital of the Company or changes to the names of the parties without the consent of the other parties hereto.

5.11 Severability. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.

5.12 Aggregation of Shares. All shares in the capital of the Company held or acquired by a Shareholder and its Affiliates and Associates shall be aggregated together for the purpose of determining the availability of any rights under this Agreement, and such Shareholder and its Affiliates and Associates may apportion such rights as among themselves in any manner they deem appropriate.

5.13 Additional Shareholders. Notwithstanding anything to the contrary contained herein, if, after the date of this Agreement, the Company enters into an agreement with any Person to issue shares to such Person, then the Company shall cause such Person, as a condition precedent to entering into such agreement, to become a party to this Agreement by executing an adoption agreement in the form attached hereto as Exhibit A, agreeing to be bound by and subject to the terms of this Agreement as a Shareholder and thereafter such Person shall be deemed a Shareholder for all purposes under this Agreement.

5.14 Entire Agreement. This Agreement (including any schedules and exhibits hereto), together with the other Shareholder Agreements, constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and all other written or oral agreements relating to the subject matter hereof existing between the parties are expressly canceled.

 

10


5.15 Dispute Resolution. The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the courts of the Province of British Columbia for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (b) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the courts of the Province of British Columbia, and (c) hereby waive, and agree not to assert, by way of motion, as a defence, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.

5.16 Waiver of Jury Trial. EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE SECURITIES OR THE SUBJECT MATTER HEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.

5.17 Delays or Omissions. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non- defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default previously or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.

5.18 Independent Legal Advice. The parties acknowledge that they have entered into this Agreement willingly with full knowledge of the obligations imposed by the terms of this Agreement. The parties further acknowledge that they have been afforded the opportunity to obtain independent legal advice and confirm by the execution of this Agreement that they have either done so or waived their right to do so, and agree that this Agreement constitutes a binding legal obligation and that they are estopped from raising any claim on the basis that they have not obtained such advice.

 

11


5.19 Conflict with Constating Documents. In the event of any conflict or inconsistency between the provisions of this Agreement and the Company's Constating Documents the provisions of this Agreement shall prevail and govern to the extent permitted by law. The Shareholders agree that they shall promptly initiate all necessary proceeding, vote their respective Shares and take any such further action as is required by the Shareholders so as to cause the Constating Documents to be amended in order to resolve such conflict or inconsistency in favour of the provisions of this Agreement.

[Signature pages follow]

 

12


SCHEDULE A

SHAREHOLDERS

Name

Redacted

 

 

 

 

 

 

Schedule A to the Shareholder Rights Agreement


- 2 -

Redacted

 

 

 

 

 

 

Schedule A to the Shareholder Rights Agreement


- 3 -

Redacted

 

 

 

 

 

 

Schedule A to the Shareholder Rights Agreement


EXHIBIT A

ADOPTION AGREEMENT

THIS ADOPTION AGREEMENT (the "Adoption Agreement") is executed on , by the undersigned ("Holder") pursuant to the terms of that certain Shareholder Rights Agreement dated as of April 12, 2021 (the "Agreement"), by and among Naqi Logix Inc. (the "Company") and its shareholders, as such Agreement may be amended and restated hereafter. Capitalized terms used but not defined in this Adoption Agreement shall have the respective meanings ascribed to such terms in the Agreement. By the execution of this Adoption Agreement, Holder agrees as follows.

1.1 Acknowledgement. Holder acknowledges that Holder is acquiring certain shares in the capital of the Company (the "Shares"), for one of the following reasons (Check the correct box):

☐ in accordance with Section 3.1 of the Agreement, in which case Holder will be a "Shareholder" for all purposes of the Agreement.

☐ in accordance with Section 5.1 of the Agreement, in which case Holder will be a "Shareholder" for all purposes of the Agreement.

☐ in accordance with Section 5.13 of the Agreement, in which case Holder will be a "Shareholder" for all purposes of the Agreement.

1.2 Agreement. Holder hereby (a) agrees that the Shares, and any other shares in the capital of the Company required by the Agreement to be bound thereby, shall be bound by and subject to the terms of the Agreement and (b) adopts the Agreement with the same force and effect as if Holder were originally a party thereto.

1.3 Notice. Any notice required or permitted by the Agreement shall be given to Holder at the address or email address listed below Holder's signature hereto.

Holder:

 

Agreed and Accepted:

By:

 

NAQI LOGIX INC.

Name:

 

By:

Title:

 

Name:

Address:

(Offline Investor)

Title:

Email:

Email:



 


________________________________________________________

 

NAQI LOGIX INC.

VOTING AGREEMENT

 

________________________________________________________



TABLE OF CONTENTS


      Page
     
1. Voting Provisions Regarding the Board of Directors 1
       
  1.1 Size of the Board  1
  1.2 Board Composition 1
  1.3 Failure to Designate a Board Member 2
  1.4 Removal of Board Members 2
  1.5 No Liability for Election of Recommended Directors  3
  1.6 Ceasing To Have the Right to Nominate a Director 3
  1.7 Board Chair 3
     
2. Voting Regarding Shareholder Actions 3
     
3. Drag-Along Right 3
       
  3.1 Definitions  3
  3.2 Actions to be Taken  4
  3.3 Exceptions 5
  3.4 Restrictions on Sales of Control of the Company 7
     
4. Remedies 7
       
  4.1 Covenants of the Company 7
  4.2 Irrevocable Proxy and Power of Attorney  7
  4.3 Specific Enforcement 8
  4.4 Remedies Cumulative 8
       
5. Term 8
     
6. Miscellaneous 8
       
  6.1 Confidentiality  8
  6.2 Additional Parties  9
  6.3 Transfers  9
  6.4 Successors and Assigns  9
  6.5 Governing Law  9
  6.6 Counterparts 10
  6.7 Titles and Subtitles  10
  6.8 No Strict Construction  10
  6.9 Including  10
  6.10 Number and Gender 10
  6.11 Notices  10
  6.12 Consent Required to Amend, Terminate or Waive  10
  6.13 Delays or Omissions  11
  6.14 Severability  11
  6.15 Entire Agreement 11
  6.16 Legend on Share Certificates 12

i




6.17 Share Splits, Share Dividends, etc. 12

6.18 Manner of Voting  12

6.19 Further Assurances 12

6.20 Dispute Resolution 12

6.21 Waiver of Jury Trial 13

6.22 Costs of Enforcement  13

6.23 Aggregation of Shares  13

6.24 Independent Legal Advice 13

6.25 Conflict with Constating Documents 13

ii


VOTING AGREEMENT

THIS VOTING AGREEMENT (the "Agreement") is made and entered into as of April 12, 2021 by and among Naqi Logix Inc., a corporation existing under the Business Corporations Act (British Columbia) (the "Company") and those shareholders of the Company listed on Schedule A (together with any subsequent shareholders, or any transferees, who become parties hereto pursuant to Section 6.2 or 6.3) (the "Shareholders").

RECITALS

WHEREAS, the Shareholders own all of the outstanding Shares (as defined below);

AND WHEREAS, the Shareholders and the Company desire to (a) provide certain Shareholders with the right, among other rights, to designate the election of certain members of the board of directors of the Company (the "Board") in accordance with the terms of this Agreement; and (b) set forth agreements and understandings with respect to how Shares (as defined below) held by the Shareholders will be voted on, or tendered in connection with, a Sale of the Company (as defined below).

NOW, THEREFORE, the parties agree as follows:

1. Voting Provisions Regarding the Board of Directors.

1.1 Size of the Board. Each Shareholder shall vote, or cause to be voted, all Shares (as defined below) owned by such Shareholder, or over which such Shareholder has voting control, from time to time and at all times, in whatever manner as shall be necessary to ensure that the size of the Board shall be set and remain at a number corresponding to the number of persons designated pursuant to Section 1.2. For purposes of this Agreement, the term "Shares" means shares in the capital of the Company, including all Voting Common Shares and Non-Voting Shares (the "Common Shares"), now owned or subsequently acquired by a Shareholder, however acquired, whether through share splits, share dividends, reclassifications, recapitalizations, similar events or otherwise, but excluding, for greater certainty, any other securities that are, directly or indirectly, convertible into or exchangeable or exercisable for shares in the capital of the Company.

1.2 Board Composition. Each Shareholder shall vote, or cause to be voted, all Shares owned by such Shareholder, or over which such Shareholder has voting control, from time to time and at all times, in whatever manner as shall be necessary to ensure that at each annual or special meeting of shareholders at which an election of directors is held or pursuant to any written resolution of the shareholders, the following persons shall be elected to the Board:

(a) up to seven individuals designated by Mark Godsy ("Godsy") for so long as Godsy continues Providing Services to the Company, one of whom shall initially be Godsy.

For purposes of this Agreement: (i) an individual, firm, corporation, partnership, association, lim- ited liability company, trust or any other entity (collectively, a "Person") shall be deemed an "Affiliate" of another Person who, directly or indirectly, controls, is controlled by or is under common control with such Person, including any general partner, managing member, officer or director of such Person or any venture capital fund now or hereafter existing that is controlled by one or more general partners or managing members of, or shares the same management company with, such Person; (ii) "Associate" means, with respect to any natural person: (1) a body corporate, if such natural person beneficially owns, directly or indirectly, voting securities carrying more than 50% of the voting rights attached to all voting securities of such body corporate; (2) a trust or estate for the benefit of such natural person or one or more of such natural person's Immediate Family Members (as defined below); (3) a registered retirement savings plan of such natural person; or (4) an Immediate Family Member of such natural person; (iii) "Immediate Family Member" means, with respect to a natural person, a child, stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in- law, brother-in-law, or sister-in-law, including adoptive relationships, of such natural person; and (iv) a Person shall be deemed to be "Providing Services to the Company" if such Person is either: (1) employed as an employee of the Company or any subsidiary of the Company on a full-time or part-time basis; (2) engaged by the Company or any subsidiary of the Company as an independent contractor, consultant or an advisor pursuant to a written or oral agreement; (3) appointed as an officer of the Company or any subsidiary of the Company; or (4) otherwise providing services to the Company or any subsidiary of the Company in his or her capacity as an owner of the Company. 


1.3 Failure to Designate a Board Member. In the absence of any designation from the Persons or groups with the right to designate a director as specified above, the director previously designated by them and then serving shall be re-elected if still eligible to serve as provided herein.

1.4 Removal of Board Members. Each Shareholder shall vote, or cause to be voted, all Shares owned by such Shareholder, or over which such Shareholder has voting control, from time to time and at all times, in whatever manner as shall be necessary to ensure that:

(a) no director elected pursuant to Sections 1.2 or 1.3 may be removed from office unless such removal is directed or approved by the affirmative vote of the Person, or Persons, entitled under Section 1.2 to designate that director;

(b) any vacancies created by the resignation, removal or death of a director elected pursuant to Section 1.2 or 1.3 shall be filled pursuant to the provisions of this Section 1; and

(c) upon the request of any party entitled to designate a director as provided in Section 1.2 to remove such director, such director shall be removed.

All Shareholders shall execute any written resolutions required to perform their respective obligations under this Section 1.4, and the Company shall, at the request of any party entitled to designate directors, call a special meeting of shareholders for the purpose of electing directors. Without limiting the foregoing, the Board shall take all steps necessary for the Company, to the extent permitted by law, to fill vacancies in accordance with this Section 1.

1.5 No Liability for Election of Recommended Directors. No Shareholder, nor any Affiliate or Associate of any Shareholder, shall have any liability as a result of designating a person for election as a director for any act or omission by such designated person in his or her capacity as a director of the Company, nor shall any Shareholder have any liability as a result of voting for any such designee in accordance with the provisions of this Agreement.


1.6 Ceasing To Have the Right to Nominate a Director. If any Shareholder ceases to have the right to designate a director pursuant to Section 1.2, then such director shall be designated by one or more Shareholders of record holding in aggregate, at the time of reference, shares to which are attached more than 50% of the votes attached to the outstanding Shares (the "Majority Holders").

1.7 Board Chair. The majority of directors then in office may vote to appoint the chair of the Board. In the case of an equality of votes, the chair of the Board (or of a particular meeting of the Board) shall not be entitled to a second or casting vote.

2. Voting Regarding Shareholder Actions. Subject to Section 3, (a) if: (i) in the case of any action that would require a "special resolution" (as defined in the Business Corporations Act (British Columbia) (the "Act")) to be approved by the Shareholders or would entitle any Shareholders to vote as a separate class or series as required pursuant to the Act, one or more Shareholders of record holding in aggregate, at the time of reference, shares to which are attached more than two-thirds of the votes attached to the outstanding Shares (the "Supermajority Holders"); (ii) in the case of any other action that would require an "ordinary resolution" (as defined in the Act) to be approved by the Shareholders; or (iii) in the case of waiving the requirement to appoint an auditor or the requirement to produce or publish financial statements under the Act which would require a "unanimous resolution" (as defined in the Act) to be approved by all Shareholders, the Majority Holders, in any such case, agree by written consent to approve such action (each action, a "Shareholder Action"); and (b) such Shareholder Action has also been approved by the Board, then all Shareholders shall: (1) vote all of their respective Shares in favour of such Shareholder Action; (2) waive any dissent, appraisal or similar rights to which they may be entitled with respect to such Shareholder Action (or the underlying action or transaction to which such Shareholder Action pertains) to the extent permitted by law; and (3) execute and deliver all resolutions, consents and other instruments in favour of such Shareholder Action.

3. Drag-Along Right.

3.1 Definitions.

(a) A "Sale of the Company" means either: (i) a transaction or series of related transactions in which a Person, or a group of related Persons, acquires from Shareholders, Shares representing more than 50% of the outstanding voting power of the Company (a "Share Sale"); or (ii) a Deemed Liquidation Event (as defined below).

(b) "Deemed Liquidation Event" means, unless the holders of a majority of the outstanding voting shares in the capital of the Company elect otherwise by written notice sent to the Company at least 10 days prior to the effective date of any such event:

(i) an amalgamation or arrangement in which: (1) the Company is a constituent party; or (2) a subsidiary of the Company is a constituent party and the Company issues shares in its capital pursuant to such amalgamation or arrangement, except any such amalgamation or arrangement involving the Company or a subsidiary of the Company in which the shares in the capital of the Company outstanding immediately prior to such amalgamation or arrangement continue to represent, or are converted into or exchanged for shares that represent, immediately following such amalgamation or arrangement, at least a majority, by voting power, of the outstanding shares in the capital of (X) the surviving or resulting corporation or (Y) if the surviving or resulting corporation is a wholly owned subsidiary of another corporation immediately following such amalgamation or arrangement, the parent corporation of such surviving or resulting corporation; or


(ii) the sale, lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions, by the Company or any subsidiary of the Company of all or substantially all the assets of the Company and its subsidiaries taken as a whole, or the sale or disposition (whether by merger or otherwise) of one or more subsidiaries of the Company if substantially all of the assets of the Company and its subsidiaries taken as a whole are held by such subsidiary or subsidiaries, except where such sale, lease, transfer, exclusive license or other disposition is to a wholly owned subsidiary of the Company.

3.2 Actions to be Taken. If, the Supermajority Holders (the "Electing Holders") and the Board approve a Sale of the Company specifying, in writing, that this Section 3 shall apply to such transaction, then each Shareholder and the Company shall:

(a) if such transaction requires shareholder approval, with respect to all Shares that such Shareholder owns or over which such Shareholder otherwise exercises voting power, vote (in person, by proxy or by action by written resolution, as applicable) all Shares in favour of, and adopt, such Sale of the Company (together with any related amendment to the articles and notice of articles of the Company (as may be amended from time to time) (the "Articles") required in order to implement such Sale of the Company) and vote in opposition to any and all other proposals that could reasonably be expected to delay or impair the ability of the Company to consummate such Sale of the Company;

(b) if such transaction is a Share Sale, sell the same proportion of Shares beneficially held by such Shareholder as is being sold by the Electing Holders to the Person to whom the Electing Holders propose to sell their Shares, and, except as permitted in Section 3.3, on the same terms and conditions as the Electing Holders;

(c) execute and deliver all related documentation and take any such other action in support of the Sale of the Company as shall reasonably be requested by the Company or the Electing Holders in order to carry out the terms and provision of this Section 3, including executing and delivering instruments of conveyance and transfer, any purchase agreement, merger agreement, amalgamation agreement, arrangement agreement, indemnity agreement, escrow agreement, consent, waiver, governmental filing, share certificates duly endorsed for transfer (free and clear of impermissible liens, claims and encumbrances) and any similar or related documents;

(d) not deposit, and cause their Affiliates and Associates not to deposit, except as provided in this Agreement, any Shares owned by such Shareholder or any Affiliate or Associate of such Shareholder in a voting trust or subject any Shares to any arrangement or agreement with respect to the voting of such Shares, unless specifically requested to do so by the acquiror in connection with the Sale of the Company;


(e) refrain from exercising any dissent rights or rights of appraisal under applicable law at any time with respect to such Sale of the Company;

(f) if the consideration to be paid in exchange for the Shares pursuant to this Section 3 includes any securities and due receipt thereof by any Shareholder would require under applicable law (i) the registration or qualification of such securities or of any person as a broker or dealer or agent with respect to such securities or (ii) the provision to any Shareholder of any information other than such information as a prudent issuer would generally furnish in an offering made solely to "accredited investors" as defined in Section 1.1 of Regulation 45-106 respecting Prospectus Exemptions in Québec and in National Instrument 45-106 elsewhere in Canada or as defined in Regulation D promulgated under the United States Securities Act of 1933, as amended (in either case, "Accredited Investors"), the Company may cause to be paid to any such Shareholder in lieu thereof, against surrender of the Shares that would have otherwise been sold by such Shareholder, an amount in cash equal to the fair value (as determined in good faith by the Board) of the securities that such Shareholder would otherwise receive as of the date of the issuance of such securities in exchange for the Shares; and

(g) if the Electing Holders, in connection with such Sale of the Company, appoint a shareholder representative (the "Shareholder Representative") with respect to matters affecting the Shareholders under the applicable definitive transaction agreements following consummation of such Sale of the Company, (i) consent to (1) the appointment of such Shareholder Representative, (2) the establishment of any applicable escrow, expense or similar fund in connection with any indemnification or similar obligations, and (3) the payment of such Shareholder's pro rata portion (from the applicable escrow or expense fund or otherwise) of any and all reasonable fees and expenses to such Shareholder Representative in connection with such Shareholder Representative's services and duties in connection with such Sale of the Company and its related service as the representative of the Shareholders, and (ii) not assert any claim or commence any suit against the Shareholder Representative or any other Shareholder with respect to any action or inaction taken or failed to be taken by the Shareholder Representative in connection with its service as the Shareholder Representative, absent fraud or wilful misconduct.

3.3 Exceptions. Notwithstanding the foregoing, a Shareholder shall not be required to comply with Section 3.2 in connection with any proposed Sale of the Company (the "Proposed Sale") unless:

(a) any representations and warranties to be made by such Shareholder in connection with the Proposed Sale are limited to representations and warranties related to authority, ownership and the ability to convey title to such Shares, including representations and warranties that (i) the Shareholder holds all right, title and interest in and to the Shares such Shareholder purports to hold, free and clear of all liens and encumbrances, (ii) the obligations of the Shareholder in connection with the transaction have been duly authorized, if applicable, (iii) the documents to be entered into by the Shareholder have been duly executed by the Shareholder and delivered to the acquirer and are enforceable against the Shareholder in accordance with their respective terms, and (iv) neither the execution and delivery of documents to be entered into in connection with the transaction, nor the performance of the Shareholder's obligations thereunder, will cause a breach or violation of the terms of any agreement, law or judgment, order or decree of any court or governmental agency;


(b) the Shareholder shall not be liable for the inaccuracy of any representation or warranty made by any other Person in connection with the Proposed Sale, other than the Company (except that and only to the extent that funds may be paid out of an escrow established to cover breach of representations, warranties and covenants of the Company as well as breach by any Shareholder of any representations, warranties and covenants provided by all Shareholders with respect to the Company);

(c) the liability for indemnification, if any, of such Shareholder in the Proposed Sale and for the inaccuracy of any representations and warranties made by the Company or its Shareholders in connection with such Proposed Sale is several and not joint with any other Person (except that and only to the extent that funds may be paid out of an escrow established to cover breach of representations, warranties and covenants of the Company as well as breach by any Shareholder of any representations, warranties and covenants provided by all Shareholders with respect to the Company), and subject to the provisions of the Articles related to the allocation of the escrow, is pro rata in proportion to, and does not exceed, the amount of consideration paid to such Shareholder in connection with such Proposed Sale;

(d) liability shall be limited to such Shareholder's applicable share (determined based on the respective proceeds payable to each Shareholder in connection with such Proposed Sale in accordance with the provisions of the Articles) of a negotiated aggregate indemnification amount that applies equally to all Shareholders but that in no event exceeds the amount of consideration otherwise payable to such Shareholder in connection with such Proposed Sale, except with respect to claims related to fraud by such Shareholder, the liability for which need not be limited as to such Shareholder;

(e) upon the consummation of the Proposed Sale, (i) each holder of each class or series of Shares will receive the same form of consideration for their Shares of such class or series as is received by other holders in respect of their Shares of such same class or series, (ii) each holder of Common Shares will receive the same amount of consideration per Common Share as is received by other holders in respect of their Common Shares, and (iii) the aggregate consideration receivable by all Shareholders shall be allocated among the Shareholders on the basis of the relative liquidation preferences to which the Shareholders are entitled in a Deemed Liquidation Event (assuming for this purpose that the Proposed Sale is a Deemed Liquidation Event) in accordance with the Articles in effect immediately prior to the Proposed Sale; provided, however, that, notwithstanding the foregoing, if the consideration to be paid in exchange for any Shareholder's Shares pursuant to this Section 3.3(e) includes any securities and due receipt thereof by any Shareholder would require under applicable law (i) the registration or qualification of such securities or of any person as a broker or dealer or agent with respect to such securities or (ii) the provision to any Shareholder of any information other than such information as a prudent issuer would generally furnish in an offering made solely to Accredited Investors, the Company may cause to be paid to any such Shareholder in lieu thereof, against surrender of such Shareholders' Shares, which would have otherwise been sold by such Shareholder, an amount in cash equal to the fair value (as determined in good faith by the Board) of the securities which such Shareholder would otherwise receive as of the date of the issuance of such securities in exchange for such Shareholder's Shares; and

(f) subject to Section 3.3(e), if any holders of any class or series of Shares are given an option as to the form and amount of consideration to be received as a result of the Proposed Sale, all holders of such class or series of Shares will be given the same option; provided, however, that nothing in this Section 3.3(f) shall entitle any holder to receive any form of consideration that such holder would be ineligible to receive as a result of such holder's failure to satisfy any condition, requirement or limitation that is generally applicable to the Shareholders.

 


3.4 Restrictions on Sales of Control of the Company. No Shareholder shall be a party to any Share Sale unless all Shareholders are allowed to participate in such transaction and the consideration received pursuant to such transaction is allocated among the parties thereto in the manner specified in the Articles in effect immediately prior to the Share Sale (as if such transaction were a Deemed Liquidation Event).

4. Remedies.

4.1 Covenants of the Company. The Company shall use its best efforts, within the requirements of applicable law, to ensure that the rights granted under this Agreement are effective and that the parties enjoy the benefits of this Agreement. Such actions include the use of the Company's best efforts to cause the nomination and election of the directors as provided in this Agreement.

4.2 Irrevocable Proxy and Power of Attorney. Each Shareholder hereby constitutes and appoints as the proxies of such Shareholder and hereby grants a power of attorney to the Chief Executive Officer of the Company (or if no such officer is appointed, the most senior officer of the Company) and a designee of the Electing Holders, and each of them, with full power of substitution, with respect to the matters set forth herein, including election of persons as members of the Board in accordance with Section 1, votes regarding any Shareholder Action pursuant to Section 2 and votes regarding any Sale of the Company pursuant to Section 3, and hereby authorizes each of them to represent and to: (a) vote, if and only if such Shareholder (i) fails to vote (whether by proxy, in person or by written resolution) (it being understood that failing to execute a written resolution within 48 hours of being requested shall constitute a failure to vote) or (ii) attempts to vote (whether by proxy, in person or by written resolution), in a manner which is inconsistent with the terms of this Agreement, all of such Shareholder's Shares in favour of the election or removal of persons as members of the Board determined pursuant to and in accordance with the terms and provisions of this Agreement or the approval of the Shareholder Action or approval of any Sale of the Company pursuant to and in accordance with the terms and provisions of Sections 2 and 3, respectively, or (b) take any action necessary to effect Sections 2 and 3, respectively. Each proxy and power of attorney granted pursuant to the immediately preceding sentence is given in consideration of the agreements and covenants of the Company and the Shareholders in connection with the transactions contemplated by this Agreement and, as such, each is coupled with an interest and shall be irrevocable unless and until this Agreement terminates or expires pursuant to Section 5. Each Shareholder hereby revokes any and all previous proxies or powers of attorney with respect to such Shareholder's Shares that conflict with the proxy and power of attorney granted pursuant to this Section 4.2 and shall not hereafter, unless and until this Agreement terminates or expires pursuant to Section 5, purport to grant any other proxy or power of attorney with respect to any of such Shareholder's Shares, deposit any of such Shareholder's Shares into a voting trust or enter into any agreement (other than this Agreement), arrangement or understanding with any Person, directly or indirectly, to vote, grant any proxy or give instructions with respect to the voting of any of such Shareholder's Shares, in each case, with respect to any of the matters set forth herein.


4.3 Specific Enforcement. Each party acknowledges and agrees that each party hereto will be irreparably damaged in the event that any of the provisions of this Agreement are not performed by the parties in accordance with their specific terms or are otherwise breached. Accordingly, it is agreed that each of the Company and the Shareholders shall be entitled to an injunction to prevent breaches of this Agreement, and to specific enforcement of this Agreement and its terms and provisions in any action instituted in any court in the Province of British Columbia.

4.4 Remedies Cumulative. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.

5. Term. This Agreement shall be effective as of the date hereof and shall continue in effect until and shall terminate, other than Section 6.1, upon the earliest to occur of (a) the consummation of the Company's first underwritten public offering of its Common Shares (other than a registration statement relating either to the sale of securities to employees of the Company pursuant to its share option, share purchase or similar plan or an SEC Rule 145 transaction); (b) the consummation of a Sale of the Company and distribution of proceeds to or in escrow for the benefit of the Shareholders in accordance with the Articles, provided that the provisions of Section 3 will continue after the closing of any Sale of the Company to the extent necessary to enforce the provisions of Section 3 with respect to such Sale of the Company; and (c) termination of this Agreement in accordance with Section 6.12. Section 6.1 shall survive the termination of this Agreement.

6. Miscellaneous.

6.1 Confidentiality. Each Shareholder shall keep confidential and will not disclose, divulge or use for any purpose (other than to monitor its ownership of the Company) any confidential information obtained from the Company pursuant to the terms of this Agreement, the Shareholder Rights Agreement dated the date hereof between the Company and the Shareholders, as may be amended, restated or replaced from time to time (the "Shareholder Rights Agreement") and the Right of First Refusal and Co-Sale Agreement dated the date hereof between the Company and the Shareholders, as may be amended, restated or replaced from time to time (the "Right of First Refusal and Co-Sale Agreement"), including notice of the Company's intention to file a registration statement, unless such confidential information (a) is known or becomes known to the public in general (other than as a result of a breach of this Section 6.1 by such Shareholder), (b) is or has been independently developed or conceived by such Shareholder without use of the Company's confidential information, or (c) is or has been made known or disclosed to such Shareholder by a third party without a breach of any obligation of confidentiality such third party may have to the Company; provided, however, that a Shareholder may disclose confidential information (i) to its lawyers, accountants, consultants and other professionals to the extent necessary to obtain their services in connection with monitoring such Shareholder's investment in the Company; (ii) to any prospective purchaser of any shares in the capital of the Company from such Shareholder, if such prospective purchaser agrees to be bound by the provisions of this Section 6.1; (iii) to any existing or prospective Affiliate, Associate, partner, member, shareholder or wholly-owned subsidiary of such Shareholder in the ordinary course of business, provided that in each case of (i), (ii) or (iii), such Shareholder informs such Person that such information is confidential and directs such Person to maintain the confidentiality of such information; or (iv) as may otherwise be required by law, provided that such Shareholder promptly notifies the Company of such disclosure and takes reasonable steps to minimize the extent of any such required disclosure.


6.2 Additional Parties. If, after the date of this Agreement, the Company enters into an agreement with any Person to issue Shares to such Person, then the Company shall cause such Person, as a condition precedent to entering into such agreement, to become a party to this Agreement by executing an adoption agreement substantially in the form attached hereto as Exhibit A, agreeing to be bound by and subject to the terms of this Agreement as a Shareholder and thereafter such Person shall be deemed a Shareholder for all purposes under this Agreement.

6.3 Transfers. Each transferee or assignee of any Shares subject to this Agree- ment shall continue to be subject to the terms hereof, and, as a condition precedent to the Com- pany's recognizing such transfer, each transferee or assignee shall agree in writing to be subject to each of the terms of this Agreement by executing and delivering an adoption agreement substantially in the form attached hereto as Exhibit A. Upon the execution and delivery of an adoption agreement by any transferee, such transferee shall be deemed to be a party hereto as if such transferee were the transferor and such transferee's signature appeared on the signature pages of this Agreement and shall be deemed to be a Shareholder. The Company shall not permit the transfer of the Shares subject to this Agreement on its books or issue a new certificate representing any such Shares unless and until such transferee shall have complied with the terms of this Section 6.3. Each certificate representing the Shares subject to this Agreement if issued on or after the date of this Agreement shall be endorsed by the Company with the legend set forth in Section 6.16.

6.4 Successors and Assigns. The terms and conditions of this Agreement shall enure to the benefit of and be binding upon the parties and their respective heirs, attorneys, guardians, estate trustees, executors, trustees, successors (including any successor by reason of amalgamation of any party) and assigns. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

6.5 Governing Law. This Agreement is a contract made under and shall be governed by and construed in accordance with the laws of the Province of British Columbia and the federal laws of Canada applicable therein.

6.6 Counterparts. This Agreement may be executed in counterparts and by means of facsimile, portable document (PDF), electronic signature or other transmission method, each of which when so executed and delivered shall be an original, but all such counterparts shall together constitute one and the same instrument.

6.7 Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.

6.8 No Strict Construction. The language used in this Agreement is the language chosen by the parties to express their mutual intent, and no rule of strict construction shall be applied against any party.


6.9 Including. Where the word "including" or "includes" is used in this Agreement, it means "including (or includes) without limitation".

6.10 Number and Gender. Unless the context otherwise requires, words importing the singular include the plural and vice versa and words importing gender include all genders.Notices. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given upon the earlier of actual receipt or: (a) personal delivery to the party to be notified, (b) when sent, if sent by email or facsimile during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient's next business day, (c) five days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one business day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery, with written verification of receipt. All communications shall be sent to the respective parties at their mailing address, email address or facsimile number as set forth in the corporate records of the Company, as the case may be, or to such mailing address, email address or facsimile number as subsequently modified by written notice given in accordance with this Section 6.11. If notice is given to the Company, it shall be sent to c/o Osler, Hoskin & Harcourt LLP, 1055 West Hastings Street, Suite 1700, Vancouver, British Columbia, V6E 2E9, Attn: Mark Godsy; email: magodsy@shaw.ca; and a copy (which shall not constitute notice) shall also be sent to Osler, Hoskin & Harcourt LLP, 1055 West Hastings Street, Suite 1700, Vancouver, British Columbia, V6E 2E0, Attn. Mark Longo, facsimile: (778) 785-2745; email: mlongo@osler.com.

6.12 Consent Required to Amend, Terminate or Waive. This Agreement may be amended or terminated and the observance of any term hereof may be waived (either generally or in a particular instance and either retroactively or prospectively) only by a written instrument executed by (a) the Company; and (b) the Supermajority Holders. Notwithstanding the foregoing:

(a) this Agreement may not be amended or terminated and the obser- vance of any term of this Agreement may not be waived with respect to a particular Shareholder without the written consent of such Shareholder unless such amendment, termination or waiver applies to all Shareholders holding the same class or series, as the case may be, of Shares in the same fashion;

(b) the consent of a particular Shareholder shall not be required for any amendment or waiver if such amendment or waiver either (1) is not directly applicable to the unique rights of such Shareholder set forth in the Agreement or (2) does not adversely affect the rights of such Shareholder in a manner that is different than the effect on the rights of the other Shareholders holding the same class or series, as the case may be, of Shares;

(c) Schedule A hereto may be amended by the Company from time to time to add information regarding additional Shareholders or to reflect transfers or repurchases of Shares or changes to the names or addresses of the parties without the consent of the other parties hereto;

(d) any provision hereof may be waived by the waiving party on such party's own behalf, without the consent of any other party; and


(e) the applicable subsection of Section 1.2 shall not be amended or waived without the written consent of the applicable Shareholder.

The Company shall give prompt written notice of any amendment, termination or waiver here- under to any party that did not consent in writing thereto. Any amendment, termination or waiver effected in accordance with this Section 6.12 shall be binding on each party and, as applicable, all of such party's heirs, attorneys, guardians, estate trustees, executors, trustees, successors (including any successor by reason of amalgamation of any party) and assigns, whether or not any such party, heir, attorney, guardian, estate trustee, executor, trustee, successor or assign entered into or approved such amendment, termination or waiver. For purposes of this Section 6.12, the requirement of a written instrument may be satisfied in the form of an action by written consent of the Shareholders circulated by the Company and executed by the Shareholder parties specified, whether or not such action by written consent makes explicit reference to the terms of this Agreement.

6.13 Delays or Omissions. No delay or omission to exercise any right, power or remedy accruing to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non- defaulting party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein, or of any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default previously or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative.

6.14 Severability. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.

6.15 Entire Agreement. This Agreement (including any schedules and exhibits hereto), together with the Shareholder Rights Agreement and the Right of First Refusal and Co- Sale Agreement, constitute the full and entire understanding and agreement between the parties with respect to the subject matter hereof, and all other written or oral agreements relating to the subject matter hereof existing between the parties are expressly cancelled.

6.16 Legend on Share Certificates. Each certificate representing any Shares issued after the date hereof shall be endorsed by the Company with a legend reading substantially as follows:

"THE SHARES EVIDENCED HEREBY ARE SUBJECT TO A VOTING AGREEMENT, AS MAY BE AMENDED FROM TIME TO TIME, (A COPY OF WHICH MAY BE OBTAINED UPON WRITTEN REQUEST FROM THE CORPORATION), AND BY ACCEPTING ANY INTEREST IN SUCH SHARES THE PERSON ACCEPTING SUCH INTEREST SHALL BE DEEMED TO AGREE TO AND SHALL BECOME BOUND BY ALL THE PROVISIONS OF THAT VOTING AGREEMENT, INCLUDING CERTAIN RESTRICTIONS ON TRANSFER AND OWNERSHIP SET FORTH THEREIN."


The Company, by its execution of this Agreement, shall cause the certificates evidencing the Shares issued after the date hereof to bear the legend required by this Section 6.16, and it shall supply, free of charge, a copy of this Agreement to any holder of a certificate evidencing Shares upon written request from such holder to the Company at its principal office. The failure to cause the certificates evidencing the Shares to bear the legend required by this Section 6.16 and/or the failure of the Company to supply, free of charge, a copy of this Agreement as provided hereunder shall not affect the validity or enforcement of this Agreement.

6.17 Share Splits, Share Dividends, etc. In the event of any issuance of Shares hereafter to any of the Shareholders (including in connection with any share split, share dividend, recapitalization, reorganization, or the like), such Shares shall become subject to this Agreement and shall be endorsed with the legend set forth in Section 6.16.

6.18 Manner of Voting. The voting of Shares pursuant to this Agreement may be effected in person, by proxy, by written consent or in any other manner permitted by applica- ble law. For the avoidance of doubt, voting of the Shares pursuant to the Agreement need not make explicit reference to the terms of this Agreement.

6.19 Further Assurances. At any time or from time to time after the date hereof, the parties agree to cooperate with each other, and at the request of any other party, to execute and deliver any further instruments or documents and to take all such further action as the other party may reasonably request in order to evidence or effectuate the consummation of the transactions contemplated hereby and to otherwise carry out the intent of the parties hereunder.

6.20 Dispute Resolution. The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the courts of the Province of British Columbia for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (b) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the courts of the Province of British Columbia, and (c) hereby waive, and agree not to assert, by way of motion, as a defence, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.

6.21 Waiver of Jury Trial. EACH PARTY HEREBY WAIVES ITS RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF THIS AGREEMENT, THE SECURITIES OR THE SUBJECT MATTER HEREOF. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL-ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING CONTRACT CLAIMS, TORT CLAIMS (INCLUDING NEGLIGENCE), BREACH OF DUTY CLAIMS, AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. THIS SECTION HAS BEEN FULLY DISCUSSED BY EACH OF THE PARTIES HERETO AND THESE PROVISIONS WILL NOT BE SUBJECT TO ANY EXCEPTIONS. EACH PARTY HERETO HEREBY FURTHER WARRANTS AND REPRESENTS THAT SUCH PARTY HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL, AND THAT SUCH PARTY KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.


6.22 Costs of Enforcement. If any party to this Agreement seeks to enforce its rights under this Agreement by legal proceedings, the non-prevailing party shall pay all costs and expenses incurred by the prevailing party, including all reasonable legal fees.

6.23 Aggregation of Shares. All Shares held or acquired by a Shareholder and its Affiliates and Associates shall be aggregated together for the purpose of determining the availability of any rights under this Agreement, and such Shareholder and its Affiliates and Associates may apportion such rights as among themselves in any manner they deem appropriate.

6.24 Independent Legal Advice. The parties acknowledge that they have entered into this Agreement willingly with full knowledge of the obligations imposed by the terms of this Agreement. The parties further acknowledge that they have been afforded the opportunity to obtain independent legal advice and confirm by the execution of this Agreement that they have either done so or waived their right to do so, and agree that this Agreement constitutes a binding legal obligation and that they are estopped from raising any claim on the basis that they have not obtained such advice.

6.25 Conflict with Constating Documents. In the event of any conflict or inconsistency between the provisions of this Agreement and the certificate of incorporation, certificate of change of name, notice of articles, and articles of the Company, together with any amendments thereof from time to time (the "Constating Documents") the provisions of this Agreement shall prevail and govern to the extent permitted by law. The Shareholders agree that they shall promptly initiate all necessary proceeding, vote their respective Shares and take any such further action as is required by the Shareholders so as to cause the Constating Documents to be amended in order to resolve such conflict or inconsistency in favour of the provisions of this Agreement.

[Signature pages follow]


SCHEDULE A

SHAREHOLDERS

Name

Redacted

 

 

 

 

 

 

Schedule A to the Voting Agreement


- 2 -

Redacted

 

 

 

 

 

 

Schedule A to the Voting Agreement


- 3 -

Redacted

 

 

 

 

 

 

Schedule A to the Voting Agreement


EXHIBIT A

ADOPTION AGREEMENT

THIS ADOPTION AGREEMENT (the "Adoption Agreement") is executed on , by the undersigned ("Holder") pursuant to the terms of that certain Voting Agreement dated as of April 12, 2021 (the "Agreement"), by and among Naqi Logix Inc. (the "Company") and its shareholders, as such Agreement may be amended and restated hereafter. Capitalized terms used but not defined in this Adoption Agreement shall have the respective meanings ascribed to such terms in the Agreement. By the execution of this Adoption Agreement, Holder agrees as follows.

1.1 Acknowledgement. Holder acknowledges that Holder is acquiring certain shares in the capital of the Company (the "Shares"), for one of the following reasons (Check the correct box):

☐  as a transferee of Shares from a party in such party's capacity as a "Shareholder" bound by the Agreement, and after such transfer, Holder shall be considered a "Shareholder" for all purposes of the Agreement.

☐ in accordance with Section 6.2 of the Agreement, in which case Holder will be a "Shareholder" for all purposes of the Agreement.

1.2 Agreement. Holder hereby (a) agrees that the Shares, and any other shares in the capital of the Company required by the Agreement to be bound thereby, shall be bound by and subject to the terms of the Agreement and (b) adopts the Agreement with the same force and effect as if Holder were originally a party thereto.

1.3 Notice. Any notice required or permitted by the Agreement shall be given to Holder at the address or email address listed below Holder's signature hereto.

Holder:

 

Agreed and Accepted:

By:

 

NAQI LOGIX INC.

Name:

 

By:

Title:

 

Name:

Address:

(Offline Investor)

Title:

Email:

Email:



EX1A-11 CONSENT 4 exhibit11-1.htm EXHIBIT 11.1 Naqi Logix Inc.: Exhibit 11.1 - Filed by newsfilecorp.com

Tel: (604) 688-5421
Fax: (604) 688-5132
www.bdo.ca
BDO Canada LLP
1100 Royal Centre
1055 West Georgia Street
Vancouver, BC
V6E 3P3
 

 

Exhibit 11.1

Consent of Independent Accounting Firm

Naqi Logix Inc.

Vancouver, British Columbia

We consent to the inclusion in this Offering Statement of Naqi Logix Inc. (the “Company”) on Form 1-A of our report dated December 29, 2021, with respect to our audit of the financial statements of the Company as of June 30, 2021 and for the period from August 4, 2020 (inception) to June 30, 2021, which report appears in this Offering Statement. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.

BDO Canada LLP

Vancouver, British Columbia

June 30, 2022

 

BDO Canada LLP, a Canadian limited liability partnership, is a member of BDO International Limited, a UK company limited by guarantee, and forms part of the international BDO network of independent member firms.


EX1A-12 OPN CNSL 5 exhibit12-1.htm EXHIBIT 12.1 Naqi Logix Inc.: Exhibit 12.1 - Filed by newsfilecorp.com

 

Osler, Hoskin & Harcourt LLP

Suite 1700, Guinness Tower

1055 West Hastings Street

Vancouver, British Columbia, Canada V6E 2E9

778.785.3000 MAIN

778.785.2745 FACSIMILE

     
Vancouver    
     
Toronto June 30, 2022  
     
Montréal    
  Naqi Logix Inc.  
Calgary 1000 - 355 Burrard Street  
  Vancouver, BC  
Ottawa V6E 2K3  
 

Canada

 
New York    
 

Dear Sirs/Mesdames:

Re: Naqi Logix Inc.

We have acted as Canadian counsel to Naqi Logix Inc. (the "Corporation"), a corporation governed by the Business Corporations Act (British Columbia), in connection with the offering circular on Form 1-A (the "Offering Statement") filed by the Corporation on the date hereof with the U.S. Securities and Exchange Commission (the "SEC") pursuant to Regulation A under the Securities Act of 1933, as amended (the "Securities Act"), for the offering and sale by the Corporation of up to 5,000,000 voting common shares of the Corporation (the "Securities").

We have examined the Offering Statement and all such corporate and public records, statutes and regulations and have made such investigations and have reviewed such other documents as we have deemed relevant and necessary and have considered such questions of law as we have considered relevant and necessary in order to give the opinion hereinafter set forth. As to various questions of fact material to such opinion which were not independently established, we have relied upon a certificate of an officer of the Corporation.

We are qualified to practice law in the Province of British Columbia and this opinion is rendered solely with respect to the Province of British Columbia and the federal laws of Canada applicable in the Province of British Columbia.

For the purposes of the opinions set forth below, we have assumed without independent investigation or verification by us that:

     
  (a) the Offering Statement and any amendments or supplements thereto (including post-effective amendments) will have been qualified by the order of the SEC and such qualification shall not have been terminated or rescinded;
     
  (b) the Securities will have the terms described in and will otherwise be issued as described in the Offering Statement;

 



   

    Page 2
     
  (c) all Securities will be issued and sold in compliance with applicable U.S. federal and state securities laws and in the manner specified in the Offering Statement;
     
  (d) there shall not have occurred any change in law affecting the validity of such Securities; and
     
  (e) neither the issuance and delivery of such Securities nor the compliance by the Corporation with the terms of such Securities will violate any applicable law or regulation or will result in a violation of any provision of any instrument or agreement then binding upon the Corporation, or any restriction imposed by any court or governmental body having jurisdiction over the Corporation.
     
 

We have also assumed (a) the legal capacity of all individuals, the genuineness of all signatures, the veracity of the information contained therein, the authenticity of all documents submitted to us as originals and the conformity to authentic or original documents of all documents submitted to us as certified, conformed, electronic, photostatic or facsimile copies, and (b) the completeness, truth and accuracy of all facts set forth in the official public records, certificates and documents supplied by public officials or otherwise conveyed to us by public officials.

On the basis of the foregoing and subject to the qualifications hereinafter expressed, we are of the opinion that when issued and sold in accordance with the terms and conditions contemplated by and upon the terms and conditions set forth in the Offering Statement and that certain subscription agreement, a form which is included in the Offering Statement as Exhibit 4.1, and upon receipt by the Corporation of the agreed upon consideration therefore, the Securities will be validly issued, fully paid and non-assessable.

We hereby consent to the filing of this opinion letter as an exhibit to the Offering Statement and to the use of our name wherever it appears in the Offering Statement and the offering circular contained therein. In giving this consent, we do not admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act.

   
  Yours very truly,
   
 
  Osler, Hoskin & Harcourt LLP


GRAPHIC 6 form1aax001.jpg begin 644 form1aax001.jpg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end GRAPHIC 7 form1aax002.jpg begin 644 form1aax002.jpg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form1aax003.jpg begin 644 form1aax003.jpg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end GRAPHIC 9 exhibit4-1x25x1.jpg begin 644 exhibit4-1x25x1.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# 0" P,# @0# P,$! 0$!0D&!04% M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_ MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86 M%A86%A86%A86%A86%A86%A86%A86%A;_P 1" 2 '@# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#ZN^/GQ7U3 MX<^(_"^F6OA2#6%\5Z@NFVDK:K]F,5PQX#KY3_)@CY@<]>*32_BY>I\3&^&_ MB;PG_8OBB\LI+S1$_M#[18:JJJQ*K<",,C#:"_;BOH1X[^%#+' M=2#2O%46H7WD6DLWV:V4@&5]BG"Y!]^*9XI3_A8_[6'@[Q]H=OJ:>$O!&F7, M^HZU<6DMK!)(P;;%%YBAI2.-V!@#O0!T?PU^-GC;QUX4UO7] ^&>GM#H-_<6 M%Q#-XE*RRS0J"RQJ+8[@=P"Y(R3TKO\ QEXY;P_\*E\7-H5U.,$XXKY?_9B?P?8Z'KOZUX@U/XG>./!MCHTZ^'+C3M-'B26+5=)>["3 MRQ^7#%C=&#(DMK<2-+#+I\UQN^SS MH2/+=PO<;6SMZ,.*Q/V=?C#J7Q2UCQ':OX2AT>#PS?-I]U+_ &K]H:2<$_<4 M1+\G!^8G/M7F'[,]Q@>"M8^)#^*'U#35UCQ/)=6#2Z3=$7$/S8=2L9XY M% 'K/[0GQLN_A1XHT2TOO!LFJ:1K$@5M0M+X^9:#S(XW9X?*.0#,FW#?,3C@ MXSM_'SQ_;> _"LFIRRB/[+"]]<$@96WBP6 !_BD8I$N>\GM7)Q^)=*\=?$#P MM)>VIMCJF@:H(+>YM9"$+7=LUJS[E 5V%OY@4X(*GTY\_P#VC=(UF']D[Q6V MNBZN]?U3[/IFG6J0O-+)%;W"$A54$\[7?/< '/-:PC'EF]@HX/(Z<%3UQ7 M)>)=;?Q/I?PV\#Z!JR:?)>00ZG<7MSITD\*&T5/+@>,E 6>89VE@1Y)..E<; MX!FUCX6?MN:Q9:S??VMIOCNQCFU"_L-*EAMK6^7)3S%!D$9(#<[\'S03BLCO M/0?A9\>7\3^*/&6G:[X]7^%6D> K"ZU#2[ :BMU/X@,,4UNS*%.!;L5?YURO('/)KRW] MG76/!7A3X9^#-5OM8\83^)](TYH!X=D2]:#SIAY?EK$\9CCQD*QHGB35_#DMUX76PL-7M+4^2]ZFS]RSR1LC*""2 03MX;M0![G\ M/BCI?Q4\*WFJ6&GW.G7.EW\FG:A9W#*YAGCQNVNO#ISPV!G!X%%>>?L-ZK9Z M-X5U+X>ZOX=N="\6:3J,[:N98IC'J\Q/S7DBBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9 end GRAPHIC 10 exhibit11-1xu001.jpg begin 644 exhibit11-1xu001.jpg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end GRAPHIC 11 exhibit11-1xu002.jpg begin 644 exhibit11-1xu002.jpg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end GRAPHIC 12 exhibit12-1xu002.jpg begin 644 exhibit12-1xu002.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #__@ [0U)%051/4CH@9V0M:G!E9R!V,2XP M("AU'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H MJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V M]_CY^O_$ !\! ,! 0$! 0$! 0$ ! @,$!08'" D*"__$ +41 (! M @0$ P0'!00$ $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P M%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_: P# M 0 "$0,1 #\ _5.BO(_VF_$VH^&/ .E/9:K-H-G?^(-,TW5-8MV"/964URB2 MR!S_ *O.0F_^'?G(QFO$[[Q%XNO=4\=>&_"'C.37- T+Q)I@L1J?B$VEQJ2/ M8R37FF0ZERY=6$4P))(&Y"P7D 'U4OC;2V\=OX0$DG]M)IJZJT?EG9]G:4Q M[NF=RGCK6]7PAXR^,&I)HVI^/_!;:G!>GX56C6]QK,JR7-HK:HT4MQ(_S!VC M3S)/,P5(C#?,#72W>J>.-.LI]+C\<&VTV_\ %'AJVM?[/\2_VQJ-K#!M.\<7HL)O%,6A^(]>DU*.3 M4+6-K2>ZA@EG&&BDF*VZ!R Q608)9PU8/B+7K"7XG6GA2Z^)6K:-X$LO"USJ M.GZQ!X@"27]ZE[)'<^9=$YE^RJL8V,Y^\=P;% 'U/17PQH?BWX@?$_1);[6_ M&/B'0+JQ^$5CXD^SZ7,++S=2:74 EVX"\;DA1C&?D.1D';QZK\%+WQ%IOQ6\ M)6FI>+=8\0P^)? ']O:A#J4P>(7RSVH,D$8 $*D7+KY:87 7C(R0#Z2HHHH M@O;*WU*SFM+NWBNK6=#'+!.@=)%(P593P01V-8S_ \\*R>'%\//X9T=M 5M MZZ4UA$;4-G=D1;=N<\YQUHHH TXM$TZ';Y=A:Q[;<6@VPJ,0CI$./N#^[TJC MI'@CP[X?L19:7H&EZ;9B<70M[2SCBC$PP1)M50-XP/FZ\"BB@">^\+:+J=OJ M4%YI%A=P:D5-]%/;(ZW150J^:",/A54#=G 4#M5:\\!>&=1TBQTF[\.Z3=:7 M8E6M+&:QB>"W*C"F-"NU,#I@#%%% &C+H]A/--+)96TDLT'V:1VB4L\/)\MC MCE?F;Y3QR?6G1:99P3Q3QVD$.1(U#)%D'8#CA<@<=.!110!:HHHH _ "_]D! end GRAPHIC 13 exhibit12-1xu005.jpg begin 644 exhibit12-1xu005.jpg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end GRAPHIC 14 exhibit12-1xu006.jpg begin 644 exhibit12-1xu006.jpg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end